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SUMMARY
The k inetics  and c e llu la r  ch arac te ris tics  o f immunosuppression 
in  (CBAxC57BL)Fl mice during graft-versus-host (GVH) reaction induced 
with spleen c e lls  from e ith e r  parental s tra in  have been investigated . 
Plaque forming ce ll (PFC) responses to a thymus-dependent antigen  
chicken red blood c e lls  (CRBC) and a thymus-independent antigen levan 
(LE) were suppressed to a comparable exten t. The unresponsive s ta te  
which developed in  GVH mice was expressed also by th e ir  spleen c e lls  
fo llow ing tra n s fe r in to  irra d ia te d  re c ip ien ts . GVH spleen c e lls  also  
suppressed the response o f normal spleen ce lls  in a mixed tra n s fe r  
system, but th is  e f fe c t  was lo s t completely by day 21 whereas the 
o rig in a l donors (or th e ir  c e lls )  remained re fra c to ry  a f te r  80 days.
This active  suppressor e f fe c t  was mediated by T ce lls  o f parental 
donor o r ig in , as demonstrated by c e ll fra c tio n a tio n  s tud ies, anti-Thy  
1.2 (e ) treatm ent and se lec tive  deletion  o f e ith e r  donor or host c e lls .  
No evidence fo r macrophage p a rtic ip a tio n  could be found from several 
in vivo or in vitro experiments. Indeed, the immune response o f normal 
c e lls  to dinitrophenylated levan (DNP-LE) was in h ib ite d  by GVH-T c e lls  
when both populations were depleted o f macrophages. Experiments in  
double Marbrook cultures which u t il iz e d  a cell-im perm eable membrane, 
demonstrated th a t suppression was mediated, a t le a s t p a r t ia l ly ,  by a 
soluble fa c to r.
Spleen c e lls  from (CBAxC57BL)Fl mice undergoing GVH reaction  
induced by C57BL c e lls  were depleted o f th e ir  FI component w ith a n t i-  
CBA alloantiserum . The suppressive a c t iv ity  o f the residual donor 
ce lls  was s t i l l  expressed against other FI c e lls  (AKR x C57BL) which 
were H-2 compatible with the o rig in a l host, but not against H-2 
incompatible c e lls  (DBA/lxC57BL)Fl. However, the la t t e r  were suppressed
in  the add itional presence o f (CBAxC57BL)Fl c e lls . Thus, in te ra c tio n  
o f donor T c e lls  w ith FI ta rg e t ce lls  containing H-2 antigens towards 
which they are sensitized  is  mandatory fo r  the subsequent m anifestation  
o f immunosuppressive a c t iv ity .  Suppressor T c e lls  were characterized  
with an ti-L y  and a n t i- la ^  sera and found to be Ly 1^2*3*Ia^ . From 
experiments in  which B c e lls  from GVH mice were supplemented w ith  
p u rifie d  normal T c e l ls ,  i t  is  concluded th a t 1) the ta rg e t fo r  sup­
pressor c e ll a c t iv ity  is  a B c e l l ,  although macrophages cannot be 
excluded and 2) suppression is  mediated by a revers ib le  a n t i­
p ro life ra t iv e  e f fe c t .
One or two in jec tio n s  o f azathioprine (approximately 200 mg/Kg) 
in to  FI rec ip ien ts  2 to 3 days a f te r  the induction o f le th a l GVH 
disease with C57BL parental c e lls  abrogated the subsequent m o rta lity .  
However, a delayed onset o f immunosuppression was observed in  some 
animals, in d ica tin g  th a t a residual 'low -grade' GVH reaction pers is ted . 
This outcome was mimicked by inducing GVH reactions with low numbers o f  
C57BL parental c e lls . S u rp ris in g ly , azathioprine was in e ffe c tiv e  in  
preventing m o rta lity  in  6 0 0 r-irra d ia te d  FI rec ip ien ts  which were under­
going GVH reaction . The delayed onset o f suppression in  GVH-mice 
treated  with azath ioprine was present when GVH reactions were induced 
with parental lymph node, but not w ith bone marrow c e lls . Since GVH- 
induced suppressor T c e lls  were not sen s itive  to treatm ent w ith  
azathioprine in vitro, i t  is  considered th a t th is  drug exerts an 
a n t i-p r o l ife r a t iv e  e ffe c t  on parental GVH-reactive T c e lls .
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LIST OF ABBREVIATIONS
FI -  mice derived from crossing two inbred parental s tra in s . 
GVH -  graft-versus-host
GVH mice -  FI mice in jected  with parental s tra in  lymphocytes.
GVH c e lls  -  spleen c e lls  from GVH mice
CRBC -  chicken red blood c e lls
SRBC -  sheep red blood c e lls
LE -  levan
DNP-LE -  d in itrophenylated  levan
PFC -  plaque-forming c e l l (s )
B -ce ll -  bone marrow derived (bursal equ iva len t) lymphocyte
T -c e ll -  thymus-derived lymphocyte
H-2 -  major h is to co m p atib ility  complex o f the mouse
PLN -  p o p litea l lymph node
MLR -  mixed lymphocyte reaction
i . v .  -  intravenously
i .p .  -  in tra p e rito n e a lly
PHA -  phytohaemagglutinin
LPS -  lipopolysaccharide
Con A -  concanavalin A
INTRODUCTION
The in je c tio n  o f allogeneic lymphoid c e lls  in to  an animal which 
is  immunologically incapable o f re jec tin g  them resu lts  in  a graft-versus- 
host (GVH) reaction which may develop in to  an overt wasting or runt 
disease (Simonsen 1957j Gillingham and Brent 1957). I t  has been 
established th a t an ongoing GVH reaction profoundly suppresses immune 
responsiveness o f the host in humoral antibody production (Howard and 
Woodruff 1961; Lawrence and Simonsen 1967; M ôller 1971), cell-m ediated  
immunity (Howard and Woodruff 1961; T re iber and Lapp 1973) or tumour 
immunity (S o ln ik , Gluckmann, Kavanah and Schwartz 1973). I t  is  known 
also th a t the ea rly  stages o f a llogeneic in te ra c tio n  can stim ulate the 
humoral immune response to thymus-dependent antigens (K atz, Paul, Goidl 
and Benacerraf 1971; Kreth and Williamson 1971). A GVH reaction  
induced by the in je c tio n  o f murine parental lymphocytes in to  an FI 
re c ip ie n t can both p o ten tia te  and in h ib it  the humoral immune response 
seq uentia lly  (to  the thymus-independent antigen S I I I )  -  the outcome 
depending so le ly  on the time in te rv a l between GVH induction and 
subsequent antigenic challenge (B y fie ld , C h ris tie  and Howard 1973).
On the basis o f c o n flic tin g  experimental resu lts  accumulated from 
murine models the suppressive stage o f the GVH reaction  has been 
a ttr ib u te d  to: (1 ) 'an tig en ic  com petition' mediated v ia  macrophages
(SjOberg 1972); (2) macrophage-derived soluble factors (Nelson 1973);
(3 ) T ce lls  (M ü lle r 1971); (4) T ce ll-induced changes in macrophages
(B y fie ld  et al, 1973); (5) a defic iency o f 'thymus c e ll products'
(Lapp, Wechsler and Kongshavn 1974).
A precise understanding o f the d e ta iled  c e llu la r  events which
operate in GVH-induced immunosuppression is  obviously d es irab le , 
p a r t ic u la r ly  in  view o f the severe complications th a t a rise  when 
patients su ffering  from immunodeficiency diseases are grafted  w ith  
histoincom patible bone marrow c e lls . The primary ob jec tive  o f th is
present study was to investiga te  the mechanism by which immuno­
suppression o f the g rafted  host ensues. The experiments to be 
described assessed the re la t iv e  contribution  to immunosuppression o f  
various defined lymphoid c e ll populations o f both donor and host o r ig in .  
The ch arac te ris tics  o f the suppressor c e ll were established and the 
therapeutic e ffe c ts  o f the immunosuppressive drug azathioprine (Imuran) 
on GVH reactions were also explored. In p a r t ic u la r , advantage was 
taken o f recently  developed fra c tio n a tio n  techniques and c e ll surface 
markers which are present on various subsets o f murine T c e lls .
For the convenience o f the reader, a b r ie f  review o f the main 
aspects o f GVH reactions w il l  be given f i r s t ,  followed by an analysis  
o f the mechanism of immunosuppression which ensues as one o f the 
m u ltip le  expressions o f GVH disease.
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LITERATURE REVIEW -  PART I
1. H is to ric a l
The o rig in a l concept o f g raft-versus-host (GVH) re a c t iv ity  was 
f i r s t  postulated by Simonsen in 1953 on the basis o f morphological 
observations on kidney a llo g ra fts  which were undergoing re je c tio n  
a f te r  transp lan tation  in dogs (Simonsen 1953, Dempster 1953). These 
workers noted a large number o f pyron inophilic  c e lls  w ith in  the renal 
cortex which they suggested were o f g ra ft  o r ig in . Although i t  is  now 
known th a t these pyron inophilic  ce lls  were o f host o rig in  (Simonsen 
1962), d ire c t evidence th a t g rafted  immunocompetent ce lls  would react 
against foreign host antigens was provided independently by the la te r  
experiments o f Simonsen (1957) and by Billingham  and Brent (1957).
These groups u t il iz e d  e ith e r  embryos or newborn animals as rec ip ien ts  
which were immunologically immature and thus incapable o f re je c tin g  
the g rafted  c e lls . Subsequently i t  was established th a t the essential 
requirements fo r  inducing GVH reactions were: 1) immunocompetent donor
c e lls ;  2) a host which was unable to re je c t  the grafted  c e l ls ,  but 
which contained antigens th a t were absent from the donor. There are 
a lte rn a tiv e  ways in  which th is  second c r ite r io n  may be met: 1) by 
using embryos or newborn animals as re c ip ie n ts , 2) by p re trea tin g  ad u lt 
hosts w ith ir ra d ia t io n  or drugs to render them immunologically 
unresponsive, or 3) by u t i l iz in g  FI hybrid re c ip ie n ts . In th is  la t t e r  
s itu a tio n , the FI hybrid is  unable to recognize grafted  parental c e lls  
as fo re ig n , whereas parental c e lls  w il l  react against the FI host since 
i t  contains antigens which are derived from the other parent.
In experimental animals systemic GVH reactions are usually induced 
by the intravenous or in trap erito n ea l in je c tio n  o f a suspension o f
immunocompetent lymphocytes. Since the in jec ted  c e lls  w il l  m igrate to
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d iffe re n t  areas o f the body, attempts have been made to confine g ra fted  
c e lls  to a p a rtic u la r  location  in  order to f a c i l i t a t e  the study o f
pathological changes. This local GVH reaction is  usually in it ia te d  by 
in je c tin g  lymphocytes in trad erm a lly , subcutaneously or under the kidney 
capsule (E lkins 1964; Warner 1964; Brent and Medawar 1966; Ford 1967). 
Another important experimental model the CAM-pock assay, developed by 
Burnet and Boyer (1961), consists o f dropping adu lt chicken lymphoid 
ce ll suspensions onto the ch o rio a llan to ic  membrane o f developing chick 
embryos. D iscrete pocks develop on the membrane and th e ir  number is  
re la ted  d ire c t ly  to the number o f lymphocytes dropped onto the membrane 
(Coppleson and Mi ch ie , 1965).
2. Pathological changes induced by GVH reaction
G raft-versus-host disease remains a major obstacle to the success­
fu l g ra ftin g  o f immunodeficient patients w ith a llogeneic immunocompetent 
c e lls . Consequently, e a r l ie r  work on th is  problem was d irected  towards 
an analysis o f the pathological changes which occur as a d ire c t re s u lt  
of GVH reaction . Their s e v e rity , in  terms o f les ions, is  extremely  
varied and determines a wide spectrum o f symptoms and signs which may 
culminate in death. In the parental FI mouse model, dramatic 
differences are evident in  the severity  o f GVH reactions between various 
genotypic s tra in s  o f mice. For example, the in je c tio n  o f 1 x 10® C57BL 
spleen ce lls  in to  (C57BLxCBA)Fl hybrid mice produces an acute reaction  
which resu lts  in  death a f te r  approximately 3-4 weeks. In con tras t, 
in je c tio n  o f the same number o f GBA spleen c e lls  causes only a chronic 
GVH reaction which is seldom le th a l.
A c h a ra c te ris tic  feature  o f severe GVH reactions in newborn 
animals is  th e ir  subsequent fa i lu r e  to increase th e ir  body weight; a 
condition which was ap tly  termed 'ru n t disease' in  the o r ig in a l work 
o f Billingham and Brent (1957). A loss in body weight and general 
d eterio ra tio n  o f health also occurs during acute GVH reactions in  
adu lt rec ip ien ts  and th is  may eventually  re s u lt in  death.
The exact cause o f death remains la rg e ly  unresolved, although i t  
seems l ik e ly  to re s u lt  from a combination o f pathological changes. In
th is  respect, depression o f m ito tic  a c t iv ity  (Cole and Rosen 1961), 
h yp ersu scep tib ility  to endotoxin (Howard 1961a) and poor immunological 
function (Howard and Woodruff 1961) may be p a r t ic u la r ly  im portant.
This la t t e r  point seems re levant since irra d ia te d  mice which were 
in jec ted  w ith immunocompetent a llogeneic c e lls  survived under germ- 
free  conditions (Jones, Wilson and Bealmear 1971; Loughman, Nordin 
and Bealmear 1973; Dauphinee and Nordin 1974), whereas ir ra d ia t io n  
chimaeras maintained under normal conditions in va riab ly  died. Hence, 
death may be a ttr ib u ta b le  to secondary in fec tions  by common pathogens 
although Cooper and Howard (1961) demonstrated th a t GVH mice survived  
in fe c tio n  w ith Diytocoocus 'pnenmoniae, but not w ith SdlmoneVla 
ty-phirrwœium.
The body organs o f most species which have been extensive ly  
examined undergo substantial macroscopic and/or h is to lo g ica l changes 
during systemic GVH reaction . In lymphoid organs and l iv e r ,  a marked 
p ro life ra t io n " o f lymphocytes or macrophages may be apparent, often  
accompanied by in tensive c e llu la r  in f i l t r a t io n .  The exact type and 
extent o f these pathological changes varies according to the species, 
but major m anifestations are as follow s:
a) Spleen
Enlargement o f the spleen (splenomegaly) is  a reproducible find ing  
in  the m ajority  o f species which have been investigated . I t  develops 
w ith in  a few days o f g ra ftin g , usually peaks between 7 and 10 days 
and then subsequently diminishes. The decline may progress to a s ta te  
o f atrophy in  acute reactions or splenomegaly may p e rs is t a t a reduced 
level fo r  long periods in  chronic reactions (Billingham  and Brent 1959). 
Frequently, the c e llu la r  a rch itec tu re  is  a lte re d  or even destroyed, 
with hyperplasia o f the germinal centres being a consistent fin d in g .
b) Lymph nodes
Enlargement o f the lymph nodes is  prominent in  ra ts  (B illingham , 
Brown, Defendi, S ilvers  and Steinm uller 1960), but th is  has been
observed more sporad ically  in other species. Generalised atrophy is  
a more common find ing  a t la te r  stages o f GVH reaction in  a l l  species. 
The c e llu la r  a rc h ite c tu re , in common w ith th a t o f the spleen, is  often  
disrupted as a re s u lt  o f extensive in f i l t r a t io n .
c) Thymus
Unlike spleen or lymph node, enlargement o f the thymus has not 
been reported, whereas there tends to be substantial atrophy.
d) L iver
Enlargement o f the l iv e r  has been reported frequently  although i t  
is  less extensive than th a t displayed by the spleen. Necrotic lesions  
have also been described in  several species (E lkins 1971). A sub­
s ta n tia l increase in  the number o f Kupffer c e lls  is  commonly observed.
e) Blood
Anaemia is in v a ria b ly  associated w ith la te r  stages o f systemic 
GVH reactions, p a r t ic u la r ly  in  the chicken (Simonsen 1962). A s ig n i f i ­
cant depression o f white c e lls  is  also evident (leukopenia).
f )  Skin
Involvement o f the skin shows a substantial in te r-spec ies  
v a ria tio n . Derm atitis is  a c lassica l symptom o f GVH disease in  man 
and is  f a i r ly  extensive in  ra ts . On the other hand, e x fo lia tio n  o f 
the skin in  mice is  much ra re r  and when present is  confined to an area 
immediately adjacent to the anus (Simonsen 1962). Thus, i t  is  obvious 
th a t the pathological lesions which have been described, together w ith  
lesser m anifestations reported in other organs such as lung, pancreas 
and g a s tro -in te s tin a l t r a c t ,  produce widespread symptoms in the 
re c ip ie n t, w ith perhaps the most extensive involvement d irected  towards 
lymphoid tissue .
3. Estimation o f GVH re a c tiv ity
Early assays fo r  estim ating GVH re a c tiv ity  re lie d  upon loss o f 
body weight or death. A considerably more sen s itive  assay was devised 
by Simonsen (1957) in  which splenomegaly was ascertained near the peak
o f enlargement (7-10 days). The increase in  spleen weight was 
expressed simply as a 'spleen in d e x ', i . e .  the spleen weight ra t io  o f 
experimental to lit te rm a te  control values. The in troduction o f the 
Simonsen assay perm itted comprehensive studies o f m ild or moderate 
GVH reactions in  which loss o f body weight was minimal and death did 
not occur.
Another assay system introduced by Howard (1961b) was based on 
the measurement o f the phagocytic clearance o f intravenously in jec ted  
c o llo id a l carbon from the bloodstream. This technique monitors hyper­
a c t iv ity  o f the re tic u lo -e n d o th e lia l system and possesses the advantage 
th a t repeated determinations may be performed without k i l l in g  the 
anim al.
More rece n tly , a lymph node weight assay was introduced to 
ascerta in  the GVH re a c tiv ity  o f ra t  c e lls  in a local GVH reaction  (Ford, 
Burr and Simonsen 1970) based on an o rig in a l observation o f Levine 
(1968). The method consists o f in je c tin g  immunocompetent a llogeneic  
c e lls  in to  the footpad o f ad u lt ra ts  and measuring the weight o f the 
p o p litea l node 7 days la te r .  The co n tra la te ra l node provides a b u i l t -  
in  con tro l. In p ra c tic e , th is  assay has proved less successful in  
mice since considerably more c e lls  are needed to induce a s ig n if ic a n t  
increase in  lymph node weight (Binz 1975).
4. Role o f h is to co m p atib ility  antigens in GVH reactions
In general, the severity  o f GVH reactions is governed by the 
degree o f d is p a rity  between h is to co m p atib ility  antigens o f host and 
donor. Thus, d ifferences between grafted  c e lls  and rec ip ien ts  a t the 
major h is to co m p atib ility  locus (H -2, AgB, B and HLA in the mouse, ra t ,  
chicken and man respective ly ) tend to produce more severe reactions  
than differences between minor lo c i.
Current knowledge o f the major h is to co m p atib ility  complex (MHO) 
has allowed a more d e ta iled  analysis o f the antigens which are involved  
in  s tim u la tio n . The a v a ila b i l i t y  o f congenic s tra in s  o f mice and the
FIGURE 1
Diagrammatic representation o f the major 
h is to co m p atib ility  complex (MHC) o f the mouse
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in troduction o f mixed lymphocyte reactions (MLR) by Bain, Vas and 
Lowenstein (1964) have been p a r t ic u la r ly  usefu l.
The MHC o f the mouse (F ig . 1) can be divided in to  a number o f 
d is t in c t  antigens which have been defined s e ro lo g ic a lly . The regions 
H-2K and H-2D stim ulate poorly in  terms o f p ro life ra t io n  as measured 
by MLR or GVH reactions, but serve as the prime ta rg e t fo r  cyto toxic  
k i l l e r  T c e lls . In con trast, H-2I d ifferences only, w h ils t providing  
exce llen t stim ulation  do not lead to s ig n ific a n t production o f cytoxic  
c e lls  (Bach, Bach and Sondel 1976). Antigens which are coded fo r  by 
the H-2I region and detectable s e ro lo g ica lly  on some lymphocytes are 
re ferred  to as I-reg io n  associated ( la )  antigens. When both H-2I ( la )  
and H-2K, H-2D antigens are presented sim ultaneously, an am p lifica tio n  
process occurs leading to the generation o f much higher numbers o f 
cytoxic T c e lls . This am plifying e f fe c t  is  probably due to the 
synergism which occurs between récognitive responder T c e lls ;  a po int 
th a t is  discussed in more d e ta il in the next section.
la  antigens are expressed predominantly on B c e lls  and macrophages 
(Sachs and Cone 1973; Hammerling, Deak, Mauve, Hammerling and McDevitt
1974), to a much lesser extent on T ce lls  (F re lin g e r, Niederhaber,
David and S h re ff le r  1974) and are absent from red blood c e lls .  This 
d is trib u tio n  corre lates with the observation th a t both B c e lls  and 
macrophages serve as good stim ulators in  MLR and GVH reactions, w h ils t  
T c e lls  are poor in th is  respect (S h re ff le r  and David, 1975).
5. C haracteris tics  o f the GVH-reactive donor ce ll
a) Factor o f immunization
Early experiments by Simonsen (1962) demonstrated th a t one funda­
mental d ifference between humoral immune responses and GVH reactions is  
the frequency o f occurrence o f an tigen -reactive  c e lls .  Whereas the 
leve l o f c e lls  reactive  to heterologous antigens lie s  in  the range o f 
approximately 1 per 1,000-10,000 (Humphrey and K e lle r  1970), the 
number o f lymphocytes which can react to major transp lan ta tion  antigens
is  3-4 orders o f magnitude higher and recen tly  th is  number has been 
estimated to be as high as 6% (Ford, Simmonds and Atkins 1975).
Simonsen and others established th a t the number o f GVH-reactive c e lls  
which are able to react against major h is to co m p atib ility  antigens 
cannot be expanded by p r io r  s e n s itiza tio n  (Lind and Szenburg 1961; 
Simonsen 1962) whereas they can be expanded by p r io r  s e n s itiza tio n  to 
minor alloantigens (Simonsen 1962; Warner and Szenburg 1964).
This high frequency prompted Simonsen to postulate th a t GVH- 
reac tive  c e lls  were m ulti po ten tia l -  an idea which contradicted the 
u n ip o te n tia l, clonal nature o f an tigen -reactive  c e lls  (Burnet 1959). 
However, i t  was suggested recently  th a t the GVH-reactive c e ll recog­
nizes a determinant w ith in  a 'mosaic' antigen structure  and therefore  
would also react against th is  same determinant when i t  was present in  
the mosaic structure  o f another a llogeneic s tra in  (Atkins and Ford 
1975; Wilson, Marshak and Howard 1976). Such a model would s t i l l  allow  
fo r  a high frequency o f s p e c ific  reac tive  c e lls  y e t cover the e n tire  
spectrum o f a llogeneic d is p a r it ie s ,
b) O rigin and d is tr ib u tio n
The f i r s t  unequivocal demonstration th a t small lymphocytes were 
responsible fo r  GVH re a c tiv ity  was reported by Gowans (1962) who used 
ra t  thoracic  duct lymphocytes, depleted o f large lymphocytes by over­
night incubation a t 37°C, as a source o f donor c e lls .  This was followed  
by evidence showing th a t ce ll suspensions derived from thymectomized 
mice were in e ffe c tiv e  in inducing GVH reactions (Good, Dalmasso,
M artinez, Archer, Pierce and Papermaster 1962; M il le r  and M itche ll 1967).
Peripheral blood lymphocytes, thoracic  duct lymphocytes, lymph 
node c e lls  and to a lesser extent spleen c e lls  are a l l  potent in it ia to r s  
o f GVH reactions, w h ils t thymocytes and bone marrow c e lls  are r e la t iv e ly  
poor (B illingham , Defendi, S ilvers  and S teinm uller 1962; Cantor and 
Asofsky 1970; S t r e i l in  and Billingham  1970; Dyminski and Argyris 1973).
I t  is  now accepted th a t GVH re a c t iv ity  is  associated exc lus ive ly  w ith
a T c e ll population. The poor re a c t iv ity  o f thymocytes is  ascribed  
to the immaturity o f c e lls  w ith in  the thymus cortex, since the small 
number (approximately 5%) o f mature co rtis o n e -res is ta n t c e lls  which 
reside predominantly in  the medulla are highly e ffe c tiv e  GVH inducers.
The proportion o f GVH-reactive T c e lls  which are present in  bone 
marrow seems to vary according to the species. For instance, when 
irra d ia te d  mice are repopulated w ith low numbers o f a llogeneic bone 
marrow c e lls ,  acute GVH reaction is  the exception ra th er than the ru le .
In contrast, canine and primate bone marrow are c le a r ly  r ic h e r in  c e lls  
which in i t ia t e  GVH reactions (Thomas, Storb, Epstein and Rudloph 1969;
Van Bekkum and Devries 1967).
c) Requirement fo r  m etabo lica lly  ac tive  donor c e lls
Donor T c e lls  must be m etabo lica lly  ac tive  to in i t ia t e  GVH 
reactions. For example, GVH reactions were abrogated when donor c e lls  
had been m etabo lica lly  in h ib ite d  w ith ir ra d ia t io n  or mitomycin C before 
tra n s fe r (Simonsen 1962; Brent and Medawar 1966; Lemmel and Good 1969; 
Longenecker, Law and Ruth 1969). I t  is  also known th a t th is  p re tre a t­
ment abolishes e n t ire ly  the a b i l i t y  o f c e lls  to respond in  MLR. However, 
recent reports have indicated th a t parental donor c e l ls ,  m ito t ic a lly  
in h ib ite d  w ith mitomycin C, could induce GVH reactions provided they 
were incubated with FI host c e lls  in vitro before in je c tio n  in to  FI 
rec ip ien ts  (L a ffe r ty , Walker, Scollay and K il l  by 1972; S co llay , Hofman 
and Globerson 1974). Although th is  find ing  awaits confirm ation, the 
authors suggested th a t the loss o f donor c e ll r e a c t iv ity  was due to an 
a lte ra tio n  in  th e ir  m igratory c h a ra c te ris tic s , thus precluding them 
from homing to areas where in te ra c tio n  w ith host c e lls  could occur.
Even though in  many cases the major part o f the GVH p r o life ra t iv e  
response is  o f host o rig in  (see section 6 ) ,  i t  seems highly u n lik e ly  
th a t recognition alone w ithout subsequent d iv is ion  could account fo r  
the in i t ia t io n  o f GVH reaction .
d) Synergism between GVH-reactive T c e lls
The f i r s t  demonstration th a t GVH-reactive T ce ll populations 
were heterogeneous was provided by experiments in  which mixtures o f 
c e lls  from thymus and lymph nodes or peripheral blood produced GVH 
reactions th a t were more severe than could be explained merely from 
the ad d itive  contribution  o f each population alone (Cantor, Asofsky 
and Talal 1970; Cantor, Mandell and Asofsky 1970). In la te r  exp eri­
ments these lymphocytes were characterized in  terms o f th e ir  longevity  
and re c irc u la tio n  patterns (Asofsky, Cantor and T ige laar 1971 ; Cantor 
and Asofsky 1972) and termed T1 and T2 lymphocytes. By means o f adu lt 
thymectomy and anti-lymphocyte serum (ALS) treatm ent i t  was established  
th a t T1 c e lls  re c irc u la te  slow ly, are s h o rt-liv e d  and in sen s itiv e  to 
ALS, whereas T2 lymphocytes re c irc u la te  ra p id ly , are lo n g -lived  and 
are elim inated by ALS treatm ent (Simpson and Cantor 1975). I t  is  
considered generally  th a t T2 ce lls  provide an am p lifica tio n  mechanism 
fo r the d if fe re n t ia t io n  o f T1 GVH precursor c e lls  in  much the same 
way as helper T c e lls  co llaborate  w ith B c e lls  in  antibody responses 
(Claman, Chaperone and T r ip le t t  1966).
More rece n tly , the mouse d if fe re n t ia t io n  antigen Ly (Boyse, 
Myazawa, Aoki and Old 1968) has been applied to the d e lin eatio n  o f T 
c e ll subsets. Each Ly system comprises a genetic locus (Ly 1 on 
chromosome 19; Ly 2 and Ly 3 which are c losely linked on chromosome 6) 
expressing two a lte rn a tiv e  a lle le s  and each a l le le  specifies  an a l t e r ­
native a lloantigen  denoted 1 and 2. Thus, the Ly 1 a lle le s  specify  
alloantigens Ly 1.1 and Ly 1 .2  and a l l  inbred mice express one or 
other on th e ir  thymocytes (Cantor and Boyse 1975). A s im ila r  s itu a tio n  
exis ts  fo r  Ly 2 and Ly 3. According to a recent report (Huber, Cantor 
Shen and Boyse 1976), Ly 1^2*3* c e lls  comprise the T1 population whereas 
Ly 1^2 3 and Ly 1 2^3* c e lls  are contained w ith in  the T2 subset.
These authors also favour the view th a t Ly 1^2 3 or Ly 1 2^3* c e lls  
arise  v ia  a d iffe re n t ia t io n  process from a common Ly 1^2^3^  ^ precursor.
Treatment w ith an ti-L y  an ti sera established th a t helper c e lls  
were Ly 1^, whereas cytotoxic  k i l l e r  T c e lls  and th e ir  progenitors  
were Ly 2^3^ (Cantor and Boyse 1975; Shiku, K isielow , Beam, Takahashi, 
Boyse, Oettgen and Old 1975). Further heterogeneity o f T c e ll populations 
is  evident in recent experiments in  which the Ly phenotype o f k i l l e r  
ce lls  was determined in CBA ra ther than C57BL mice and i t  was found 
th a t CBA k i l l e r  T c e lls  were Ly 1^2^3^ (Beverley, Woody, Dunkley,
Feldmann and McKenzie 1976). These authors also demonstrated th a t  
k i l l e r  c e lls  could be discrim inated from suppressor c e lls  on the basis 
th a t the former were la" whereas the la t t e r  were la^ .
e) The fa te  o f GVH-reactive c e lls
One o f the more curious aspects o f GVH reactions across major 
h is to co m p atib ility  barrie rs  is  the apparent lim ita t io n  o f clonal expan­
sion which is  usually associated w ith immunogenic s tim u la tio n . On 
cursory examination, i t  might be assumed th a t parental lymphocytes when 
in jected  in to  FI rec ip ien ts  would undergo p ro life ra t io n  and expand 
considerably. However, in  chronic GVH s itu a tio n s , d iv id ing  c e lls  o f  
donor o r ig in , a f te r  an in i t i a l  burst o f m ito tic  a c t iv i ty ,  usually f a l l  
to a very low or even undetectable le v e l. Furthermore, attempts to 
s e r ia l ly  passage GVH-reactive c e lls  through successive hosts demonstrated 
th a t th is  was only possible fo r one or two transfers  a t the most 
(Simonsen 1962).
E a r lie r  claims fo r  successful s e ria l passage o f chicken GVH- 
reac tive  c e lls  through embryos (Simonsen 1957) are now considered to 
have been due to immunocompetent c e lls  derived from the f i r s t  host which 
arose as a re s u lt o f immunological maturation in subsequent re c ip ie n ts .
The eventual apparent disappearance o f GVH-reactive c e l ls ,  
p a rt ic u la r ly  noticeable when small numbers o f donor c e lls  are g ra fte d , 
is  not fu l ly  understood, but possible explanations include the 
fo llow ing:
1) Lxnaustion or nost antigenic ta rg e t c e iis
Since host ta rg e t c e lls  are subject to immunological a ttack by 
s p e c ific  e ffe c to r  c e lls  o f donor o r ig in , i t  has been postulated th a t  
th e ir  number could gradually decrease, producing a s itu a tio n  in  which 
there were in s u ff ic ie n t  ava ilab le  to continue stim ulation  o f a GVH 
reaction (Howard 1963; S t r e i l in  1972). However, there are recent 
examples o f instances where the decreased level o f host lymphoid c e lls  
was too small to substantiate such an exhaustion theory (S o ln ik , 
Gleichmann, Kavanah and Schwartz 1973).
i i ) Hybrid resistance
Cudkowicz (1967) o r ig in a lly  argued th a t some undefined recog­
n itio n  o f parental c e lls  by FI host c e lls  lim ite d  the magnitude o f GVH 
reactions. D irect support fo r  th is  view comes from more recent observa­
tions which demonstrated the existence o f a n ti-rece p to r antibody (Ramseier 
and Lindenmann 1971). These authors discovered th a t when low numbers o f 
parental c e lls  were in jec ted  in to  FI rec ip ien ts  an antibody was produced 
directed against the recognition structure  on parental lymphocytes 
which recognized FI c e lls . Furthermore, a n ti-rece p to r antibody was 
shown to in h ib it  GVH reactions (B inz, Lindemann and W igzell 1973; Binz
1975).
On the other hand, a n ti-rece p to r antibody has only been demon­
strated  in  a lim ite d  number o f s tra in  combinations. Furthermore, the 
onset o f generalized immunosuppression which accompanies GVH reactions  
(see l i te r a tu r e  review Part I I )  would tend to argue against th is  
mechanism in the recovery from GVH disease.
i i i )  Blocking antibody
Since antibody against host antigens is  known to be produced by 
the B c e ll component o f donor ce ll g ra fts , i t  has been envisaged th a t  
th is  may mask host antigenic determinants and preclude th e ir  recogni­
tio n  by (and subsequent in te ra c tio n  w ith ) donor T ce lls  (Schlesinger 
and G oitein 1965; Vo is in , Kinsky and M a illa rd  1968). However, i t  is
not established conclusively whether such antibody plays a causal 
ro le  in  the spontaneous term ination o f GVH disease or is  merely a by­
product. The fa c t th a t GVH reactions induced w ith B c e ll-d e p le ted  
lymphocytes are also subject to donor c e ll senescence, im plies th a t  
donor-derived antibody does not play a regulatory ro le  in  th is  
instance.
iv )  Acquisition o f tolerance
The idea th a t grafted  c e lls  may become to le ra n t o f host antigens 
is supported by experimental data demonstrating tolerance in  donor 
ce ll populations a f te r  repopulation o f irra d ia te d  FI mice w ith parental 
bone marrow (M ichie, Zeiss and Woodruff 1961; Van Bekkum 1963).
Proponents o f th is  idea argue th a t i t  is  possible to detect r e a c t iv ity  
to th ird  party a lloantigens in  hosts which have survived a GVH reaction  
despite the absence o f re a c t iv ity  to i n i t i a l  ta rg e t antigens (Atkins  
and Ford 1972). However, murine bone marrow is  a p a r t ic u la r ly  poor 
source o f GVH-reactive ce lls  (E lkins 1971) and ra th er d if fe re n t  
resu lts  are obtained when g ra fts  contain mature GVH-reactive T c e lls  
(Grebe and S tre ile in  1976).
v) Suppressor c e lls
The discovery o f suppressor T c e lls  (Gershon and Kondo 1970) has 
provided a highly a ttra c tiv e  a lte rn a tiv e  explanation fo r  spontaneous 
recovery from GVH reactions. Since s p e c ific  antigen-induced  
(Kontiainen and Feldmann 1973) and non-specific  concanavalin A-induced 
(Dutton 1972) suppressor T c e lls  are known to regulate the antibody  
response to heterologous antigens, i t  is  conceivable th a t they might 
function in a s im ila r  manner during the antigen-induced p ro life ra t io n  
which ensues during a GVH reaction .
I t  is  known th a t suppressor c e lls  which are capable o f in h ib it in g  
MLR or GVH reactions are detectable in  normal or sensitized  lymphoid 
ce ll populations (Gershon and Leibhaber 1972; Hardin, Chused and 
Steinberg 1973; Rich and Pierce 1973; Rich and Rich 1974). Contradictory
properties have been ascribed to these suppressor c e lls . In one study 
i t  was concluded th a t 1) they must be syngeneic with respect to the 
donor, 2) they are blocked by mitomycin C and 3) exposure to antigen  
is  not required (Blomgren and Jacobsson 1974a, 1974b). However, other 
studies have ind icated th a t 1) suppressor c e lls  may be syngeneic with  
the re c ip ie n t as well as the donor (Gershon, Gohen, Hencin and Leibhaber 
1972), 2) mitomycin C does not block th e ir  suppressive a c t iv ity  (Folch 
and Waksman 1974) and 3) pre-exposure to antigen is  necessary fo r  
th e ir  development (Rich and Rich 1974).
Consequently, although suppressor T c e lls  have been shown to be 
im plicated in GVH reactions, fu rth e r d e f in it iv e  studies are required  
before th e ir  exact ro le  and mechanism o f action can be defined. 
Suppressor c e lls  which are induced as a d ire c t consequence o f ongoing 
GVH reactions w il l  be discussed f u l ly  in  Part I I  o f th is  l i te r a tu r e  
review.
f )  Activated T c e lls
An experimental model o f T ce ll a c tiv a tio n  by transp lan tation  
antigens (Sprent 1976; Sprent and M il le r  1976a,1976b) provides a 
considerable amount o f inform ation on the d is trib u tio n  c h a ra c te ris tics  
and longevity o f GVH-reactive c e lls  fo llow ing allogeneic a c tiv a tio n . 
These authors demonstrated th a t thoracic  duct c e lls  from irra d ia te d  FI 
mice in jec ted  4 days previously w ith parental thymocytes contained a 
high proportion o f T blasts o f parental o r ig in . These ac tiva ted  T 
c e lls  were ra d io lab e lle d , transferred  to secondary irra d ia te d  syngeneic 
rec ip ien ts  and th e ir  subsequent fa te  determined.
I t  was shown th a t 1) a high proportion o f the tran sferred  c e lls  
homed to the small in te s tin e , 2) the m ajority  survived fo r  only 1-2  
weeks and were therefore  re la t iv e ly  sh o rt-lived , 3) a small proportion  
o f the m inority which remained in  the re c irc u la tin g  lymphocyte pool 
underwent fu rth e r d iv is ion  a t some stage and rejo ined the re c irc u la tin g  
pool in  expanded numbers, 4) the in a b i l i ty  o f activated  T c e lls  to
evoke normal MLR and GVH reactions was reversed a f te r  they had resided  
in  secondary syngeneic rec ip ien ts  fo r  4-6 weeks.
6. Host p a rtic ip a tio n  in  GVH reactions
One fa c e t o f p a r t ic u la r  importance in GVH reactions concerns the 
re la t iv e  proportions o f donor and host ce ll p ro life ra t io n . Shortly  
a fte r  the concept o f GVH re a c tiv ity  was va lidated  i t  was noted th a t  
in  many instances the major part o f the p ro life ra t iv e  response was 
confined to c e lls  o f host o rig in  (Biggs and Payne 1959; Howard, Michie 
and Simonsen 1961; Fox 1962; Zeiss and Fox 1963). This p r o life ra t iv e  
response by the host has been confirmed subsequently in  several 
d iffe re n t  models (E lkins 1966; Nakic and Kastelan 1967; N isbe tt and 
Simonsen 1967; Longenecker, Sheridan, Law and Ruth 1970; Weber 1970).
Host p ro life ra t io n  is  not essential fo r  the development o f GVH 
disease since 1) sublethal ir ra d ia t io n , w h ils t abrogating host c e ll 
d iv is io n , tends to increase the severity  o f the disease, 2) l i t t l e  
host c e ll p ro life ra t io n  is  evident in certa in  genotypic combinations, 
e .g . C57BL->(CBAxC57BL)Fl (Fox 1962). However, host c e ll p ro life ra t io n  
does appear to account fo r  the major part o f the increased c e ll numbers 
in  most s tra in  combinations. This is  true fo r  both systemic (spleno­
megaly) and local (p o p lite a l lymph node enlargement) GVH reactions, 
although exceptions have been reported (E lk ins 1970).
In te re s tin g ly , a recent study in  rats  has indicated th a t the 
m ajority  o f host ce ll d iv is io n  which occurs in  the p o p litea l lymph 
node during a local GVH reaction is  o f B c e ll o r ig in  (Rolstad 1976). 
This conclusion was based on the observations th a t node enlargement 
was not reduced in T ce ll-d e p le ted  rec ip ien ts  and the node was com­
prised o f a t le a s t 90% host c e lls  as evaluated w ith s p e c ific  cyto toxic  
an tisera .
7. Refractoriness o f GVH survivors to fu r th e r  GVH reaction
A c h a ra c te ris tic  feature  o f mice (Fox and Howard 1963), ra ts  
(F ie ld  and Gibbs 1966) and hamsters (S t r e i l in  1972) which have
recovered from an in i t i a l  GVH reac tion , is  th e ir  subsequent lack o f 
s u s c e p tib ility  to a second GVH reac tion . From a (C57BLxCBA)Fl mouse 
model, Howard (1963) suggested th a t a second in je c tio n  o f C57BL spleen 
c e lls  might f a i l  to induce a GVH reaction in FI rec ip ien ts  which had 
received a p rio r in je c tio n  o f C57BL parental c e l ls ,  because c e lls  
in jec ted  fo r  the second time homed to areas devoid o f FI s tim u lator  
c e lls . This view o f 'host antigen exhaustion' was also shared by 
S tr e i l in  (1972) who demonstrated th a t an in je c tio n  o f FI lymphocytes 
in to  GVH survivors sometimes reactivated  the disease. In te re s tin g ly ,  
Howard (1963) discovered th a t re fractoriness  was also evident in  FI 
survivors o f C57BL-induced GVH reac tio n , when CBA ra ther than C57BL 
parental c e lls  were used fo r  the second in je c tio n  and he suggested 
th a t th is  was caused by CBA c e lls  s e tt lin g  in  lymphoid s ite s  which 
were la rg e ly  repopulated with C57BL ce lls  which were demonstrably 
immune to the CBA a llo an tig en .
In con trast. F ie ld  and Gibbs (1966) postulated th a t re frac to rin ess  
was a ttr ib u ta b le  to the existence o f c irc u la tin g  antibody which in te r ­
fered with the recognition o f host c e lls  by GVH-reactive donor c e lls .
In view o f much more recent fin d in g s , the phenomenon o f acquired  
re fractoriness  now requires re -eva luatio n  taking in to  account a n t i­
receptor antibody and suppressor T c e lls . Whatever the mechanism by 
which a fu rth e r GVH reaction is  in h ib ite d , i t  is  c le a r ly  in d ic a tiv e  
o f p rio r exposure to parental c e lls . A very recent report (Shearer, 
Garberino and Cudkowicz 1976) has demonstrated th a t FI spleen c e lls  
are able to mount a cytotoxic response against irra d ia te d  parental 
c e lls  in vitro. Although the k ine tics  o f e ffe c to r  ce ll production were
s im ila r  to those o f a n ti-a llo a n tig e n  responses, the magnitude was 
considerably lower. However, there does appear to be a p o s itive
co rre la tio n  between the in vitro assay and the a b i l i t y  o f ir ra d ia te d  
FI rec ip ien ts  to 'r e je c t '  parental haemopoietic g ra fts .
8. Prevention o f GVH re a c tiv ity
A major aim o f many investigators  has been to devise methods o f
e lim inating  GVH-reactive ce lls  from lymphoid populations to avoid the
/■
GVH disease which in v a ria b ly  develops fo llo w in g /g ra ftin g  o f a llogeneic  
immunocompetent c e lls . The approaches_wsd3have included s p e c ific  
depletion by antigen-binding, non-specific  depletion by physical means 
or w ith a n ti-T  c e ll sera and the prevention or attenuation o f GVH 
disease by chemotherapy,
a) S p ecific  depletion
Following the demonstration th a t i t  is  possible s e le c tiv e ly  to 
deplete lymphoid suspensions o f an tigen -reactive  B c e lls  v ia  antigen- 
coated columns (W igzell and Andersson 1969), a s im ila r  approach was 
applied to the se lec tive  removal o f s p e c ific  GVH-reactive I  c e lls .  
Attempts made to deplete ce ll suspensions o f GVH-reactive lymphocytes 
in vitro have produced controversial re s u lts . For instance, i t  was 
claimed by some investigators  th a t GVH-reactive T c e lls  could be 
absorbed onto ta rg e t c e ll monolayers (Lonai, E lv ia rz , Wekerle and 
Feldman 1973; Bonavida and Kedar 1974). However, negative resu lts  
were obtained by other groups (W igzell 1970; Mage and McHugh 1973).
At present, i t  appears th a t the e f f ic ie n t  depletion o f GVH-reactive 
lymphocytes from c e ll suspensions in vitro is  d i f f i c u l t  to achieve.
In con trast, cytotoxic e ffe c to r  I  c e lls  can be re a d ily  depleted by 
these same procedures.
On the other hand, the e f f ic ie n t  depletion o f GVH-reactive c e lls  
has been accomplished in vivo. Ford and Atkins (1971) showed th a t when 
parental lymphocytes were in jected  in to  FI re c ip ie n ts , th e ir  thorac ic  
duct lymphocytes,when collected  24-48 hours la te r ,  were d e fic ie n t in  
s p e c ific  GVH-reactive ce lls  as evaluated in secondary syngeneic FI 
re c ip ien ts . However, these ' f i l t e r e d '  c e lls  s t i l l  reta ined normal 
a c t iv ity  against th ird  party a llo an tigen s. Atkins and Ford (1975) also 
demonstrated more recently  th a t the m ajority  o f these s p e c ific  GVH-
reactive  c e lls  were sequestered in  the spleen,
b) Non-specific depletion
Further approaches designed to control GVH disease have re lie d  
upon the depletion from ce ll suspensions o f e ith e r  the e n tire  T lympho­
cyte population or sub-populations by means o f density gradient 
fra c tio n a tio n  (M il le r  and Osoba 1967; Gillingham 1968; P h illip s  and 
M ille r  1970; Dicke and Van Bekkum 1971; Argyris 1974; Mandel and 
Asofsky 1974). Although such approaches were re la t iv e ly  successful 
in  mice, complications have arisen from residual GVH re a c tiv ity  in  
both canine and human s itu a tio n s , presumably due to the higher 
incidence o f GVH-reactive c e lls  or th e ir  precursors in the bone marrow 
o f these species.
Anti-lymphocyte serum (ALS) and anti-thym ocyte g lobulin  (ATG) 
have been used extensively  e ith e r  to p re tre a t donor lymphocytes before 
g ra ftin g  or to t re a t  rec ip ien ts  a f te r  g ra ftin g . In the la t t e r  
s itu a tio n  ALS provides the add itional b e n e fit o f suppressing g ra ft  
re je c tio n . The resu lts  which have been obtained w ith ALS or ATG remain 
equivocal, which may be re la te d  to major d ifferences between ind iv idu al 
batches o f a n tis e ra , fo r  both the source o f c e lls  and the species in  
which ALS is  raised are known to a ffe c t  i t s  a c t iv ity  (Darrow,
LaFontaine, Smith, M artin , Sell and Keyhoe 1971). An add itional problem 
is  th a t the precise ta rg e t o f ALS is  unknown, although attempts to  
increase i ts  s p e c if ic ity  by absorption have been p a r t ia l ly  successful 
(T ren tin  and Judd 1973). In one recent study in chickens, fo r  which 
s p e c ific  anti-thymus serum (ATS) is  a v a ila b le , i t  was shown th a t ATS 
treatm ent o f bone marrow ce lls  p rio r to g ra ftin g  abrogated e a rly  GVH 
symptoms (splenomegaly) but only p a r t ia l ly  a lle v ia te d  subsequent death 
(Lydyard and Ivanyi 1975). These authors suggested th a t since th e ir  
ATS was non-toxic, as assessed by pretreatm ent o f syngeneic bone marrow, 
the la te r  onset o f death was a ttr ib u ta b le  to maturation in  the host 
o f GVH-reactive T ce ll precursors.
c) Drug-induced a lte ra tio n  o f GVH reactions
Various pharmacological agents have been used e ith e r  to p re tre a t  
donors or t re a t  rec ip ien ts  a f te r  g ra ftin g . Donor pretreatm ent w ith  
the a lk y la tin g  agent cyclophosphamide produced a lim ite d  degree o f  
success in  ab lating  GVH disease and surviving mice were shown to be 
chimaeric (Owens and Santos 1971). Cyclophosphamide appeared to be 
p a rt ic u la r ly  e ffe c tiv e  when administered to donors who were under­
going s e n s itiza tio n  to the a lloantigens o f the prospective re c ip ie n t  
(Fink and Cloud 1974). This increased e ffic ie n c y  was probably due to  
the greater s e n s it iv ity  to the drug o f donor T c e lls  which were 
activated  by exposure to re c ip ie n t a llo an tigen s.
The therapeutic app lication  o f cytotoxic or cy to s ta tic  drugs 
administered to rec ip ien ts  before or a f te r  g ra ftin g  o ffe rs  an a ttra c ­
t iv e  method fo r  c o n tro llin g  GVH disease. Drugs which have been used 
with variab le  degrees o f success include: methotrexate, 6-mercaptopurine, 
mitomycin C, le c tin s  and azathioprine (Imuran) an analogue o f  
6-mercaptopurine. The ra tio n a le  fo r  such treatments is  to in h ib it  
GVH-reactive T c e lls  w h ils t allowing other c e lls  to p ro life ra te  and 
estab lish  chimaerism. Azathioprine in p a r t ic u la r  has been u t i l iz e d  
c l in ic a l ly  fo r  many years as an immunosuppressive agent to control 
homograft re jec tio n  in  man and i t  appears th a t human T c e lls  are 
esp ec ia lly  sen s itive  to th is  drug. Although azathioprine has received  
considerable a tten tio n  in  human kidney transp lan tation  i ts  e f fe c t iv e ­
ness in  modulating GVH disease remains equivocal.
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LITERATURE REVIEW -  PART I I
Immunosuppression induced by the GVH reaction
1. H is to ric a l
I t  has been known fo r  20 years (Main and Prehn 1957) th a t the 
a b i l i t y  o f irra d ia te d  mice repopulated with allogeneic bone marrow 
ce lls  to re je c t  histoincom patible skin g ra fts  is  severely impaired 
when compared w ith irra d ia te d  rec ip ien ts  o f syngeneic bone marrow 
c e lls . However, since ir ra d ia t io n  alone abrogates immune responsive­
ness and the recovery o f immunocompetence a f te r  syngeneic bone marrow 
grafts  is ra ther v a ria b le , i t  was not possible to conclude whether 
GVH reactions in  the absence o f ir ra d ia t io n  were immunosuppressive.
The la t t e r  was f i r s t  demonstrated by Howard and Woodruff (1961) 
u t i l iz in g  a parentaT+unirradiated FI system. They showed th a t some 
(C57BLxCBA)Fl rec ip ien ts  o f C57BL parental spleen c e lls  developed a 
reduced capacity to re je c t  th ird  party s tra in  A skin g ra fts  and in  
addition were d e fic ie n t in producing antibody to Salmonella typhi H 
antigen as assessed by ag g lu tin a tio n . In te re s tin g ly , they were unable 
to demonstrate s ig n ific a n t immunosuppression with equ ivalent numbers 
of CBA parental c e lls  and concluded th a t suppression was associated  
p re fe re n tia lly  w ith severe GVH reactions as exem plified by the C57BL» 
(C57BLxCBA)Fl mouse model. These experiments provided c le a r evidence 
th a t both antibody production and cell-m ediated  immunity were a ffe c te d .
In an extensive series o f experiments performed several years 
la te r ,  Lawrence and Simonsen (1967) analysed the e ffe c t  o f the 's tren g th ' 
o f h is to co m p atib ility  antigens in  re la tio n  to the subsequent leve l o f 
suppression induced against sheep red blood c e lls . They e f fe c t iv e ly  
demonstrated a d ire c t re la tio n sh ip  between strong h is to co m p atib ility  
d is p a ritie s  and subsequent leve ls  o f suppression and postulated th a t  
the GVH model was a c lassica l case o f 'an tig en ic  com petition' as
defined by Michael is  (1904). These experiments only examined the 
immunopotential o f donor lymphocytes, since irra d ia te d  FI hosts were 
used as re c ip ie n ts , thus barring host lymphocytes from p a r t ic ip a tin g .  
However, s im ila r  leve ls  o f suppression to SRBC were observed when GVH 
reactions were induced in un irrad ia ted  FI re c ip ie n ts , thereby 
demonstrating th a t FI host lymphocytes were also in h ib ite d  (M ü ller
1971).
Although the vast m ajority  o f work on GVH-induced immunosuppression 
has been confined to mice, i t  has been reported in both rabbits  (Vrubel 
1961) and chickens (Lydyard and Ivanyi 1975). The e ffe c t  o f GVH 
disease on immunological function in  man is  more d i f f i c u l t  to e luc idate  
since a llo g ra fts  are in v a riab ly  accompanied by the adm inistration o f 
immunosuppressive drugs. A considerable degree o f heterogeneity in  
the magnitude o f suppression is  evident from reports in the l i t e r a tu r e .  
This may well be re la ted  to the various protocols used fo r  GVH induc­
t io n . Most o f the experiments which ind icate  th a t immunosuppression 
is  not in v a ria b ly  associated with an ongoing GVH reaction can be
discounted on the grounds th a t GVH reactions were in it ia te d  w ith
m ultip le  in jec tio n s  o f low numbers o f donor c e lls  -  a protocol known 
to provoke re fractoriness  ( L i t .  Review Part I ,  7 ) .
GVH reactions have also been investigated  fo r  th e ir  e f fe c t  on 
tumour growth. Several experiments have provided evidence fo r  both 
enhancement (S o ln ik , Gleichmann, Kavanah and Schwartz 1973; Okubo, 
Oettgen, Caiazza and Ovary 1974) and in h ib it io n  (Carnaud, Markowicz 
and Tra in in  1974; Ptak, Hanczakowska and Skowron-Cendrzak 1975;
Bomford, Shand and C h ris tie  1975). These contradictory resu lts  w il l  
be discussed more fu l ly  in  Section 4.
2. Suppression o f antibody responses by GVH reaction
Following the o rig in a l observation o f Howard and Woodruff (1961 ), 
animals undergoing GVH reaction have been tested fo r  immunocompetence 
with a v a rie ty  o f antigens. G enerally , there is  broad agreement th a t
responses to thymus-dependent antigens are severely in h ib ite d  in mice 
which are grafted  w ith immunocompetent lymphocytes d iffe r in g  a t the 
H-2 locus providing th a t 1) GVH reactions are induced w ith a r e la t iv e ly  
high number o f allogeneic c e lls  and 2) antigen challenge is  given 
several days la te r .
The question as to whether responses to thymus-independent 
antigens are suppressed to the same extent as those to thymus-dependent 
antigens is  con trovers ia l. The response to lipopolysaccharide (LPS) 
in mice undergoing GVH reaction was reported as e ith e r  normal (Solnick  
et dl. 1973) or suppressed (M ü ller 1971; Sjoberg 1972). In te re s tin g ly ,  
i t  was reported th a t although the immune response o f GVH mice to LPS 
was suppressed a f te r  a s ingle challenge, m u ltip le  in jec tio n s  o f the 
same antigen produced a near normal response (T re ib er and Lapp 1976). 
Responses against two other thymus-independent antigens (pneumococcal 
polysaccharide type 3 ( S I I I )  and levan) were shown to be suppressed 
in GVH mice (B y fie ld , C h ris tie  and Howard 1973). In con trast, the 
in vitro response o f spleen c e lls  from GVH mice to DNP-LPS was normal, 
whereas the anti-SRBC response was suppressed in p a ra lle l cultures  
(McMaster and Levy 1975). One c r itic is m  which can be le v e lle d  a t  
these la t t e r  experiments concerns the protocol o f GVH induction; four  
weekly in trap erito n ea l in jec tio n s  o f donor c e lls .
3. Suppression o f cell-m ediated immunity by GVH reaction
The survival o f ‘ th ird  party ' skin a llo g ra fts  on mice in je c te d  
previously w ith a llogeneic lymphocytes is  s ig n if ic a n tly  prolonged 
when compared to rec ip ien ts  o f syngeneic lymphocytes (Howard and Woodruff 
1961; Lapp and M üller 1969; T re iber and Lapp 1973). I t  was postulated  
(T re ib er and Lapp 1976) th a t the suppression o f cell-m ediated immunity 
was less intense than th a t o f humoral immune responses. This was 
based on the observation th a t p re -s e n s itiza tio n  o f GVH mice to antigens 
o f the 'th ir d  party ' skin donor abrogated suppression and skin g ra fts  
were re jected  w ith in  normal times. I t  was also demonstrated th a t
whereas p re -s e n s itiza tio n  o f GVH mice to SRBC abrogated the suppression 
o f delayed h yp ersen s itiv ity  responses to SRBC, humoral responses to 
th is  same antigen remained suppressed.
Other T c e ll functions which have been investigated in  GVH mice 
include: 1) s tim ulation  by the T ce ll mitogens phytohaemaggTutinnin 
(PHA) and concanavalin A (Con A) and 2) generation o f s p e c ific  
cytotoxic e ffe c to r  c e lls  by the in je c tio n  o f ce lls  from germ-free  
allogeneic rad ia tio n  chimaeras in to  histoincom patible re c ip ie n ts .
The mitogenic responses to PHA and Con A were found to be suppressed 
in  GVH mice (R otter and Tra in in  1975; McMaster and Levy 1975), w h ils t  
lymphocytes from allogeneic or syngeneic chimaeras were equally e ffe c ­
t iv e  in  giving r is e  to cytotoxic e ffe c to r  c e lls  a f te r  tra n s fe r  to  
' th ir d  party ' irra d ia te d  rec ip ien ts  (Dauphinee and Nordin 1974).
4. E ffe c t o f GVH reaction on tumour growth
Both enhancement (Okubo et al. 1974) and in h ib it io n  (Carnaud et 
al. 1974; Bomford et al. 1975) o f tumour growth have been reported in  
GVH mice. In h ib it io n  o f tumour growth was also described in  guinea 
pigs undergoing GVH reaction (K atz, Ellman, Paul, Green and Benacerraf
1972). The influence o f an ongoing GVH reaction on tumour growth 
could be re la ted  both to the time which elapsed between the in je c tio n  
o f a llogeneic lymphocytes and tumour challenge and to the type o f 
tumour which was used. Several reports have indicated th a t in h ib it io n  
o f tumour growth was highly dependent on the time in te rv a l elapsed 
fo llow ing GVH induction. I f  the in te rv a l before tumour challenge was 
e ith e r  too short (Okubo et al. 1974) or too long (Bomford et al. 1975) 
the in h ib ito ry  e f fe c t  was not detectab le . I t  is  o f in te re s t to note 
th a t enhancement (Okubo et al. 1974) was observed a f te r  subcutaneous 
challenge w ith a chemically-induced sarcoma ( i . e .  a so lid  tumour). By 
contrast, in  the m ajo rity  o f instances in  which suppression o f tumour 
growth was observed, the challenge consisted o f a leukaemia or 
m etastasizing tumour.
The in h ib ito ry  e f fe c t  o f GVH reaction on tumour growth has been 
ascribed to 1) p o ten tia tion  o f the immune response to tumour s p e c ific  
transp lan tation  antigen (TSTA) 2) suppression o f an enhancing antibody 
response to TSTA and 3) s tim ulation  o f the mononuclear phagocyte system. 
The f i r s t  two a lte rn a tiv e s  seem u n lik e ly  since suppression o f tumour 
growth is  evident when mice are immunosuppressed a t day 7 and tumour 
resistance declines a t day 21 when immunosuppression is  s t i l l  pronounced 
(Bomford et al. 1975). The like lih o o d  th a t activated  macrophages are 
responsible is  supported by experiments in vitro which demonstrate a 
d ire c t in h ib ito ry  e ffe c t  o f adherent c e lls  from GVH mice on tumour 
growth (Ptak et al. 1975; Bomford et al. 1975). Furthermore, the 
in h ib it io n  o f tumour growth which is  due to macrophages ac tiva ted  by 
a lte rn a tiv e  means (e .g . C. parvum or BCG) is  well known (O liv o tto  and 
Bomford 1974).
5. Possible mechanisms o f immunosuppression
Several a lte rn a tiv e  mechanisms have been advanced as explanations  
fo r the onset o f the generalised immunosuppression which accompanies 
GVH reactions. The causation o f suppression has been viewed as both 
pos itive  (suppressor or cytoxic c e lls )  and negative (d efic iency or 
absence o f c e lls  or fa c to rs ). The observation th a t spleen c e lls  from 
mice undergoing GVH reaction could suppress the antibody response o f  
normal c e ll populations in vitro (Sjoberg 1972) and in vivo (B y fie ld  
et al. 1973) has fa c i l i ta te d  a more d e ta iled  analysis o f defined c e ll 
populations which p a rtic ip a te  in suppression,
a) Lymphocyte destruction
The cause o f GVH-induced suppression was o r ig in a lly  thought to 
be due to the destruction o f re c ip ien t lymphocytes by donor-derived  
c e lls .  This explanation was based on the observation th a t leukopenia 
in v a ria b ly  accompanied GVH reac tio n , p a r t ic u la r ly  during the la te r  
stages o f acute disease. This reason is  no longer tenab le , however, 
since immunosuppression is  often complete long before leukopenia is
detectable.
b) T cell-m ediated suppression
T c e lls  were f i r s t  im plicated in  suppression as a re s u lt o f 
experiments in  which normal or immune parental or FI c e lls  were trans­
ferred  in to  un irrad ia ted  or irra d ia te d  GVH mice (M ü ller 1971). This 
author considered th a t donor-derived T c e l ls ,  activated  by h is to ­
co m p a tib ility  antigens o f the host, produced a fa c to r which in te rfe re d  
with e ith e r  antigen-induced B ce ll p ro life ra t io n , helper T c e ll function  
or both. B y fie ld  et at, (1973) showed th a t the immunosuppressive 
e ffe c t  o f GVH spleen c e lls  on normal FI c e lls  was p a r t ia l ly  abrogated 
by pretreatm ent with anti-Thy 1.2 (e) serum and complement. Although 
T c e lls  were im plicated i t  was also suggested th a t they may not 
function d ire c t ly  but exe rt th e ir  e f fe c t  through interm ediate accessory 
c e lls  (e .g . macrophages). This p o s s ib ility  is  discussed more f u l ly  
in Section 5c.
In contrast to the 'p o s itiv e ' evidence th a t suppression is  due to 
'suppressor' T c e l ls ,  Lapp and his colleagues have shown th a t suppression 
was p a r t ia l ly  abrogated when FI mice undergoing GVH reaction were 
subsequently in jec ted  with FI thymus ce lls  (Lapp, Wechsler and Kongshavn 
1974). They also demonstrated th is  phenomenon in vitro and showed in  
addition th a t soluble factors derived from thymus ce lls  were almost 
as e ffe c tiv e  as v iab le  FI thymocytes (E lie  and Lapp 1976). From these 
data they concluded th a t suppression was a ttr ib u ta b le  to a defect in  
helper T c e ll function . However, th is  conclusion fa i ls  to explain  
why antibody responses to thymus-independent antigens can be suppressed 
to an extent comparable with those o f thymus-dependent antigens. Any 
attempt to in teg ra te  suppressor a c t iv ity  w ith absence o f helper 
function would imply th a t a t le a s t two m utually exclusive suppressive 
mechanisms were operating simultaneously.
c) Macrophage-mediated suppression
Since GVH reactions can induce intense a c tiva tio n  o f the
mononuclear phagocytic system (Howard i9 6 i ) ,  the p o s s ib ilit ie s  e x is t  
th a t 1) activated  macrophages could in h ib it  lymphocyte function and 
2) an overa ll increase in  the number o f phagocytic c e lls  w il l  re s u lt  
in a high macrophage/lymphocyte r a t io ,  a s itu a tio n  known to favour 
in h ib it io n  o f antibody responses in vitro (Woffmw 1970). Macrophages 
which are activated  by other procedures (e .g . C, parvm) possess the 
capacity to in h ib it  T c e ll function profoundly in vitro as assessed 
by in h ib it io n  o f MLR and PHA m itogenic ity  (Scott 1972). Moreover, 
adherent c e lls  from the peritoneal cav ity  o f mice which are under­
going GVH reaction w il l  in h ib it  tumour c e ll DNA synthesis and lung 
nodule formation (Ptak et at, 1975; Bomford et at, 1975).
One report has demonstrated GVH-induced macrophage-mediated 
suppression in vitro (Sjoberg 1972). The depletion by carbonyl-iron  
o f phagocytic c e lls  from spleen suspensions obtained from FI mice 
in jec ted  7 days previously w ith parental lymphocytes, abrogated th e ir  
suppressive e ffe c t  on normal c e lls  in a Mi shell-D utton cu ltu re  system 
against SRBC. Treatment o f the GVH spleen suspension w ith anti-Thy
1.2 serum and complement p r io r  to cu lture  fa ile d  to abolish th e ir  
suppressive a c t iv ity .  I t  is  re levant to note here th a t suppression 
was tested against normal parental c e lls  which were o f the same 
s tra in  as those used fo r  GVH induction. In la te r  in vivo experiments 
(Byfield et at, 1973) macrophage depletion fa ile d  to abolish the 
suppressive a c t iv ity  o f GVH spleen c e lls  using normal FI c e lls  as 
ta rg e ts . However, p a r t ia l a lle v ia tio n  was achieved by pretreatm ent 
with anti-Thy 1.2 serum and complement and th is  e f fe c t  was greater i f  
adherent ce lls  were also depleted. Hence, i t  was suggested th a t GVH- 
induced immunosuppression may be a ttr ib u ta b le  to T ce ll dependent 
changes in  the macrophage population, the la t t e r  acting as a mediator 
of a T c e ll-d e riv e d  fa c to r ,
d) Soluble factors
Evidence suggesting the p a rtic ip a tio n  o f soluble factors  in  ac tive
suppression by GVH spleen c e lls  has been obtained by some (Nelson 
1973; McMaster and Levy 1975) but not by others (B y fie ld  et al, 1973; 
Parthenais, E lie  and Lapp 1974). The former stems mainly from studies 
on the in h ib it io n  o f e ith e r  MLR or m itogenic ity  by macrophage super­
natants (Nelson 1973) or serum (McMaster and Levy 1975) obtained from 
GVH mice. In con trast, negative resu lts  were obtained from studies  
in which the suppressive a c t iv ity  o f soluble factors was monitored 
by in h ib it io n  o f antibody responses in vivo (B y fie ld  et al, 1973) and 
in vitro (Parthenais et al, 1974).
Only a marginal in h ib it io n  o f PHA m itogenic ity  was reported by 
Nelson (1973) and the greater e ffe c ts  observed by McMaster and Levy 
(1975) are open to the c ritic ism s  th a t 1) serum from GVH mice may 
contain a non-specific  tox ic  substance even though the precaution was 
taken o f d ia lyz ing  serum p r io r  to cu ltu re  and 2) a m u ltip le  in je c tio n  
regime was used to induce GVH reactions.
Thus i t  appears th a t a v a rie ty  o f ce ll types and e ffe c to r  
mechanisms are im plicated in  GVH-induced immunosuppression. The e v i­
dence av a ila b le  a t the commencement o f th is  in vestig a tio n  did not 
allow us to conclude ca teg o rica lly  which c e ll type plays a causative  
ro le  and by what mechanism immunosuppression develops.
6. Relationship between immunosuppression and the 'a llo g en e ic  e f fe c t '
The induction o f a GVH reaction usually has a profound e f fe c t  on 
subsequent immune responses o f the re c ip ie n t to a v a rie ty  o f an tigen ic  
s tim u li. The outcome o f a llogeneic in te ra c tio n  between lymphocytes o f 
d iffe re n t  h is to co m p atib ilities  may re s u lt in  e ith e r  immune stim u lation  
or suppression. H is to r ic a lly ,  the discovery o f GVH-induced immuno­
suppression preceded the discovery o f s tim ulation  by one decade.
Although the major ob jective  underlying th is  thesis was to in ves tig a te  
the suppressive stage o f ongoing GVH reac tions , the phenomenon o f  
allogeneic stim ulation  also requires b r ie f  discussion here.
I t  was observed in 1971 th a t an in je c tio n  o f v iab le  a llogeneic
lymphocytes in to  guinea pigs caused a marked stim ulation  o f immune 
responses (K atz, Paul, Goidl and Benacerraf 1971). These experiments 
were performed w ith rec ip ien ts  which were primed to the hapten- 
c a rr ie r  complex DNP-ovalbumin (DNP-OVA). The subsequent tra n s fe r o f  
allogeneic lymphocytes in to  these primed rec ip ien ts  enabled them to 
mount a vigorous antibody response to DNP when they were challenged 
with DNP-bovine gamma g lobulin  (DNP-BGG). This e f fe c t  was not 
demonstrable when syngeneic lymphocytes were transferred  unless they 
were primed previously w ith BGG. Thus, the tra n s fe r o f a llogeneic  
c e lls  appeared to circumvent the requirements fo r  s p e c ific  helper T 
c e lls . A s im ila r  stim ulation  o f anti-hapten responses by allogeneic  
c e lls  was reported by Kreth and Williamson (1971) using a mouse model 
in  which the ‘ a llogeneic e ffe c t"  was a ttr ib u te d  to a soluble fa c to r;  
a re s u lt  which has since been amply confirmed by several other groups 
(Dutton et al, 1971; Katz 1972; Schimple and Wecker 1972). The fa c to r  
was found to replace e f fe c t iv e ly  T c e lls  or T ce ll factors in  nude 
mice (Kettman and Skarvall 1974), in  T-depleted mice (B ritto n  1972) 
and in a n ti-e  treated  spleen c e ll cultures (Armerding and Katz 1974).
Factors induced by allogeneic c e ll in te rac tio n s  have been 
investigated in te n s ive ly  as a means o f analysing B-T c e ll cooperation  
(Feldmann and Basten 1972; B ritto n  1974; Waldmann, Pope and Munro 1975). 
Although d e ta iled  analyses o f allogeneic factors  have contributed  
s ig n if ic a n tly  to the f ie ld  o f B-T cooperation, controversial find ings  
regarding th e ir  characteriza tion  and th e ir  comparison w ith antigen- 
induced s p e c ific  T c e ll factors have not y e t been f u l ly  resolved. In  
fa c t ,  i t  has been proposed th a t a llogeneic fa c to rs , although circum­
venting the requirement fo r  helper T c e l ls ,  act on B ce lls  a t a la te r  
stage o f the immune response as a non-specific  stimulus o f p r o l ife r a ­
tio n  (Feldmann and Basten 1972).
Antibody responses to thymus-dependent antigens in vitro are 
known to be influenced by the re la t iv e  proportions o f p a rtic ip a tin g
c e ll types present. For example, an increase in  the number o f ad­
herent ce lls  can impair anti-SRBC responses (Hoffman 1970). The 
observations th a t GVH reactions would induce stim ulation  when antigen  
was introduced a t the same time as, or sho rtly  a f te r ,  GVH induction , 
whereas suppression in v a ria b ly  occurred when challenge was delayed 
(SjOberg 1972; B yfie ld  et al, 1973) led to the suggestion th a t both 
m anifestations could be produced by a common mechanism, i . e .  whether 
stim ulation  or suppression developed would depend so le ly  on q u a n tita ­
t iv e  aspects. In s tim u la tio n , helper a c t iv ity  would be present in  
optimal concentration, whereas an excess o f these same components 
during the la te r  stages o f GVH reaction would lead to in h ib it io n .
The evidence presented by SjOberg (1972) showing th a t s tim u lation  
or suppression o f antibody responses by a llogeneic ce ll mixtures was 
dependent on c e ll density does not provide d ire c t support fo r  a 
q u a n tita tiv e  mechanism since 1) optimal responses in vitro are h ighly  
dependent on ce ll density (M ishell and Dutton 1967) and 2) an a lte ra tio n  
in  the k in e tics  o f the onset o f immunosuppression can be produced in 
vivo merely by reducing the number o f parental lymphocytes used fo r  
GVH induction (B y fie ld  et al, 1973). Furthermore, attempts to demon­
s tra te  d ire c t ly ,  both stim ulatory and suppressive e ffe c ts  o f the same 
GVH c e ll population on the antibody response o f transferred  normal 
ce lls  by d ilu tio n  analysis have fa ile d  (B y fie ld  et al, 1973).
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MATERIALS AND METHODS
Animals
Mi ce : Mice o f the C57BL and CBA stra in s  and FI hybrids derived from
them were bred by th is  laboratory . (AKRxC57BL)Fl and (DBA/1xC57BL)FI 
mice from the same source were used in  a lim ite d  number o f experiments. 
Male and female animals were used between 3 and 6 months o f age.
Rabbits : Adult New Zealand white rabbits o f both sexes were used to
raise  anti-mouse immunoglobulin serum.
Induction o f GVH reactions
Donor spleen ce ll suspensions were prepared from parental s tra in  
mice by homogenization in medium 199 w ith a loose f i t t in g  ground glass 
tissue grinder. Suspensions were f i l t e r e d  through fin e  s ta in less  steel 
mesh, centrifuged a t 300 g fo r  5 min and resuspended to a v iab le  c e ll 
concentration o f 2.4xl0®/ml as evaluated by trypan blue dye exclusion.
A volume o f 0.33 ml (8x1O^  v iab le  c e lls )  was in jected  in to  FI rec ip ien ts  
via a la te ra l t a i l  vein . This number o f c e lls  was chosen on the basis 
of previous experience in th is  laboratory .
The times o f antigen challenge or ce ll harvest are specified  in  
ind iv idual experiments. Unless stated otherw ise, a l l  GVH reactions  
were in it ia te d  by in je c tin g  male or female parental c e lls  in to  FI 
rec ip ien ts  o f the same sex. FI hybrids in jec ted  previously w ith  
parental spleen c e lls  and spleen ce lls  removed from them are h e re a fte r  
re fe rred  to as GVH mice and GVH c e lls  resp ective ly .
M o rta lity  assays
FI hybrids in jec ted  w ith C57BL parental spleen c e lls  were mon­
ito re d  fo r  survival on a d a ily  basis. Mean survival times and standard 
errors o f the mean were calcu lated  and expressed as the a rith m etic  
mean ± standard e rro r .
P o p litea l lymph node enlargement assay
The method used was th a t described by Ford, Burr and Simonsen
(1970). B r ie f ly ,  ce lls  were in jec ted  in to  the hind footpad o f FI 
rec ip ien ts  (usually  2x10? in a volume o f 0.05 ml) taking care to 
avoid leakage back through the in je c tio n  s i te .  One hind footpad was 
used fo r  in je c tin g  te s t  c e ll suspensions and the other fo r  the same 
quantity  o f syngeneic c e l ls ,  thus providing a b u i l t - in  co n tro l. A fte r  
7 days, mice were k i l le d  by cerv ica l d is location  and the p o p litea l 
lymph nodes removed from both hind legs. They were dissected fre e  o f  
surrounding f a t  and weighed on a s ingle pan 5 place balance. The 
geometric mean ± standard e rro r fo r each group was calculated from the 
lymph node weight in  mg (5 to 6 mice per group). The mean weight o f  
the control nodes (in je c te d  w ith syngeneic c e lls )  was subtracted from 
the mean weight o f the te s t nodes to give the lymph node index o f  
enlargement (L N I). The standard e rro r o f th is  LNI was calcu lated  
according to the fo llow ing formulae:
se o f LNI = y /se j + se|
where se^ = standard e rro r o f control nodes
and se2 = standard e rro r o f te s t nodes
Irra d ia t io n
Mice were irra d ia te d  with 900 rad (600 rad in  some experiments 
where spec ified ) in  Perspex containers by a i3?Cs source d e live rin g  
approximately 19 rad/min a t a distance o f 60 cm. Irra d ia te d  mice 
used in tra n s fe r experiments were repopulated intravenously w ith ce ll 
suspensions between 1 and 3 hr a f te r  ir ra d ia t io n .
Thymectomy
Mice were thymectomized by a m odification o f the method described
by M il le r  (1960). Mice, 6 -8  weeks o f age, were anaesthetized w ith
A v e rtin (0.01 ml/g body weight o f a 1/50 d ilu tio n  in  10% ethyl a lc o h o l). 
A small inc is ion  was made a t the upper end o f the thorax, close to the 
sternum, and both lobes o f the thymus removed under vacuum with a 
‘ flared-end* pasteur p ip e tte . The in c is io n  was closed ra p id ly  w ith  
Mishell c lip s  and mice were allowed to recover in the warm. In some
experiments, thymectomized mice were le th a lly  irra d ia te d  (900r) 3 
weeks a f te r  thymectomy and repopulated w ith 2x10^ syngeneic bone marrow 
c e lls  which had been pretreated with anti-Thy 1-2 (e ) serum and comple­
ment. Spleens from these animals were used as a source o f T-deprived  
c e lls  4 weeks th e re a fte r .
Skin g ra fts
Female (CBAxC57BL)Fl mice were grafted  w ith C57BL male skin 
according to the method o f Billingham  and Medawar (1951). Recip ient 
mice were anaesthetized w ith A v e rtin as described previously and a 
c irc u la r  area o f skin approximately 1 cm in  diameter was removed from 
the flan k  to provide a bed fo r  the g r a f t .  One cm c irc le s  o f C57BL 
male donor skin were cut w ith a cork-borer and the g ra ft  placed in to  
position  on the prepared g ra ft  bed. The g ra ft  was covered w ith a small 
square o f gauze impregnated w ith petroleum j e l l y  and th is  in  turn was 
covered with a la rg e r square o f 3-4 thicknesses o f dry gauze. F in a lly ,  
a p la s te r o f Paris bandage (2 .5  cm x 15 cm) was wrapped around the torso  
to secure the g ra ft .
Dressings were removed a t day 9 and skin biopsies taken a t day 
21 to be stained with haematoxylin and eosin. Spleens from those animals 
which showed d e fin ite  h is to lo g ica l evidence o f round c e ll in f i l t r a t io n  
were pooled as a source o f c e lls  th a t were immune to the C57BL male 
antigen. Biopsies from eleven out o f twelve successful g ra fts  which 
were macroscopically normal showed moderate to heavy round c e ll i n f i l ­
t ra t io n ;  a re s u lt in  agreement w ith the e a r l ie r  observations o f Zaalberg  
(1959) and Howard (1961c) on the chronic re je c tio n  o f C57BL male skin  
grafts  by (C57BLxCBA)Fl females.
Antigens
For in vivo challenge
Chicken red blood c e lls  (CRBC) were obtained from birds housed 
in  th is  department and washed three times in  sa lin e  p r io r  to use.
Native levan (LE ), a polyfructose o f approximately 2x10? daltons mol.
immunological properties have been described by Miranda (1972). I t  was 
dissolved in  sa line  to give a concentration o f 40 yg /m l. Mice were 
challenged intravenously (16-20 hr a f te r  repopulation in tra n s fe r experi­
ments) w ith a s ingle in je c tio n  o f 0.25 ml o f LE to which was added 15% 
washed CRBC. D irec t plaque forming c e lls  (RFC) to both LE and CRBC 
were assayed 5 days la te r .  Prelim inary experiments revealed no 
d ifferences in  geometric means o f d ire c t PFC counts between mice given 
both antigens simultaneously and groups o f mice challenged w ith e ith e r  
antigen alone. In a few experiments where washed sheep red blood c e lls  
(SRBC) were also used as antigen, 5x108 in 0.25 ml were in je c te d  i . v .  
and d ire c t PFC assayed 4 or 5 days la te r .
For in vitro challenge
Washed SRBC obtained from a sing le sheep or d in itrophenylated  
levan (DNP-LE, kindly donated by Dr. C. Desaymard) were used as antigens 
fo r  in vitro Marbrook cu ltu res .
Plaque-forming ce ll assays
0-stearoyl levan was coupled to SRBC as described by Miranda (1972). 
B r ie f ly ,  0 .2  ml o f packed washed SRBC were added to 19.8 ml o f 0 -stearoyl 
levan (1 yg/m l) in  phosphate buffered sa line  pH7.2. A fte r 30 min a t 37°C, 
the sensitized  c e lls  were washed 3 times in  sa line  and resuspended to a 
concentration o f 10%. CRBC were washed 3 times and resuspended to 13%,
SRBC were washed 3 times and resuspended to 10%.
PFC assays were performed in  S te r i l in  9 cm p la s tic  p e tr i dishes using
0.9% agarose (L 'In d u s tr ie  Biologique, Française, S .A .) in medium 199. Plates  
were poured from tubes containing 2 ml agarose held a t 48°C to which 0.1 ml 
o f the appropriate in d ica to r red blood ce lls  and 0.1 ml o f washed spleen c e ll 
suspensions had been added. Spleen c e ll suspensions were prepared as 
described in  'induction o f GVH reactions' and resuspended in a volume o f  
10 ml. Plates were incubated a t 37°C in 5% COg fo r  1 | h r, 2 .5  ml o f  
guinea pig complement d ilu te d  1/10 were added and plates were reincubated
fo r a fu rth e r  hour before plaques were counted. Background PFC to 
SRBC were subtracted from anti-LE  PFC to express the s p e c ific  anti-LE  
response.
Anti-SRBC PFC from in vitro cultures were assayed in  a s im ila r  
manner fo r  primary responses. For secondary responses, p lates were 
incubated a t 37°C fo r  30 min w ith a 1/200 d ilu tio n  o f rab b it a n t i­
mouse immunoglobulin serum p rio r  to adding the complement to detect 
in d ire c t (IgG) PFC. This d ilu tio n  o f anti-immunoglobulin serum was 
known to develop in d ire c t plaques (IgG) optim ally  but not in h ib it  
d ire c t plaques (IgM ). Cunningham's m odification (Cunningham and 
Szenberg 1968) o f the plaque assay was u t i l iz e d  to detect anti-DNP PFC. 
SRBC were conjugated w ith DNP-anti-SRBC Fab' as described by Desaymard 
and Feldmann (1975). Background PFC to SRBC were subtracted from the 
anti-DNP PFC to give the s p e c ific  anti-DNP response.
Geometric mean t i t r e s  ± the standard e rro r o f the means were 
calculated fo r  a l l  in vivo experiments and arith m etic  means fo r  in 
vitro experiments.
Alloantiserum  preparation
Anti-CBA alloantiserum  was prepared in  C57BL mice by i .p .  in je c ­
tion  o f 5x10? CBA spleen c e lls  in  Freund's complete adjuvant. One 
month la te r ,  1 x 10^ CBA spleen c e lls  were in jec ted  intravenously  
followed by a fu rth e r in je c tio n  o f 1x10^ c e lls  1 week la te r .  Mice were 
bled from the re tro -o rb ita l sinus on 3 consecutive days s ta rtin g  1 week 
a f te r  the f in a l in je c tio n . Antisera obtained from these blood samples 
were pooled, inactiva ted  a t 56°C fo r 30 min and stored a t -20°C . T itre s  
were evaluated in  a m ic ro -cy to x ic ity  assay against CBA thymocytes using 
trypan blue dye exclusion.
Anti-Thy 1.2 serum (AKR anti-C^H) was obtained commercially from 
G. D. Searle , High Wycombe, Bucks., England, or from Dr. D. W. Dresser, 
National In s t itu te  fo r  Medical Research, M ill H i l l ,  London NW7.
Treatment o f c e lls  w ith alloantiserum
Spleen c e lls  (4x10®) were incubated in  4 ml o f a 1 /4  d ilu t io n  
o f anti-CBA alloantiserum  fo r  45 min a t 37°C. The ce lls  were c e n tr i­
fuged, resuspended in 4 ml o f guinea pig complement d ilu ted  1/5 and 
re-incubated a t 37°C fo r  30 min. F in a lly , suspensions were recentrifuged  
and resuspended to a concentration su itab le  fo r  in je c tio n . This a l lo ­
antiserum a t a d ilu t io n  o f 1/16 k i l le d  a t le a s t 90% o f CBA thymus 
c e lls  as assessed by trypan blue exclusion. A s im ila r  procedure was 
employed fo r  anti-Thy 1.2 treatments using a d ilu tio n  o f 1 /25 . In one 
experiment w ith the anti-Thy 1.2 serum generously provided by 
Dr. D. W. Dresser, ra b b it complement (supplied by Dr. H. Zola), instead  
o f guinea pig complement, was used a t a d ilu t io n  o f 1 /5 .
Anti-immunoglobulin preparation
Pooled mouse serum from CBA mice was p rec ip ita ted  by adding 2 
volumes o f 27% sodium sulphate to one volume o f the serum and s t ir r in g  
continuously. This mixture was allowed to stand a t room temperature 
fo r  4 hr and then centrifuged a t 1500 g fo r  10 min. The re s u ltin g  
p re c ip ita te  was redissolved in  d is t i l le d  water and dialyzed against
0.01 M phosphate b u ffe r pH 8.0 fo r  48 hr a t  4°C. The d ialyzed so lu tion  
was frac tio n a ted  on a D i-ethyl-am ino-ethyl ce llu lose  column (DE52) 
eq u ilib ra ted  w ith 0.01 M phosphate b u ffe r pH 8 .0 . The e luate  from 
th is  column consisted predominantly o f mouse IgG as evaluated by Immuno­
electrophoresis.
Approximately 100 yg o f the m aterial was em ulsified in  Freund's 
complete adjuvant and in jected  intram uscularly in to  rab b its . Six weeks 
la te r  these rabb its  were in jected  intram uscularly w ith a fu r th e r  100 yg 
pro te in . Two weeks la te r  an intravenous in je c tio n  o f 100 yg was given. 
Rabbits were te s t  bled 7 days la te r  and those animals which showed 
s u ff ic ie n t ly  high t i t r e s  were bled out the fo llow ing day. The sera 
obtained were in activa ted  a t 56°C fo r  30 min and stored a t -20°C.
This anti serum was used fo r  T c e ll p u r if ic a tio n  (vide in f r a ) ,  or
a f te r  absorption with SRBC, fo r  in d ire c t PFC development.
P u rif ic a tio n  o f T c e lls
P u rifie d  T c e ll populations were prepared by a f f in i t y  chromato­
graphy, e s s e n tia lly  according to the procedure described by W ig ze ll, 
Sundqvist and Yoshida (1972). Mouse immunoglobulin was coupled to  
'Diakon' p la s tic  beads (Im perial Chemical Industries Ltd) by incubat­
ing fo r  1 hr a t 45°C and pH 7.4  (1 .5  mg o f ammonium sulphate 
p rec ip ita ted  mouse immunoglobulin per ml o f packed beads). A fte r  
overnight incubation a t 4°C, coated beads were washed three tim es, 
poured in to  1.5 x 30 cm chromatographic columns and e q u ilib ra ted  w ith  
PBS a t 4°C. Columns were saturated with a 1 /3  d ilu tio n  o f ra b b it -a n t i-  
mouse Ig serum, l e f t  fo r  1 | hr and washed extensively  w ith PBS. Spleen 
c e ll suspensions were added to the columns a t a concentration o f 
5xlO?/ml and eluted using a flow ra te  o f 2-3 ml/min.
Eluates were monitored fo r  B ce ll depletion by an in d ire c t immuno­
fluorescence assay u t i l iz in g  rab b it anti-mouse Ig serum and a chicken 
a n ti-ra b b it-f lu o re s c e in  (FITC) conjugate. B c e ll leve ls  were reduced 
a f te r  fra c tio n a tio n  from 40-45% to 0.2-0.5%  and approximately 25% o f  
to ta l c e lls  was recovered. This technique provided an add itional bonus 
by g rea tly  reducing macrophage le v e ls . Passage o f a spleen c e ll 
suspension from mice which had been in jec ted  3 hr previously w ith  
rhodamine-labelled C, parvum (B ell and Shand 1972), through a mouse 
immunoglobulin-anti-immunoglobulin column, reduced the number o f C. 
parvum containing c e lls  (presumably macrophages) from 10.6% to 1%. 
Consequently the p u rifie d  T c e ll populations used in  the experiments 
to be described were depleted s u b s ta n tia lly  o f both B c e lls  and 
macrophages.
Macrophage depletion
Macrophages were depleted from spleen ce ll suspensions e ith e r  
by a magnetic separation method (Shand and Bell 1972) or by fra c tio n a ­
tion  on Sephadex GIO columns (Ly and M ishell 1974) in  la te r  experiments.
The former was performed by incubating spleen c e lls  w ith carbonyl 
iron powder (100 mg carbonyl iro n /sp leen) a t 37°C fo r  45 min. A fte r  
resuspending the c e lls ,  the tube was drawn between the poles o f a 
powerful magnet and the supernatant recovered. This procedure was 
repeated three more tim es. Sephadex G-10 columns, prepared in  20 ml 
p la s tic  syringes, were e q u ilib ra te d  with medium 1 9 9 + 5 %  fo e ta l c a lf  
serum. Spleen ce ll suspensions (2 ml a t lxlO®/m l) were run through 
the column under g rav ity  and the e luted c e lls  co llec ted . Approximately 
one h a lf  o f the to ta l ce ll input was recovered.
The level o f macrophage depletion by both procedures was deter­
mined by incubating a sample o f ce lls  w ith fluorochrom e-labelled C. 
parvwn a t 37°C fo r  1 h r. A fte r  thorough washing, the number o f phago­
c y tic  c e lls  was enumerated d ire c t ly  under a fluorescence microscope.
A depletion level o f more than 90% was achieved in  a l l  cases.
Spleen c e ll cultures
Single Marbrook chambers (Marbrook 1967) were seeded w ith 2x10? 
viab le  spleen c e lls  and 3x10^ washed SRBC or 0.1 yg DNP-LE in 0 .5  ml 
as a source o f antigen. For anti-DNP responses, 2-mercaptoethanol was 
added a t a f in a l concentration o f 10“  ^ M. The outer chamber o f double 
Marbrook cultures (Feldmann 1972) was seeded w ith 6x10? spleen c e lls  
and 1x10? washed SRBC in 2 .0  ml as a source o f antigen. The inner  
chamber was sealed w ith a 0.22 ym Nucleopore membrane and contained 
3x10? c e lls  in  0 .5  m l.
Medium RPMI 1640 was used throughout supplemented w ith 10% c a lf  
serum fo r  outer reservoirs (10 ml) and 5% fo e ta l c a lf  serum fo r  chambers 
which contained ce ll suspensions. Harvested spleen c e lls  were c e n tr i­
fuged through fo eta l c a lf  serum a t 300 g fo r  5 min p r io r  to  
standard ization and seeding. Cell v ia b i l i t ie s  were usually between 88 
and 92% as assessed by trypan blue exclusion. In some experiments, 
the inner chamber o f double cultures was removed and the residual 
outer chamber was used fo r  single cultures u t i l iz in g  6x10? spleen c e lls
and 1x10? SRBC as described previously.
Primed spleen c e lls  were obtained from FI mice in jected  i . v .
14-21 days previously w ith 5x10? washed SRBC. Cells were harvested 
from t r ip l ic a te  or quadruplicate groups o f cultures a f te r  4 days 
incubation a t 37°C in  5% COg, washed and resuspended in 2 ml medium 
199. They were assayed fo r  d ire c t PFC (primary responses) or to ta l 
PFC i . e .  d ire c t and developed (secondary responses).
Treatments w ith an ti-L y  and a n t i - la  antisera
Anti sera raised in  congenic mice against the Ly mouse T c e ll
kd if fe re n t ia t io n  antigens, a n t i - la  anti serum and rab b it complement 
absorbed w ith mouse c e lls  were generously provided by Dr. M. Feldmann, 
Tumour Immunology U n it, U n ivers ity  College, London. GVH spleen c e lls  
(9x106) were added to 1 ml d ilu ted  a n ti-L y  1.1 ( 1 /8 ) ,  an ti Ly 2.1 ( 1 /5 ) ,  
anti Ly 1 .2  (1 /8 )  or a n t i- la ^  (1 /1 0 ) antiserum and incubated a t  37°C 
fo r  45 min. Tubes were then f i l l e d  to 10 ml w ith medium and c e n tr i­
fuged a t 300 g fo r  5 min. Cell p e lle ts  were resuspended in 1 ml 
rab b it complement d ilu ted  1/10 and re-incubated a t 37°C fo r  45 min.
A fte r washing, trea ted  c e lls  were assayed fo r  suppressive a c t iv ity  by 
adding 3x106 c e lls  to t r ip l ic a te  cultures o f 2x10? primed FI spleen 
c e lls  in  Marbrook chambers. Controls consisted o f 2x10? primed c e lls  
alone, or w ith the add ition o f 3 x 106 ra b b it complement-treated GVH 
spleen c e lls .
Responses to mitogens in vitro
FI spleen c e lls  were cultured in  1 ml RPMI 1640 supplemented 
with 5% fo eta l c a lf  serum in Falcon p la s tic  tubes (16 x 125 mm). E ith e r  
1 yg phytohaemagglutinin (PHA) or 10 yg lipopolysaccharide (LPS) was 
added to quadruplicate cultures in  a volume o f 0.1 ml. PHA was
obtained from Wellcome Reagents Ltd. and LPS from Difco Laboratories.
A fte r 48 hr a t  37°C in 5% CO2» 1 yci o f ^H-thymidine in  0.1 ml was
added to each cu ltu re  tube and incubation continued fo r  a fu rth e r
18-20 h r. Tubes were centrifuged, the c e lls  resuspended in 1 ml sa lin e
and 1 ml o f 10% tr ic h lo ra c e tic  acid was added. The p re c ip ita te  was 
f i l t e r e d  onto 2 .5  cm diameter glass f ib re  discs (Whatman GF/B) which 
were then washed through with 5% tr ic h lo ra c e tic  acid followed by 
in d u s tr ia l methylated s p i r i t .  The discs were placed in s c in t i l la t io n  
v ia ls  and dried completely a t 80°C fo r  2 hr before adding 4 ml 
s c in t i l la t io n  f lu id  (Toluene containing 0.8% butyl PBO (Ciba) and 
5% Bio-solV BDS-3 (Beckman Instrument Incorporated). F in a lly ,  the 
samples were counted in  a Beckman liq u id  s c in t i l la t io n  counter set 
to give counts with standard deviation o f 2%.
In experiments where normal FI and GVH spleen c e lls  were 
cu ltu red , ce ll densities in  controls were kept constant by adding the 
same number o f FI spleen c e lls . For some experiments, c e lls  were 
pretreated w ith 50 yg/ml mitomycin C (Sigma) fo r  30 min a t  37°C, and 
washed before use. A rithm etic means ± standard e rro r were calcu lated  
from the counts per minute (CPM) o f each group o f quadruplicate  
cu ltu res.
Azathioprine
Mice were in jec ted  i .p .  w ith azathioprine (Imuran, Wellcome 
Foundation L td ). Prelim inary studies in  the s tra in s  o f mice used fo r  
these experiments revealed th a t the maximum to le ra te d  dose was approx­
im ately 200 mg/Kg body weight. For tre a tin g  c e ll suspensionsm vitro, 
azathioprine was dissolved a t a concentration o f 30 mg/ml in  sodium 
hydroxide ( IN ) .  This was immediately made up to 10 ml w ith  d is t i l le d  
water and then to 90 ml with phosphate buffered sa line  pH 7 .2 . The 
pH was adjusted to pH 7.2  w ith hydrochloric acid (IN ) and s u f f ic ie n t  
PBS added to bring the to ta l volume to 100 ml. This so lution  o f  
azathioprine (300 yg/m l) was f i l t e r e d  through a 0.22 M illip o re  mem­
brane and kept a t room temperature u n til d ilu ted  fo r  use.
S ta t is t ic a l analysis
P ro b a b ility  values (p) fo r  leve ls  o f s ign ificance were ca lcu la ted  
by Student's t  te s t .
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CHAPTER 1
Studies on GVH-induced immunosuppression in vivo and in vitro
RESULTS PART I
Studies in vivo
Spleen c e lls  from C57BL and CBA parental s tra in  mice were compared 
fo r  th e ir  a b i l i t y  to suppress the d ire c t RFC response to LE and CRBC a t  
various times a f te r  induction o f GVH reac tion . In ad d itio n , a c e ll 
tra n s fe r system u t i l iz in g  le th a lly - ir ra d ia te d  FI rec ip ien ts  was used 
to  examine the immune status and suppressive properties o f GVH c e lls .
1. K inetics o f immunosuppression during GVH reactions induced in  
FI mice by spleen c e lls  o f e ith e r  parental s tra in  
(CBAxC57BL)Fl mice were in jec ted  i . v .  w ith 8x10? v iab le  spleen 
c e lls  obtained from CBA or C57BL donors. At selected times th e re a fte r  
groups o f them were challenged w ith both the thymus-independent antigen  
LE and thymus-dependent antigen CRBC. At the time o f challenge, spleen 
c e lls  were harvested from p a ra lle l groups o f animals and 5x10? c e lls  
transferred  to 900r irra d ia te d  FI rec ip ien ts  which were e ith e r  
repopulated w ith 5x10? normal syngeneic FI spleen c e lls  or l e f t  
unrepopulated. These la t t e r  groups were challenged the fo llow ing  day 
with LE and CRBC and RFC assays performed 5 days la te r .
F ig . 2 shows th a t the onset and in te n s ity  o f suppression in  GVH 
animals over a 21-day period was comparable when parental spleen c e lls  
o f e ith e r  s tra in  were used fo r  induction. The immune status o f GVH 
c e lls  which were transferred  in to  le th a lly - ir ra d ia te d  FI rec ip ien ts  
was e s s e n tia lly  the same as th a t o f the in ta c t  animal (data not shown). 
The in h ib ito ry  e f fe c t  o f GVH c e lls ,  a t  various times a f te r  induction , 
on normal FI spleen c e lls  transferred  to an irra d ia te d  FI re c ip ie n t  
was maximal between days 7 and 14. S u rp ris in g ly , however, spleen
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The in a b i l i t y  o f  spleen ce lls  from GVH mice in jected 80 days 
previously with CBA parental spleen ce lls  to suppress the 
response o f  transferred  normal FI ce lls  even though in ta c t  
GVH mice and th e ir  transferred ce lls  were unresponsive
Recipient Cells in jected
PFC/spleen*
LE CRBC
Normal None 26,300 
(4.42 ± 0.16)
112,200 
(5 .05 ± 0.09)
GVH None 562
(2.75 ± 0.13)
2,138  
(3 .33  ± 0 .18)
900r 5x10? normal FI 20,400 
(4.31 ± 0.10)
10,960 
(4 .04  ± 0 .08)
II 5 x 1 GVH 1,604 
(3 .20 ± 0.08)
917
(2.96 ± 0 .11)
II 5x10? Normal FI 18,018 24,040
+
5x1 o’  GVH
(4.26 ± 0.07) (4 .38  ± 0 .14)
^Geometric mean ± s .e .  (n = 4)
ce lls  from day 21 GVH mice had lo s t  completely th e ir  a b i l i t y  to 
suppress normal FI c e l ls .  This in a b i l i t y  to suppress transferred  
normal ce lls  was apparent a t  leas t  up to 80 days a f te r  GVH induction  
with CBA parental c e l ls ,  even though in ta c t  mice and th e i r  transferred  
spleen ce lls  remained unresponsive (Table 1 ) .  The la te r  stages o f  
C57BL-induced GVH reaction could not be investigated due to the high 
m o rta lity  which occurred a f te r  21 days.
Another consistent finding was tha t  spleens from ir ra d ia te d  FI 
mice which had been in jected with GVH ce lls  alone, or with suppressive 
GVH and normal FI c e l ls ,  were hypoplastic. On average, they contained 
only 10-20% o f the ce ll numbers present in recip ients o f  normal spleen 
c e lls  only (see la s t  column. Table 4 ) .
2. Splenomegaly and to ta l  nucleated ce ll  levels  in FI rec ip ients
o f  parental s tra in  spleen cells
The degree o f splenomegaly was assessed over a 21 day period in  
FI mice undergoing GVH reaction induced with 8x10? spleen c e l ls  o f  
e ith e r  parental s t ra in .  In add ition , the to ta l  number o f  nucleated 
ce lls  in the spleens o f  these animals was enumerated a t the same time 
in te rv a ls .  The peak o f splenic enlargement occurred at day 11 when 
e ith e r  CBA (F ig . 3) or C57BL (F ig . 4) spleen ce lls  were in jec ted .  
However, there was a more profound decrease in splenomegaly values and 
nucleated ce ll numbers a f te r  day 11 in FI rec ip ients  o f C57BL parental 
c e lls  when compared to FI recip ients o f  CBA c e l ls .  This is  probably 
a re f le c t io n  o f  the high m o rta li ty  which is  invar iab ly  associated with  
C57BL-induced GVH reactions.
3. T i t ra t io n  o f  suppressor ce ll a c t iv i t y  in vivo
The level to which suppressor ce lls  could be d ilu ted  and s t i l l  
produce detectable in h ib it io n  was ascertained by trans fe rr ing  varying  
numbers o f  GVH ce lls  to le th a l ly - i r r a d ia te d  FI recip ients repopulated 
with 5x10? syngeneic spleen c e l ls .  The results  (Table 2) show th a t
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T it ra t io n  o f  GVH-induced suppressor ce ll a c t iv i t y  in vivo
900 rad FI rec ip ien t  
+ 5x10? syngeneic 
c e lls  in jected with
Number o f  PFC/spleen^ 
LE CRBC
Nil 18,444 
(4 .27 ± 0 .13)
30,711 
(4 .49 ± 0 .06)
5x10^ C57BL-induced GVH* ce l ls 146
(2.16 ± 0.06)
544
(2 .74  ± 0 .07)
2x107 " " 4,684 
(3 .67  ± 0 .04)
6,503  
(3.81 ± 0 .02)
1x107 " " " " 8,521 
(3 .93 ± 0.16)
13,120 
(4 .12 ± 0 .14)
5x10® " 8,771 
(3:94 ± 0 .15)
7,522 
(3 .8 8  ± 0 .12)
5x107 CBA-induced GVH* ce l ls 289
(2.46 ± 0.27)
136
(2 .14  ± 0 .25)
2 x 1 0 7 ........................................ 1,382 
(3 .14 ± 0 .22)
1,081 
(3 .03  ± 0 .22)
Ix l0 7  " " " " 2,939  
(3 .47  ± 0.18)
1,499  
(3 .18  ± 0 .11)
5x10® " 15,047 
(4 .18  ± 0 .10 )
20,610  
(4.31 ± 0 .16)
t Geometric mean ± s .e .  (n = 4)
*GVH reaction induced 9 days previously with 8x10? parental 
spleen c e l ls .
SxlQG C57BL“induced GVH ce lls  are s t i l l  s ig n i f ic a n t ly  suppressive. 
CBA-induced GVH ce lls  appear to be marginally less e f fe c t iv e  here, 
although th is  degree o f  var ia t io n  occurs also between individual  
preparations o f  C57BL-induced GVH c e l ls .
4. Id e n t ity  o f  the suppressor ce ll
The following experiments were designed to investigate  whether 
p u rif ied  populations o f GVH-T ce lls  were capable o f  suppressing an 
adoptive primary response. Spleen ce lls  from GVH mice in jected  7 days 
previously with C57BL ce lls  were fractionated  on immunoglobulin-anti- 
immunoglobulin columns and tested fo r  th e i r  a b i l i t y  to in h ib i t  the 
primary immune response o f  transferred  normal c e l ls .  The results  
(F ig . 5) show that 5x10? GVH-T ce lls  abrogated the response o f  5x10? 
normal ce l ls  to both LE and CRBC. Normal T ce lls  had no such e f fe c t .  
These observations id e n t i fy  the suppressive component of GVH c e l ls  as 
a T ce ll  since macrophages were depleted by approximately 90% by the 
column frac tio n a tio n  (see M aterials and Methods).
Further confirmation tha t  the suppressive a c t iv i t y  was a t t r ib u t ­
able to a T ce l l  is provided by the following experiments. Spleen 
ce lls  from GVH mice in jected  14 days previously with C57BL spleen 
ce lls  were fractionated  on immunoglobulin-anti-immunoglobulin columns 
and the eluted ce lls  were treated with anti-Thy 1.2 (e) serum + comple­
ment before they were transferred to le th a l ly - i r r a d ia te d  FI rec ip ients  
repopulated with syngeneic spleen c e l ls .  The e f f icacy  o f  anti-Thy 1.2  
treatment was monitored fu nctio na lly  by t re a tin g  normal FI spleen 
c e lls  before tran s fe r  to le th a l ly - i r r a d ia te d  FI rec ip ien ts . Table 3 
demonstrates unequivocally th a t  anti-Thy 1.2 treatment o f  GVH-T ce l ls  
abrogated th e ir  suppressive properties. Although these experiments 
implicate the T ce ll in suppression they do not a t  th is  stage exclude 
the p o s s ib i l i ty  tha t  other ce ll  types (e .g . macrophages) may function  
as intermediary e f fe c to r  c e l ls .
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The e f fe c t  o f  anti-Thy 1.2 (9) treatment 
on p u r if ie d  GVH-T ce lls
900r (CBAxC57BL)Fl Number o f  PFC/spleen*
rec ip ien t in jected  with Levan CRBC
5x10? normal FI 3.95 ± 0.19 4.19 ± 0.14
(8,884) (15,553)
5x10? normal FI 
+
<2.00 <2.00
2.5x10? GVH-T (<100) (<100)
normal serum treated
5x10? normal FI 3.57 ± 0 .1 1 4.15 ± 0.08
+
2.5x10? GVH-T
(3,716) (14,193)
a n t i -8  treated
5x10? norT.al FI 3.37 ± 0.04 3.13 ± 0.10
a n t i -6  treated (2,339) (1 ,352)
*Geometric mean ± s .e .  (n = 4)
^GVH reactions induced T4 days previously with 8x10? C57BL 
parental spleen c e l ls .
5. Origin o f the suppressor ce ll
Further experiments were designed to determine whether suppressor 
T ce ll  a c t iv i t y  was o f  parental or FI hybrid o r ig in .  I n i t i a l l y ,  the 
problem was approached in two ways: (1) FI host ce lls  were elim inated
from spleen suspensions obtained 9 days a f te r  the in je c t io n  o f 8x10? 
C57BL parental ce lls  into FI recip ients by pretreatment in vitro with  
anti-CBA alloantiserum and complement; (2) advantage was taken o f  the 
observation described by Howard (1961) tha t a GVH reaction could not 
be induced by C57BL male spleen ce lls  when in jected  into  FI female 
recip ients which had previously re jec ted , or were in the process o f  
re je c t in g ,  a C57BL male skin g ra f t .  GVH reactions were induced in FI 
female recip ients with C57BL male spleen ce l ls  and 9 days l a t e r ,  ce lls  
from these mice were tested fo r  th e ir  a b i l i t y  to suppress the response 
of transferred  spleen ce lls  which were obtained from FI female mice 
grafted with C57BL male skin 24 days previously. I f  parental (C57BL 
male) ce lls  play a ro le  then i t  would be predicted that suppressive 
a c t iv i ty  should be abrogated by FI female anti-C57BL male c e l l -  
mediated alloimmunity.
Both o f these procedures described above were applied simul­
taneously. Whereas C57BL male^Fl female GVH spleen ce lls  were able 
to suppress f u l l y  the response o f transferred  normal FI female c e l ls ,  
they fa i le d  to in h ib i t  the response o f FI female anti-C57BL male 
alloimmune ce lls  (Table 4 ) .  In contrast, these FI female anti-C57BL 
male alloimmune ce lls  were suppressed by C57BL female+Fl female GVH 
ce lls  and pretreatment o f  th is  l a t t e r  population with anti-CBA a l lo ­
anti serum + complement did not impair th e ir  in h ib ito ry  properties  
(Table 4 ) .
Thus, e lim ination  o f  FI host ce lls  with anti-CBA alloantiserum  
from GVH ce ll suspensions does not a f fe c t  th e i r  suppressive p roperties ,  
w h ils t  cell-mediated elim ination  o f  male parental donor c e l ls  by FI 
female anti-C57BL male alloimmune ce lls  abrogates the suppressive
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a c t iv i t y  e n t i re ly .  Taken together, these results  establish th a t  the 
suppressor T ce ll  is  o f parental o r ig in .
These experiments were extended by: (1) in h ib it in g  the host
ce ll p ro l i fe ra t io n  which occurs a f te r  parental ce ll  in je c t io n ,  by 
sub letha lly  i r ra d ia t in g  FI rec ip ients  p r io r  to GVH induction;
(2) endeavouring to generate suppressor T ce l ls  by inducing GVH 
reactions with spleen ce lls  from thymectomized parental donors;
(3) using thymectomized, i r ra d ia te d ,  bone marrow reconstituted
(Th X BM)FI mice as recip ients  fo r  GVH induction. The f i r s t  o f  these 
approaches showed that suppressor T ce lls  were s t i l l  induced in sub- 
le tha l ly - i r r a d ia te d  (600r) FI rec ip ien ts ,  again implying th a t  they 
were o f  donor o r ig in  (Table 5 ) .  Secondly, GVH spleen ce ll suspensions
from FI mice in jected  with spleen ce lls  from thymectomized donors
were devoid o f  suppressive a c t iv i t y  (Table 6 ) .  This suggests tha t  
donor T ce l ls  are necessary fo r  the generation o f  suppressor T c e l ls .  
T h ird ly , suppressor T ce ll  a c t iv i t y  was s t i l l  evident when GVH 
reactions were induced in Th x BM FI mice (Table 5 ) .  Since these 
animals are depleted sub stan tia l ly  o f thymus-derived lymphocytes, th is  
re s u lt  implies th a t  host FI T ce lls  are not essential as stimulators  
fo r  the allogeneic ac t iva t ion  o f donor T c e l ls .
6. B c e l1 re a c t iv i ty  in GVH mi ce
The next series o f  experiments were in i t ia te d  to answer the 
question; are B ce l ls  in GVH mice revers ib ly  or i r re v e rs ib ly  inh ib ited?  
GVH spleen ce lls  were depleted o f both T ce lls  and macrophages with  
anti-Thy 1,2 serum + complement and carbonyl iron respective ly . The 
residual (B c e l l )  population was supplemented with immunoglobulin-anti- 
immunoglobulin column-fractionated normal FI spleen ce lls  as a source 
of normal T ce lls  p r io r  to adoptive tra n s fe r  to i r ra d ia te d  FI re c ip ie n ts .  
The addition of an equal number o f B-depleted normal FI spleen ce l ls  
(which are themselves poorly responsive) f u l l y  restored the response 
o f macrophage-depleted, anti-Thy 1.2 treated  day 7 GVH (C57BL^F1)
Suppression of transferred  normal FI spleen ce lls  by GVH 
spleen ce lls  obtained from FI rec ip ients  which were 
e ith e r  sub-1ethally ir ra d ia te d  or thymectomized, 
i r ra d ia te d  and bone marrow reconstituted p r io r  to GVH induction
900r FI 
Normal FI
rec ip ien t in jected with  
ce lls  GVH cells^
Number o f  PFC/spleen* 
Levan CRBC
5x10? None 4.08 ± 0.20  
(12,159)
3.62 ± 0.10  
(4 ,191)
5x10? 5x10? CBA-induced GVH <2.00 <2.00
in 600r FI mice (<100) (<100)
5x10? 5x10? C57BL-induced GVH 2.09 ± 0.09 2.69 ± 0.21
in 600r FI mice (122) (489)
5x10? 2.5x10? C57BL-induced GVH <2.00 <2.00
in ThxBM FI mice (<100) (<100)
^GVH reactions induced 7 days previously with 8x10? parental 
spleen c e l ls .
^Geometric mean ± s .e .  (n = 4)
Absence o f  suppressor ce ll  induction in FI mice 
in jected  with spleen ce lls  from thymectomized parental donors
Recipient
1*Number o f  PFC/spleen 
LE CRBC
Normal FI 2,758 14,434
(3.44 ± 0 .42) (4.16 ± 0 .51)
FI in jected  with
8x10? C57BL spleen ce lls 7,181 16,307
from Thx* mice 15 days (3.86 ± 0 . 1 7 ) (4.21 ± 0 .34)
previously
4*
Geometric mean ± s .e .  (n = 4)
*Thymectomy performed 94 days p r io r  to spleen harvest
ce lls  to CRBC (F ig . 6 ) .  A s im ila r  restoration  o f  the anti-CRBC RFC 
response by B ce ll-dep le ted  normal FI ce l ls  was also observed when 
GVH ce lls  were derived from day 24 GVH (CBA-^Fl ) mice (F ig . 7 ) .  Although 
th is  p a r t ic u la r  population o f  macrophage-depleted anti-Thy 1.2 treated  
day 24 GVH ce lls  produced a higher response than usual (3 .63 ± 0 .0 8 ) ,  
the addition o f an equal number o f  B ce ll-dep le ted  normal FI ce lls  
resulted in a s ig n if ic a n t  (P <0.001) increase o f  the PFC response 
(4.51 ± 0 .0 5 ) .  For reasons which are not c le a r ,  the anti-LE response 
which was shown previously to be independent o f  both T ce lls  and macro­
phages (Desaymard and Feldmann 1975) was only p a r t ia l l y  restored by 
macrophage-depletion and anti-Thy 1.2 treatment (F ig . 6 ) .  These 
results  imply tha t  GVH-induced immunosuppression is not a t tr ib u ta b le  
to cytotoxic deletion o f B c e l ls ,  since suppression is reve rs ib le .
7. E ffec t  o f  delayed GVH ce ll t ransfer
Further experiments were designed to determine whether GVH ce lls  
suppress an adoptive primary response by: (1) in te r fe r in g  with the
stage o f  antigen recognition; (2) a ffec ting  the migratory character­
is t ic s  o f  transferred normal c e l ls ;  or (3) an a n t i -p r o l i f e r a t iv e  
e f fe c t  on the B ce l l  population, e i th e r  a t  the ear ly  p re -m ito t ic  stage 
of antigen-induced stim ulation or a t  the l a te r  stage o f  ce l l  d iv is io n .  
Four groups o f  FI mice were irra d ia te d  and repopulated with 5x10? 
syngeneic normal FI c e l ls .  One group was in jected  with 5x10? day 7 
GVH spleen ce lls  and a l l  groups were challenged with LE and CRBC 6 hr 
l a te r .  The second and th ird  groups received 5x10? GVH ce lls  on days 
1 and 2 respective ly , w h ils t  the f in a l  group served as a con tro l.
The results (Table 7) indicate th a t  even 2 days a f te r  normal 
spleen ce lls  had been transferred and challenged with antigen, GVH 
ce lls  s t i l l  retained th e i r  potentia l to in h ib i t  the response. This 
re s u lt ,  together with the splenic a c e l lu la r i t y  observed following the 
t ra n s fe r  o f  GVH ce lls  into ir ra d ia te d  rec ip ien ts ,  suggests th a t  the 
exertion o f  a n t i -p r o l i f e r a t iv e  a c t iv i t y  plays a ro le  in the mechanism
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As Fig. 6 , but showing only anti-CRBC RFC 
responses. GVH reactions were induced 24 
days previously with CBA parental c e l ls .
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Finure 7
The e f fe c t  o f  delayed GVH ce ll  t ra n s fe r  on the d ire c t  RFC 
response o f 5x10? normal FI spleen ce l ls  transferred  
to 900r ir ra d ia te d  FI recip ients
Time in te rva l between 
antigen challenge and
RFC/spleen*
GVH^  ce ll  t ra n s fe r  (hr) LE CRBC
No GVH ce lls 12,739 
(4 .10 ± 0 .08)
14,274 
(4 .15 ± 0 . 0 9 )
-6 663
(2.82 ± 0 .22)
1,849 
(3.26 ± 0 .21)
24 1,798  
(3.25 ± 0 .10)
4,036  
(3 .60 ± 0 .11)
48 3,438  
(3 .53 ± 0 .17)
4,325  
(3 .63 ± 0 .17)
^Geometric mean ± s .e .  (n = 4)
^GVH reactions were induced 7 days previously with 8x10? C57BL
parental spleen c e l ls .
of immunosuppression.
8. A lte rna t ive  rec ip ien t  treatments applied as a substitu te  fo r  
i r ra d ia t io n  to demonstrate suppression by transferred GVH ce lls  
One o f  the anomalies presented by the present and previous (B yfie ld
et al, 1973) studies is  the observation th a t  GVH ce lls  adoptively trans­
ferred to normal unirradiated FI recip ients f a i l  to exert any 
suppressive influence, even though they are able to suppress f u l l y  the 
response o f an equal number o f  normal FI ce lls  when both are transferred  
to le th a l ly - i r r a d ia te d  mice. I n i t i a l l y ,  the p o s s ib i l i ty  was considered 
that th is  could be merely a qua n tita t ive  phenomenon, but even the trans­
fe r  of 4x108 GVH ce lls  to an unirradiated FI rec ip ien t fa i le d  to modify 
i ts  responsiveness (Table 8 ) .  However, a more l ik e ly  explanation fo r  
th is apparent lack o f  suppressive a c t iv i t y  in unirradiated FI mice is  
that d ifferences e x is t  in the homing characteris t ics  o f GVH ce lls  when 
they are transferred to ir ra d ia te d  FI mice, p a r t ic u la r ly  since i t  is  
known that H-2 activated thymus ce lls  possess migratory properties  
that are e n t i re ly  d i f fe re n t  from those o f  normal thymus ce lls  (Sprent 
1976; Sprent and M i l le r  1976).
The p o s s ib i l i ty  was also explored th a t  an activated macrophage 
might be necessary as a secondary e f fe c to r  ce ll which would be induced 
by active  p ro l i fe ra t io n  in the environment o f  the i r ra d ia te d  re c ip ie n t .  
Therefore, low doses o f  i r ra d ia t io n  and pretreatment with c, parvum (a 
known reticu loendothe lia l stimulant) were substituted fo r  le th a l  
i r ra d ia t io n .  A ll these procedures fa i le d  to produce a rec ip ien t  in  
which GVH ce lls  were able to express th e i r  suppressive properties  
(Table 9 ) .
9. E ffec t  o f suppressor ce l ls  on normal ce lls  d i f fe r in g  a t  major 
or minor h is tocom patib il ity  loci
Since i t  was now established tha t the suppressor T ce lls  involved 
were o f parental o r ig in ,  an experiment was designed to ascerta in whether 
they could suppress other ce l ls  which lacked the major h is to co m p atib il ity
The failure of day 7 GVH cells to suppress
the response of intact FI recipients
Recipient
PFC/spleen*
LE CRBC
Normal FI 5,129 61,660
(3.71 ± 0 .03) (4.79 ± 0 .02)
Normal FI
9,772 134,900
+
4x10® GVH^  ce l ls
(3.99 ± 0 .02) (5 .13  ± 0 .05)
^Geometric mean ± s .e .  (n = 4)
GVH reactions were induced 9 days previously with 8x10? 
C57BL parental spleen c e l ls .
The inability of day 7 GVH cells to suppress the response of
lightly irradiated or C, parvum treàted recipients
Recipient Cells
in jected
PFC/spleen 
LE CRBC
Normal 1x10® normal 15,860 
(4 .20  ± 0 .05)
61,317  
(4 .78  ± 0 .09)
lOOr II 30,051 
(4 .47 ± 0.10)
35,864 
(4.55 ± 0.03)
300r II 46,919 
(4 .67 ± 0 .03)
28,262 
(4 .45 ± 0 .10)
900r II 55,461 
(4 .74  ± 0.07)
39,659 
(4.59 ± 0 .14)
Normal 1x10® GVH 12,455 
(4 .09 ± 0 .16)
19,348 
(4 .28  ± 0 .02)
lOOr II 26,115 
(4.41 ± 0.09)
23,665 
(4 .37 ± 0 .17)
300r II 13,275 
(4 .12 ± 0 .17)
25,936 
(4.41 ± 0 .07)
900r II 254
(2.40 ± 0 .27)
210
(2 .32  ± 0 .07)
+
C, parvum 1x10® normal 65,863 151,472
treated (4 .82  ± 0.22) (5 .1 8  ± 0 .07)
C. parvum 1x10® GVH 93,902 226,547
treated (4 .97  ± 0 .09) (5 .35  ± 0 .05)
*Geometric mean ± s .e .  (n = 4)
^Recipients in jected i . v .  with 350 yg c, parvum 4 days before ce l l  
transfers .
antigens towards which they were sensitized . GVH reactions were 
induced in (CBAxC57BL)Fl mice with C57BL parental spleen ce l ls  and 
13 days la te r  th e ir  spleen ce lls  were iso lated  and treated with a n t i -  
CBA alloantiserum and complement. The residual ce ll  population was 
transferred  to le th a l ly - i r r a d ia te d  mice o f  the (CBAxC57BL)Fl,
(AKRxC57BL)Fl and (DBA/lxC57BL)Fl stra ins which had a l l  been repopulated 
with 5x10^ syngeneic FI spleen c e l ls .  AKR and DBA/1 were chosen as 
parental stra ins representing respective ly  minor (non-H-2) and major 
(H-2) h is tocom patib il ity  differences from the CBA s tra in .
Whereas anti-CBA-treated GVH ce lls  v i r tu a l ly  abrogated the 
anti-LE and CRBC RFC response o f  both (CBAxC57BL)Fl and (AKRxC57BL)Fl 
transferred  ce lls  they had l i t t l e  e f fe c t  on the response o f  ( DBA/1xC57BL)FI 
transferred ce lls  (Table 10). This implies th a t  e i th e r  GVH ce lls  w i l l  
not suppress ce lls  o f other H-2 s p e c if ic i t ie s  or else the absence o f  
a matching FI host stim ulator ce ll  precludes tr iggering  o f  the 
suppressor ce ll  so tha t  i t s  suppressive potentia l is not expressed.
To decide between these a lte rn a t iv e s ,  2x10? (CBAxC57BL)Fl spleen ce lls  
were added to 5x10? anti-CBA-treated GVH ce lls  before transferrence  
to le th a l ly - i r r a d ia te d  ( DBA/1xC57BL)FI rec ip ients  repopulated with  
5x10? syngeneic c e l ls .  The tran s fe r  o f  th is  mixture caused substantial 
in h ib it io n  o f the d ire c t  RFC response to LE and CRBC; a re s u lt  which 
could not be obtained by transferr ing  anti-CBA-treated GVH c e lls  alone 
(Table 11). Thus, immune parental ce lls  require spec if ic  s tim ulation  
by ta rge t ce l ls  to which they are sensitized fo r  them to exert th e i r  
suppressive p o te n t ia l i ty .
10. Lack o f e f fe c t  o f C57BL-induced GVH suppressor ce l ls  on transferred
C57BL spleen ce lls
An in vivo t ransfer  system was tested to confirm the f ind ing  
(Sjtiberg 1972) that normal parental ce l ls  o f  the same genotype as those 
used fo r GVH induction are suppressed by GVH ce lls  in vitro. Host FI 
ce lls  were depleted from C57BL-induced GVH spleen suspensions with
The suppressive a c t iv i t y  o f alloantiserum -treated GVH spleen 
ce lls  on the d ire c t  RFC response o f  transferred ce lls  from 
mice o f d i f fe re n t  histocom patabilit ies
900 rad rec ip ien t Anti-CBA treated  
repopulated with 5x107 C57BL-induced GVH^  
syngeneic spleen ce lls  spleen (5x10?)
Number of  
RFC/spleen* 
Levan CRBC
(CBAxC57BL)Fl - 4.03 ± 0.15  
(10,717)
4.30 ± 0.16  
(19,086)
{CBAxC57BL)Fl + <2.00
(<100)
2.12 ± 0.07  
(132)
(AKRxC57BL)Fl - 3.47 ± 0.11 
(2 ,9 37 )
4.07 ± 0.11 
(11,863)
(AKRxC57BL)Fl + <2.00
(<100)
<2.00
(<100)
(DBA/1XC57BL)FI - 4.39 ± 0.07  
(24,412)
4.54 ± 0.14  
(34,627)
(DBA/1XC57BL)FI + 3.91 ± 0.01 
(8 ,045)
4 .78  ± 0.05  
(59,603)
*Geometric mean ± s .e .  (n = 4)
^GVH reactions induced 13 days previously with 8x10? C57BL 
parental spleen c e l ls .
Suppression o f  H-2 incompatible transferred  
spleen ce lls  by GVH ce lls
900 rad FI rec ip ien t
5x107
Number o f
repopulated with 5x10^ anti-CBA PFC/spleen^
syngeneic spleen cells treated
GVH* ce lls LE CRBC
(CBAxC57BL)Fl + <100
(<2.00)
206
(2.31 ± 0 .16)
(DBA/1XC57BL)FI + 13,115 
(4.12 ± 0.17)
5,477  
(3 .74  ± 0 .25)
( DBA/1XC57BL)FI 
also in jected with 
2x107 (CBAxC57BL)Fl
+
1,075 
(3 .03 ± 0.20)
936
(2.97 ± 0 .16)
^Geometric means ± s .e .  (n = 4)
*GVH reaction induced 11 days previously with 8x10? C57BL 
parental spleen c e l ls .
anti-CBA alloantiserum  plus complement and the residual c e lls  tested  
fo r  th e ir  capacity to in h ib it  the immune response given by transferred  
normal FI or C57BL parental c e lls .  Table 12 shows th a t suppressor 
a c t iv ity  is  expressed against FI c e lls  but not against C57BL parental 
c e lls .
11. Resistance o f GVH-induced immunosuppression to ir ra d ia t io n
Since immunocompetent FI c e lls  transferred  in to  irra d ia te d  GVH
mice have been reported as being unable to express th e ir  immuno- 
potentia l (MOller 1971), v e r if ic a t io n  o f th is  observation was 
undertaken in  the present model. FI mice in jec ted  6 or 21 days 
previously w ith e ith e r  CBA or C57BL spleen c e lls  were le th a lly  
irra d ia te d  and repopulated with 5 x 1 0^ normal FI c e lls . The anti-LE  
RFC response was in h ib ite d  s u b s ta n tia lly  in a l l  groups as compared 
with irra d ia te d  FI controls (Table 13).
The phenomenon was explored fu rth e r  by tra n s fe rrin g  5 x 1 0^ spleen 
ce lls  from le th a lly - ir ra d ia te d  GVH mice, immediately or 4 hr a f te r  
ir ra d ia t io n , in to  le th a lly - ir ra d ia te d  FI mice repopulated w ith 5 x 1 0^ 
syngeneic spleen c e lls . The resu lts  (Table 14) show th a t GVH spleen 
c e lls  harvested immediately a f te r  ir ra d ia t io n  were s t i l l  suppressive. 
However, when harvested and transferred  4 hr a f te r  ir ra d ia t io n , l i t t l e  
suppressive a c t iv ity  was evident.
12. E ffe c t o f host-versus-g ra ft (HVG) spleen c e lls  on the response
o f transferred  normal c e lls
CBA or C57BL parental s tra in  mice were in jec ted  intravenously  
with 1 x 1 Q8 (CBAxC57BL)F1 spleen c e lls . Ten days la te r  th e ir  spleen 
ce lls  (5x10?) were transferred  to le th a lly - ir ra d ia te d  syngeneic CBA 
or C57BL mice repopulated with 5 x 1 0^ syngeneic spleen c e lls .  These 
animals were challenged with LE and CRBC on the fo llow ing day and 
RFC assays performed a f te r  a fu rth e r 5 days. Table 15 shows th a t only 
a s lig h t diminution o f anti-LE  RFC responses resulted  in both CBA and 
C57BL irra d ia te d  repopulated rec ip ien ts  o f HVG c e lls  as compared w ith
Lack o f suppressive e f fe c t  o f C57BL-induced 
GVH c e lls  on transferred  C57BL spleen c e lls
900 rad re c ip ie n t  
in jec ted  with 5x107 
syngeneic spleen ce lls
2.5x107 
anti-CBA 
treated  
GVH* ce lls
Number o f 
PFC/spleen^
LE CRBC
(CBAxC57BL)Fl - 24,395 
(4 .39  ± 0 .1 4 )
31,647 
(4 .50  ± 0 .11)
(CBAxC57BL)Fl + 406
(2.61 ± 0 .21)
1,446 
(3 .16  ± 0 .24 )
C57BL - 4,867  
(3 .69  ± 0 .17)
10,698  
(4 .03  ± 0 .19 )
C57BL + 6,735 
(3 .83  ± 0 .05)
26,255 
(4 .42  ± 0 .06 )
Geometric means ± s .e . (n = 4)
*GVH reaction induced 13 days previously ^ ith  8x10^ C57BL 
parental spleen c e lls .
The inability of immunocompetent FI spleen
cells to respond when transferred to
irradiated GVH recipients
900 rad recip ien ts
Number o f anti-LE  PFC/spleen* 
Days a f te r  GVH induction  
6 21
CBA-induced GVH 2.46 ± 0.26  
(286)
2.17 ± 0.17  
(149)
C57BL-induced GVH 2.64 ± 0.24  
(436)
N .D .t
Normal FI 4 .18  ± 0 .18  
(15,112)
3.87 ± 0.06  
(7 ,381)
*Geometric mean ± s .e . (n = 4)
t Not done due to 100 per cent m o rta lity
The suppressive a c t iv ity  o f irra d ia te d  GVH c e lls  when 
transferred  immediately or 4 hr a f te r  ir ra d ia t io n
Number o f anti -LE PFC/spleen*
900 rad FI rec ip ien ts Expt. 1. GVH^  c e lls Expt. 2. GVH^cells
in jec ted  with transferred transferred
immediately a f te r  4 hr
5x107 normal FI 3.63 ± 0.11 4.00 ± 0.06
(4,278) (10,026)
5x107 normal FI 
+ 2.10 ± 0.10 2.12 ± 0.10
5x107 un irrad iated  GVH (126) (132)
5x107 normal FI 2.89 ± 0.14 3.86 ± 0.06
5x107 irra d ia te d  GVH (777) (7 ,248)
*Geometric mean ± s .e . (n = 4)
^GVH reactions induced 9 days previously w ith 8x10^ parental 
spleen c e lls .
The e f fe c t  o f hos t-versus -g ra ft (HVG) c e lls  on the 
response o f transferred  normal spleen ce lls
Irra d ia te d  re c ip ien t In je c tio n  o f Number o f
repopulated with 5x10^ 5x107 HVG* PFC/spleen^
syngeneic spleen c e lls spleen c e lls LE CRBC
CBA 4.11 ± 0.06 4.65 ± 0.04
(12,769) (44,300)
CBA + 3.58 ± 0.09 4.32 ± 0.03
( 3,833) (20,897)
C57BL _ 3.76 ± 0.08 4.07 ± 0 .08
( 5,702) (11 ,734)
C57BL + 3.47 ± 0.08 4.32 ± 0 .08
( 2,922) (21 ,005)
*HVG reactions were induced in  parental s tra in  mice w ith 8x10^ 
FI spleen c e lls  10 days previously.
4*
Geometric mean ± s .e . (n = 4)
contro ls . This suppressive e f fe c t  is  a t le a s t 2 orders o f magnitude 
less than th a t consis ten tly  obtained w ith GVH c e lls . Moreover, in  
the case o f anti-CRBC RFC responses, whereas a s lig h t in h ib it io n  by 
HVG c e lls  occurred in  CBA mice, s lig h t p o ten tia tion  was evident in  
C57BL mice.
RESULTS PART I I
Studies in vitro
Further work was concerned w ith an in vitro analysis o f GVH 
c e lls  since th is  approach could provide a superior means o f assessing 
the re la t iv e  contributions o f p u rifie d  c e ll populations to immuno­
suppression.
1. Immune responsiveness o f GVH c e lls  and th e ir  suppressive 
properties in vitro
The immune status o f spleen c e lls  from (CBAxC57BL)Fl mice 
in jec ted  previously w ith e ith e r  CBA or C57BL parental spleen c e lls  to 
SRBC was compared in vitro (Table 16a). These data confirm th a t the 
unresponsive s ta te  which develop in  GVH mice is  expressed in vitro to 
an extent which is  comparable w ith th a t previously observed in vivo 
(see F ig . 2 ) .
The suppressive ch arac te ris tics  o f GVH c e lls  in vitro were 
analysed i n i t i a l l y  in  two experiments. F ir s t ly ,  day 7 C57BL-induced 
GVH spleen ce lls  (2x10^) were capable o f v ir tu a l ly  abrogating the a n t i-  
SRBC response o f 6x10? primed (CBAxC57BL)Fl spleen c e lls  when both 
were cultured together (Table 16b), whereas the add ition  o f 2x10? normal 
FI spleen c e lls  to the primed c e ll population caused only an in s ig n if i ­
cant decrease in  the number o f PFC generated (p > 0 .25 ). Secondly, GVH 
ce lls  which had been frac tiona ted  on immunoglobulin-anti-immunoglobulin 
columns were tested fo r th e ir  a b i l i t y  to suppress the in vitro a n t i-  
SRBC primary response o f normal FI spleen c e lls . Table 16c shows th a t
Immune suppression mediated by GVH cells in vitro
Experiment Spleen c e lls  cultured
Number o f  
PFC/culture*
a) F a ilu re  o f day 7 GVH Normal FI (2x10?) 1,045 ± 78
spleen c e lls  to CBA-induced GVH (2x10?) 26 ± 8
respond to SRBC C57BL-induced GVH (2x10?) 7 ± 3
b) Suppression o f the Primed FI (6x10^) 8,535 ± 3,356
secondary anti-SRBC Primed FI (6x10?) 233 ± 26
response by day 9 + GVH (2x107)
GVH^  spleen c e lls Primed FI (6x107)
+ normal FI (2x107)
5,466 ± 2,033
c) Suppression o f the Normal FI (6x10?) 490 ± 100
primary anti-SRBC Normal FI (6x107) 48 ± 8
response by day 8 + GVH-T (1x10?)
Ig -a n t i - Ig  frac tiona ted  
GVH^  spleen c e lls
Normal FI (6x10?) 
+ NOR-T (1x107)
527 ± 282
^Arithm etic mean ± s .e . (n = 4) o f d ire c t  (expt. a and c) or 
to ta l (expt b) PFC to SRBC a f te r  4 days in  cu ltu re .
t GVH reactions induced w ith C57BL parental spleen c e lls .
IxlO? GVH-T c e lls  suppressed the primary anti-SRBC response o f 6x10? 
normal FI c e lls , whereas normal FT T c e lls  were w ithout e f fe c t .
2. The a b i l i t y  o f  GVH c e lls  to suppress normal c e lls  in vivo and 
in vitro is  unaffected by macrophage depletion  
Spleen c e lls  from FI mice in jec ted  with C57BL parental spleen 
ce lls  13 days previously were passed through Sephadex G-10 columns to 
deplete them o f macrophages. They were then transferred  to le th a lly -  
irra d ia te d  FI rec ip ien ts  repopulated w ith 5 x 1 0^ syngeneic spleen c e lls .  
Table 17 shows th a t G-10 fra c tio n a tio n  fa ile d  to abrogate the suppressor 
a c t iv ity  in d ica tin g  th a t GVH macrophages are not suppressive.
In fu rth e r  experiments using a two-stage Marbrook cu ltu re  system, 
1x107 GVH spleen ce lls  from FI mice in jec ted  with C57BL spleen c e lls  
10 days previously were cultured overnight a t 37°C in  5% COg. The 
non-adherent ce lls  were then removed by thorough washing o f the d ia ly s is  
membranes and the cultures reseeded w ith 2x107 primed FI spleen c e lls .  
Primed FI c e lls  were added to another group o f unwashed cultures to 
serve as contro ls . Table 18 shows th a t whereas unwashed GVH spleen 
ce lls  produced a 15 -fo ld  suppression o f the anti-SRBC response, the  
adherent fra c tio n  from the same GVH suspension produced a mere 2 -fo ld  
in h ib it io n . Pre-cultured normal FI spleen c e lls  also caused a s lig h t  
in h ib it io n  o f the PFC response, presumably due to sub-optimal cu ltu re  
conditions associated with higher c e ll d en s ities . The experiments 
were extended by p re -cu ltu rin g  1x107 GVH spleen c e lls  and tra n s fe rr in g  
th e ir  non-adherent fra c tio n  on the next day to fresh Marbrook chambers. 
The d ia lys is  membranes o f the o rig in a l chambers were washed thoroughly  
to ensure th a t only adherent c e lls  remained. Both groups were 
reseeded w ith 2 x l Q 7  primed FI spleen c e lls  and SRBC as a source o f  
antigen. A th ird  control group consisted o f primed FI spleen c e lls  
and SRBC. The resu lts  (Table 19) demonstrated th a t the non-adherent 
fra c tio n  suppressed the anti-SRBC PFC response w h ils t the adherent 
fra c tio n  was w ithout e f fe c t .
The in a b i l i ty  o f macrophage-depletion to modify the 
suppressive a c t iv ity  o f GVH c e lls  in vivo
Spleen ce lls  in jec ted
Number o f d ire c t PFC/spleen* 
Levan CRBC
5x10? syngeneic FI 3.56 ± 0 .18 4.70 ± 0.09
(3 ,646) (49,772)
5x107 syngeneic FI <2.00 2.26 ± 0.18
+
2.5x107 GVH^ (<100) (182)
5x10? syngeneic FI <2.00 2.10 ± 0.10
+
2,5x10? GVH (GIO frac tio n a ted ) (<100) (126)
^Geometric means ± s .e . (n = 4)
^GVH reactions were induced 13 days previously w ith 8x10? 
C57BL parental spleen c e lls .
Removal o f suppressive a c t iv ity  from GVH 
suspensions by depletion o f non-adherent c e lls
Precultured  
spleen c e lls  
(1x107)
Primed FI 
spleen c e lls  
(2x107)
Total 
PFC/culture^
None + 3,160 ± 409
GVH* -  unwashed + 215 ± 20
GVH -  washed + 1 ,625 ± 321
FI -  unwashed + 1,710 ± 113
FI -  washed + 3,190 ± 412
A rithm etic mean ± s .e . (n = 3)
*GVH reactions induced 10 days previously w ith 8x10? C57BL 
parental spleen c e lls .
The e f fe c t  o f adherent and non-adherent frac tio n s  o f GVH 
c e lls  on the anti-SRBC response o f primed FI c e lls  in vitro
Pre-cultured GVH^ Primed FI c e lls Number o f to ta l
spleen c e lls  (1x10?) (2x10?) PFC/culture*
None + 2,215 ± 260
Adherent fra c tio n + 2,782 ± 525
Non-adherent fra c tio n + 622 ± 8
^Arithm etic mean ± s .e . (n = 4)
^GVH reactions were induced 10 days previously with 8x10^ 
C57BL parental spleen c e lls .
3. Suppression o f B c e ll responses by GVH-T c e lls  in  the absence 
o f macrophages
The p o s s ib ility  th a t normal FI splenic macrophages were involved  
in  the mechanism o f suppression was excluded by means o f the in vitro 
response to DNP-LE, which is  known to be independent o f macrophages 
(Desaymard and Feldmann 1975). Normal FI spleen ce lls  were depleted  
of macrophages by Sephadex G-10 fra c tio n a tio n  and cultured w ith GVH-T 
c e lls  (p u r if ie d  by a f f in i t y  chromatography) using both DNP-LE and 
SRBC as antigens. Although macrophage depletion s u b s ta n tia lly  
diminished the anti-SRBC PFC response, the anti-DNP response was 
unaffected (Table 20). The add ition o f 5x106 GVH-T c e lls  (13 days 
a f te r  GVH induction) to 2x10^ macrophage-depleted FI c e lls  in h ib ite d  
the anti-DNP PFC response to the same extent as the anti-SRBC response 
o f untreated FI c e l ls ,  in d ica tin g  th a t the presence o f macrophages is  
not required fo r  T c e lls  to exert th e ir  suppressive p o te n tia l.
4. Suppression o f FI c e lls  by GVH c e lls  across a cell-im perm eable  
membrane
The next series o f experiments was designed to determine whether 
GVH immunosuppression is  mediated by soluble factors or whether i t  
requires c e l l - to -c e l l  contact. Both C57BL and CBA-induced GVH spleen 
c e lls  were tested in  double Marbrook chambers in which GVH suspensions 
were separated from responding FI c e lls  by a Nucleopore membrane. 
S u rp ris in g ly , only CBA induced GVH c e lls  were found to be suppressive 
(Table 21a). S ig n ific a n t suppression was not observed w ith C57BL- 
induced GVH c e lls  in any o f seven ind iv idual experiments, even though 
transfers o f the same ce ll populations demonstrated th a t they were 
highly suppressive in vivo (data not shown).
The re la t iv e  proportions o f donor and host c e ll p ro life ra t io n  
in (CBAxC57BL)Fl mice undergoing CBA and C57BL-induced GVH reactions  
are known to be qu ite  d iffe re n t:  v ir tu a l ly  100% donor p ro life ra t io n
is  found in the case o f C57BL, but less than 1% in CBA a f te r  the
The ability of GVH-T cells to suppress the anti-DNP-LE
response of macrophage-depleted FI cells in vitro.
Spleen (2x10?) 
c e lls  cultured
Addition o f 
5x10® GVH-f*'cells
Antigen
Number o f d ire c t  
PFC/culture* 
SRBC DNP
Normal FI - DNP-LE 470 ± 64
Normal FI - SRBC 1,745 ± 5 3 3
GIO passed - DNP-LE 680 ± 28
normal FI
GIO passed - SRBC 260 ± 178
normal FI
GIO passed + DNP-LE <40
normal FI
Normal FI + SRBC <40
*A rithm etic  mean ± s .e . (n = 4)
^GVH reactions were induced 13 days previously w ith 8x10? C57BL 
parental spleen c e lls .
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i n i t i a l  burst o f donor c e ll m itosis (Fox 1962). To explain the 
d if fe re n t ia l  suppressive e f fe c t  between CBA and C57BL-induced GVH 
c e lls  across a Nucleopore membrane, i t  was argued th a t the add ition  
of FI host c e lls  to the C57BL-induced GVH c e ll suspension might be 
necessary to provide the s tim u lator c e l l .  This postulate was con­
firmed in two experiments (Table 21b and c) which showed th a t whereas 
C57BL-induced GVH c e lls  alone are incapable o f suppressing the 
anti-SRBC response o f primed FI c e lls  across a membrane, the 
addition o f normal FI c e lls  to the chamber containing GVH c e lls  
produced s ig n ific a n t in h ib it io n  o f PFC responses on the other side 
o f the membrane (Expt. b, p <0.005, Expt. c p <0 .001).
5. Comparison o f GVH suppressive fa c to r w ith immunoglobulin
binding fac to r IBF)
I t  has been reported th a t a fa c to r (IBF) is  produced fo llow ing  
allogeneic T ce ll ac tiv a tio n  which suppresses the in vitro d ire c t PFC 
response o f normal c e lls  to thymus-dependent and independent antigens 
n o n -sp ec ifica lly  (G is le r and Fridman 1975). More rece n tly , these 
same authors also showed th a t the suppressive e f fe c t  o f th is  fa c to r  
could be abrogated by the add ition  o f heat-aggregated mouse immuno­
g lobulin  to the cu lture  system (G is le r  and Fridman 1976). Consequently, 
i t  was decided to study the e f fe c t  o f aggregated mouse immunoglobulin 
on the suppression which is  induced by GVH c e lls  vitro.
Day 8 C57BL-induced GVH c e lls  (5x10^) were added to 2x10? primed 
FI spleen c e lls  in Marbrook chambers in the presence o f varying amounts 
o f mouse immunoglobulin which had been heat-aggregated a t 63°C fo r  20 
min as described by G is le r and Fridman (1976). The resu lts  show th a t  
even in  the presence o f the highest concentration o f aggregated mouse 
immunoglobulin (150 yg /m l), the suppression o f anti-SRBC responses by 
GVH c e lls  was not a ffected  (Table 22 ). I t  seems l ik e ly ,  th e re fo re , 
th a t the suppressive e ffe c ts  induced by GVH c e lls  and IBF involve  
d is s im ila r  mechanisms.
Suppressor a c t iv ity  in vitro is  not abrogated 
by aggregated mouse immunoglobulin
Primed FI 
spleen c e lls  
2x10?
GVH* 
spleen c e lls  
5x106
Aggregated 
mouse IgG 
(yg /c u ltu re )
Number o f to ta l 
anti-SRBC PFC/culture^
+ - - 5,347 ± 676
+ + - 37 ± 9
+ + 150 30 ± 10
+ + 30 60 ± 26
+ + 6 26 ± 7
4.
A rithm etic mean ± s .e . ( n = 3)
*GVH reaction induced 8 days previously w ith 8x10? C57BL 
parental spleen c e lls .
DISCUSSION
1. K inetics o f immunosuppression
The present studies on the k ine tics  o f the immunosuppression 
which develops in FI mice in jec ted  w ith parental spleen c e lls  reveals  
th a t the time o f onset and in te n s ity  o f suppression are comparable in  
GVH reactions induced by e ith e r  parental s tra in . The findings th a t  
immunosuppression is  detectable a t day 4 , profound a t day 7 and max­
imal by day 10-14, is  in  agreement with the resu lts  obtained by 
previous workers (M ü ller 1971; B y fie ld  et al. 1973; Zaleski and 
Milgrom 1973; Lapp e t al. 1974). I t  thus appears to be a reproducible  
phenomenon irres p ec tiv e  o f the mouse s tra in s  which are used.
I t  has been claimed th a t a co rre la tio n  exists  between the 
in te n s ity  o f a GVH reaction as assessed by splenomegaly and the subse­
quent degree o f immunosuppression (Howard and Woodruff 1961; Lawrence 
and Simonsen 1967). However, in  the mouse s tra in s  used in  the present 
experiments no d ifferences were apparent between GBA and C57BL parental 
ce lls  in  respect o f the level o f suppression a tta in e d , even though a 
GVH reaction e l ic ite d  w ith GBA c e lls , although chronic, can be regarded 
as mild in  terms o f m o rta lity  and donor ce ll p ro life ra t io n  (Fox and 
Howard 1963).
The number o f parental c e lls  which are used to induce a GVH 
reaction has a profound e ffe c t  on the k in e tics  o f immunosuppression. 
Experiments in  which GVH reactions were induced w ith 2x10? G57BL 
parental spleen c e lls  (see Table 39, Ghapter 3 ), together w ith e a r l ie r  
resu lts  o f others (B y fie ld  et al. 1973), ind ica te  th a t the onset o f  
suppression occurs a t a la te r  stage and tends to be much more 
variab le  when compared with reactions induced by 8x10? parental c e lls .  
When only 5x106 G57BL parental spleen c e lls  were used fo r  GVH induction , 
suppression was not detectable even 84 days la te r .
In s tra in  combinations where mice undergoing GVH reaction usually
survive (e .g . CBA->F1), the accompanying immunosuppression is  long- 
la s tin g  and animals remain generally  unresponsive to challenge even 
80 days a f te r  GVH induction. This agrees w ith an e a r l ie r  report in  
which (CBAxC57BL)Fl mice undergoing GVH reaction induced w ith CBA 
parental c e lls  were found to be immunosuppressed beyond 100 days 
(B y fie ld  et a7. 1973). I t  is  important to stress th a t , w ithout excep­
t io n , antibody responses to the thymus-independent antigen LE were 
suppressed to an extent comparable w ith those to the thymus- 
dependent antigen CRBC.
2. Suppression o f normal ce lls  by GVH ce lls
The e a r l ie r  observation o f B yfie ld  et al. (1973) th a t GVH c e lls  
could a c tiv e ly  suppress the antibody response o f normal FI c e lls  when 
both were transferred  in to  le th a lly  irra d ia te d  FI rec ip ien ts  has been 
confirmed. However, th is  face t o f suppression was found to be 
r e la t iv e ly  tra n s ien t since, with e ith e r  parental ce ll induction , GVH 
c e lls  completely lo s t th e ir  a b i l i t y  to suppress normal c e lls  by day 21 
even though the GVH mice themselves remained unresponsive (F ig . 2 ) .  
Furthermore, spleen c e lls  from day 21 GVH mice did not respond when 
transferred  alone to irra d ia te d  FI re c ip ien ts .
Possible explanations fo r  th is  apparent dichotomy are: 1) B
c e ll damage occurs only during the la te r  stages o f GVH reac tion ;
2) a q u a n tita tiv e  reduction o f suppressor c e l ls ,  or 3) the maintenance 
o f suppression during la te r  stages by another ce ll type. The f i r s t  
o f these a lte rn a tiv e s  is  elim inated by the find ing  th a t B c e lls  from 
GVH mice a t both 7 and 24 days a f te r  GVH induction are fu n c tio n a lly  
reactive  (F igs. 6 and 7 ). Moreover, i t  has been reported th a t there  
is  no rad ical change in the number o f immunoglobulin-bearing c e lls  in  
GVH mice (B y fie ld  et al. 1973; Sol n ik et al. 1973). Although a 
progressive reduction in the number o f suppressor c e lls  which are 
present in GVH spleen cannot be excluded, i t  is d i f f i c u l t  to under­
stand why detectable suppressor a c t iv ity  should disappear e n t ire ly .
A lte rn a tiv e ly , i t  is  possible th a t suppressor c e lls  may migrate out 
o f the spleen, enter the re c irc u la tin g  lymphocyte pool and s e t t le  in  
other lymphoid organs. The th ird  p o s s ib il ity ,  th a t another type o f  
ce ll (most l ik e ly  a macrophage) maintains suppression, is  d i f f i c u l t  
to prove w ith tra n s fe r experiments because o f the problems associated  
with the homing ch arac te ris tics  o f transferred  macrophages. However, 
i t  is  c lea r th a t macrophages from GVH mice do not possess detectable  
suppressive a c t iv ity  when tested in vitro (Table 19) and th is  may 
imply th a t they do not play a ro le  in vivo. Thus, none o f these 
explanations provide a s a tis fa c to ry  so lu tion .
Why are GVH c e lls  unable to suppress the immune response o f  
un irrad iated  FI mice when they are p e rfe c tly  capable o f abrogating  
the response o f normal spleen c e lls  when both are transferred  to 
irra d ia te d  recip ients? I t  is  conceivable th a t activated  macrophages 
are needed as secondary e ffe c to r  c e lls  and these would be induced by 
le th a l ir ra d ia t io n  and repopulation. However, attempts to demonstrate 
suppressive a c t iv ity  by GVH c e lls  when transferred  to l ig h t ly  
irra d ia te d  or C. parüwm-pretreated rec ip ien ts  were unsuccessful (Table  
9 ). Furthermore, the present in vitro experiments have demonstrated 
two features: 1) th a t suppressive a c t iv ity  is  not associated w ith
adherent ce lls  (Tables 18,19) and 2) th a t suppression o f the anti-DNP- 
LE response o f macrophage-depleted normal FI c e lls  by GVH-T c e lls  
alone is  unimpaired (Table 20). These resu lts  imply th a t , in  th is  
model, macrophages do not play a major ro le  in  the suppression o f  
antibody responses. I t  seems more l ik e ly  th a t the in a b i l i ty  o f GVH 
c e lls  to modulate the response o f un irrad iated  rec ip ien ts  is  re la ted  
to the m igratory ch arac te ris tics  o f GVH c e lls ;  i . e .  they f a i l  to home 
to areas where they can exert th e ir  suppressive in fluence. This 
explanation is  substantiated by the find ing  th a t GVH c e lls  w il l  
suppress the response o f normal FI c e lls  in vitro (Table 16 ).
Evidence supporting the view th a t suppression is  associated
exc lus ive ly  with GVH, and not HVG, reactions comes from experiments 
in  which spleen c e lls  from mice undergoing HVG reactions were found 
to be r e la t iv e ly  in e ffe c tiv e  in  suppressing the immune response o f  
transferred  normal c e lls  (Table 15 ).
3. Id e n tity  o f the suppressor c e ll
Several d if fe re n t  experimental approaches ind icate  th a t suppression 
is  mediated by T c e lls :  1) GVH-T ce lls  p u rifie d  by a f f in i t y  chromato­
graphy suppressed the antibody response o f normal FI c e lls  both in 
vivo and in vitro\ 2) the suppressive a c t iv ity  o f GVH-T c e lls  is
abrogated completely by pretreatm ent w ith anti-Thy 1.2  (e ) serum and 
complement; 3) suppressor ce lls  are not detectable in FI mice in jec ted  
with parental spleen ce lls  obtained from T-deprived mice. A ll o f these 
findings c o n flic t  with the e a r l ie r  observations o f SjOberg (1972) who 
found th a t GVH suppressor c e ll a c t iv ity  was unaffected by an ti-Thy 1.2  
(e) treatm ent but abrogated by macrophage depletion using carbonyl iro n .
Since adherent c e lls  from GVH mice are known to in h ib it  DNA 
synthesis by tumour c e lls  in vitro (Bomford et al. 1975) i t  is  possible  
th a t the macrophage-mediated suppression o f antibody responses noted 
by SjOberg (1972) represents a non-specific  in h ib it io n  by ac tivated  
macrophages, s im ila r  to th a t present in C. parvim treated  mice (Bomford 
and O livo tto  1974). However, the lack o f e f fe c t  o f adherent c e lls  on 
antibody responses in  the present studies im plies th a t in  our p a r t ic u la r  
mouse s tra in s , activated  macrophages are not present in s u ff ic ie n t  
numbers a f te r  GVH induction to produce detectable in h ib it io n .
A fu rth e r d is s im ila r ity  is  th a t SjOberg tested fo r  suppression 
against parental ta rg e t ce lls  which were o f the same genotype as those 
used fo r  GVH induction. In the present experiments, suppression o f  
parental c e lls  was not observed (Table 12) thus re in fo rc in g  the idea 
th a t a non-specific  suppressive macrophage component was not involved.
4. O rigin o f the suppressor T ce ll
Experiments which were designed to ascerta in  whether the
suppressor T ce ll was o f parental donor or FI host o rig in  have demon­
s tra ted  unequivocally th a t i t  is  the former. This conclusion is  
based on the fo llow ing observations: 1) Suppressor a c t iv ity  is  not
diminished by pretreatm ent o f GVH c e lls  w ith alloantiserum  d irected  
against the other parental genotype present on FI host c e lls ;  2) trans­
ferred  female FI c e lls  from donors which were immune to the C57BL male 
antigen are not suppressed by C57BL male-induced GVH c e lls  whereas 
they are suppressed by C57BL female-induced GVH c e lls ;  3) sub-lethal 
ir ra d ia t io n  (600r) o f the FI host p r io r  to GVH induction does not 
abolish the development o f suppressor a c t iv ity ;  4) spleen c e lls  from 
FI mice in jec ted  with parental spleen c e lls  from thymectomized donors 
are devoid o f suppressor a c t iv ity ;  5) suppressor c e lls  are s t i l l  
generated when T ce ll-d e p le ted  FI hosts are u t i l iz e d  fo r  GVH reac tion .
Since the suppressor T c e ll is  o f parental donor o rig in  i t  is  
possible th a t suppressor a c t iv ity  would be d irected s p e c if ic a lly  
against ta rg e t c e lls  to which suppressor c e lls  are immune. This is  
substantiated by resu lts  discussed in the next section.
5. The mechanism by which suppression is  mediated
The exact mechanism by which GVH-induced immunosuppression occurs 
remains co n tro vers ia l. Lapp and his colleagues (Lapp et at, 1974; E lie  
and Lapp 1976) have ascribed the unresponsive s ta te  o f GVH mice to a 
defic iency o f a thymus ce ll product. However, th is  cannot be the sole  
mechanism as the present experiments (F ig . 2) and those o f o ther workers 
(M ü lle r 1971; Sjüberg 1972; B y fie ld  et al. 1973) have shown th a t  
responses against thymus-independent antigens are suppressed to the 
same extent as are those to thymus-dependent antigens.
The active  suppression o f normal c e lls  by GVH c e lls  in vitro 
investigated by Sjüberg (1972) was considered to have been mediated 
by macrophages, whereas the present studies have demonstrated th a t  
suppression is  mediated by T c e lls .  A ll attempts to im p licate  macro­
phages e ith e r  in vivo or in vitro fa ile d  con s is ten tly . The dep letion
o f macrophages by Sephadex G-10 fra c tio n a tio n  from GVH spleen suspen­
sions did not a ffe c t  th e ir  suppressive p roperties . When GVH spleen 
ce lls  were precultured and separated in to  adherent and non-adherent 
fra c tio n s , i t  was found th a t suppression was associated exc lus ive ly  
w ith the non-adherent population. The p o s s ib ility  th a t macrophages 
mediate suppression only in  the continuing presence o f T c e lls  was 
excluded by taking advantage o f the in vitro response to DNP-LE, 
which is  known to be independent o f macrophages (Desaymard and Feldmann
1975). GVH-T c e lls ,  p u rifie d  by a f f in i t y  chromatography, were found 
to in h ib it  completely the anti-DNP-LE response o f macrophage-depleted 
normal FI c e lls .  This find ing  provides strong evidence in support o f  
the contention th a t macrophages are not involved in  the GVH-induced 
suppression o f antibody responses.
Since the tra n s fe r o f GVH c e lls  in to  irra d ia te d  repopulated 
rec ip ien ts  even 48 hours a f te r  antigen challenge s t i l l  generates 
suppression (Table 7 ) ,  i t  appears th a t GVH c e lls  do not in h ib it  the 
response by modifying the m igratory ch a ra c te ris tics  o f tran sferred  
normal ce lls  nor by in te r fe r in g  only w ith the antigen processing or 
presentation stage. In vitro studies using the 'hot pulse' technique 
(Dutton and M ishell 1967) have shown th a t DNA synthesis s ta rts  
approximately 24 hours a f te r  antigenic stim ulation  and therefore  GVH 
c e lls  which are transferred  48 hours a f te r  antigen challenge are 
u n lik e ly  to a ffe c t  p re -m ito tic  stages. I t  is  more l ik e ly  th a t GVH- 
induced suppressor T c e lls  exert th e ir  in fluence on B c e lls  which are 
in  the stage o f active  p ro life ra t io n . Additional support fo r  an 
a n t i-p r o l ife r a t iv e  e f fe c t  comes from the observations on the sp len ic  
a c e llu la r ity  which was associated w ith the tra n s fe r o f GVH c e lls .
Spleen c e lls  from C57BL-induced GVH mice depleted o f (CBAxC57BL)Fl 
host c e lls  with anti-CBA alloantiserum  and complement, were unable to 
in h ib it  the response o f transferred  (DBA/lxC57BL)Fl spleen c e l ls ,  
w h ils t f u l ly  in h ib it in g  the response o f transferred  (CBAxC57BL)Fl
c e lls . This im plies th a t recognition and subsequent stim u lation  by 
corresponding alloantigens is  a mandatory p re -re q u is ite  fo r  the 
expression o f suppressor function . The p o s s ib ility  th a t suppressor 
ce lls  can act only against c e lls  to which they are immune is  excluded 
by the find ing  th a t: 1) (AKRxC57BL)Fl transferred  c e lls  are
suppressed completely and 2) re -ad d itio n  o f (CBAxC57BL)Fl c e lls  to 
allo antiseru m -treated  GVH c e lls  enables them to suppress the response 
of transferred  ( DBA/1xC57BL)FI c e lls .
Two recent reports have demonstrated a s im ila r  dependency on FI 
stim ulator c e lls  in  the ac tiv a tio n  o f cytoxic T c e lls  using models in  
which cytotoxic c e lls  were generated e ith e r  by GVH (Gleichmann, 
Gleichmann, Schiedewitz and Scheele 1976) or mixed lymphocyte reactions  
(F itc h , Engers, C e ro ttin i and Bruner 1976). These authors also con­
cluded th a t cytotoxic T c e lls  induced in th e ir  models were h ighly  
re s is ta n t to ir ra d ia t io n . Data from the present experiments agree 
with th is  find ing  as well as with the radioresistance o f a llo g e n e ic a lly  
activated  T c e lls  which was reported previously (Katz and Benacerraf 
1972; Sprent, Andersson and M il le r  1974). The observation th a t spleen 
c e lls  from GVH mice were suppressive when harvested imm ediately, but 
not 4 hours a f te r  ir ra d ia t io n , may be due to rad iation-induced migra­
tion  o f suppressor c e lls  away from the spleen. A lte rn a t iv e ly , i f  i t  
is  assumed th a t suppression is  mediated by a soluble fa c to r (see next 
se c tio n ), then suppressor c e lls  may continue releasing the fa c to r  
when harvested immediately, but not 4 hours a f te r  ir ra d ia t io n .
S ig n ific a n t in h ib it io n  o f antibody responses can be achieved in 
vivo and in vitro w ith suppressor to ta rg e t c e ll ra tio s  o f approximately  
1 to 10, thus making i t  u n lik e ly  th a t suppression is  mediated s o le ly  
by cytotoxic k i l l in g .  Further evidence against th is  mechanism is  the 
fa c t th a t 1) functional B c e lls  can be recovered from GVH mice and 
2) there is  no s ig n ific a n t d ifference in residual c e ll v ia b i l i t ie s  
between Marbrook cultures o f primed FI c e lls  alone or primed FI plus
GVH c e lls  (Table 25).
6. Soluble factors
Some controversy s t i l l  surrounds the question o f whether GVH- 
induced immunosuppression is  mediated by soluble fac to rs . Previous 
experiments in vivo in  which serum from GVH mice was tested fo r  
suppressive a c t iv ity  proved to be negative (B y fie ld  et al. 1973). 
Negative resu lts  were also obtained in vitro from experiments u t i l i z ­
ing double Marbrook chambers (Parthenais et al. 1974). However, in  
more recent in vitro s tud ies, serum from GVH mice was found to 
suppress both anti-SRBC and mitogenic responses o f normal spleen 
c e lls  (McMaster and Levy 1975), although i t  is  d i f f i c u l t  to ru le  out 
tox ic  e ffe c ts  from serum in experiments o f th is  type. An e a r l ie r  
report (Nelson 1973) also ind icated th a t the response o f normal c e lls  
to PHA was m arginally depressed by supernatants obtained from cultures  
o f peritoneal c e lls  from GVH mice.
The involvement o f a soluble T c e ll-d e riv e d  'fa c to r ' was 
demonstrable in  the present double Marbrook chamber experiments, where 
CBA-induced GVH c e lls  suppressed anti-SRBC PFC responses when separated 
from responding FI spleen c e lls  by a cell-im perm eable membrane. The 
lack o f suppressive a c t iv ity  by C57BL-induced GVH c e lls  in  th is  system 
corroborates the findings o f Parthenais et al. (1974). However, when 
normal FI c e lls  were added to C57BL-induced GVH c e lls  in  the inner 
chamber, suppression was evident on the other side o f the membrane. 
Since i t  is  known th a t p ro life ra t io n  in  C57BL-induced GVH reactions  
is  almost exc lus ive ly  o f donor o rig in  (Fox 1962), the lack o f 
suppression by these GVH ce lls  alone may be exp licab le  by the paucity  
o f FI host c e lls  which would be required as stim u lators . Conversely, 
the fa c t th a t CBA-induced GVH spleen contains a high proportion o f  
div id ing  FI host c e lls  (Fox 1962) is  compatible w ith the suppressive 
a c t iv ity  o f these c e lls ,  as an adequate number o f FI s tim u la to r c e lls  
would be a v a ila b le . The stim ulator c e ll is  always a va ilab le  in  an
in vivo tra n s fe r or in vitro admixture system which employs FI c e lls  
to which GVH suppressor c e lls  are immune. The lack o f suppression 
noted by Parthenais et al. (1974) in  th e ir  double chamber experiments 
may also have been due to a splenic 'takeover' by parental ce ll 
p ro life ra t io n .
The level o f suppression found when the c e ll populations were 
separated by a cell-impermeable membrane was less than th a t obtained  
when they were in  d ire c t contact. . The sim plest explanations fo r  th is  
d ifference would be e ith e r  1) d ilu tio n  o f a lo c a lly  acting fa c to r  or 
2) a high proportion o f the fa c to r may bind to FI c e lls  serving as 
stim ulators in  the inner chamber, thus making i t  unavailable on the  
other side o f the membrane.
A d ire c t comparison was made between th is  soluble fa c to r  and 
the immunoglobulin-factor (IBF) described by G is le r and Fridman (1975,
1976). One o f the c h a ra c te ris tic  features o f IBF is  the a b i l i t y  o f 
heat-aggregated mouse IgG to block i ts  suppressive action . In one 
experiment, the addition o f heat-aggregated mouse IgG to cultures o f 
normal FI and GVH c e lls  fa ile d  to abrogate the subsequent suppression, 
thereby implying th a t these two factors are d is t in c t .
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CHAPTER 2
Further characteriza tion  and mode o f action  
o f GVH-induced suppressor T c e lls
The ob jective  o f the next series o f experiments was to : 1) com­
pare the Ly phenotype o f GVH-induced suppressor T c e lls  w ith th a t o f 
antigen-induced suppressor T ce lls  and cytotoxic T c e lls ,  2) in v e s t i­
gate whether GVH-induced suppressor T ce lls  could be s e le c tiv e ly  
depleted by adsorption on FI ta rg e t c e ll monolayers and 3) explore  
the e f fe c t  o f GVH-induced suppressor T c e lls  on the function o f 
other T c e lls .
RESULTS
1. Ly phenotype o f GVH-induced suppressor ce lls
GVH reactions were induced in 600r irra d ia te d  FI rec ip ien ts  w ith  
8x10? CBA parental spleen c e lls . A sub-lethal dose o f ir ra d ia t io n  was 
given to abolish the host p ro life ra t iv e  response and thereby avoid 
d ilu tio n  o f donor-derived suppressors w ith host-derived c e lls .  This 
induction protocol was necessary since an ti-L y  and a n t i- la ^  sera are  
in  extremely short supply. In a prelim inary experiment, GVH c e lls  
induced in  th is  way were t i t r a te d  to estab lish  the minimal number usable 
which retained s ig n ific a n t suppressive a c t iv ity .  Table 23 shows the 
level o f suppression obtained by adding varying numbers o f GVH c e lls  
to 2x10? primed FI c e lls . In subsequent experiments, 2 .5 -3 x1 0 6  GVH 
c e lls  were u t il iz e d  since th is  number is  compatible with s ig n if ic a n t  
suppression and economy o f reagents.
Spleen c e lls  from 600r GVH mice were treated  with a n ti-L y  1 .1 ,  
an ti-L y  2.1 or a n t i- la ^  serum and ra b b it complement. GVH c e lls  
incubated with medium and treated  with ra b b it complement only served
T itra t io n  o f GVH- induced suppressor ce ll a c t iv ity  in vitro
Primed FI 
spleen c e lls  
+ SRBC (3x106)
GVH* c e lls Total RFC/culture^
2x10^ Nil 1,300 ± 376
2x10? 1x10? 110 ± 36
2x10? 3x106 312 ± 47
2x10? IxlOG 678 ± 67
2x10? 3x105 1,270 ± 118
4*
A rithm etic mean ± s .e . (n = 4)
*GVH reaction induced in 600r FI rec ip ien ts  8 days 
previously w ith 8x10? CBA parental spleen c e lls .
as contro ls . Treated GVH c e lls  (3x106) and SRBC as a source o f 
antigen were added to 2x10? primed FI c e lls  in  Marbrook chambers and 
PFC assays performed a f te r  4 days incubation a t 37°C in 5% C02* The 
resu lts  (Table 24) demonstrate c le a r ly  th a t suppressor a c t iv ity  is  
abrogated by pretreatm ent w ith an ti-L y  1.1 or an ti-L y  2.1 serum.
A n ti-Ia ^  pretreatm ent also produced a s ig n ific a n t (p <0.025) abrogation  
o f suppressor a c t iv ity ,  although PFC leve ls  did not reach those o f  
control cu ltu res.
The next step was to ascerta in  whether the Ly 1.1 and Ly 2.1 
lo c i were expressed on the same c e ll or whether suppression was 
mediated by a cooperative e f fe c t  between c e lls  sen s itive  to a n ti-L y
1.1 and ce lls  sen s itive  to an ti-L y  2 .1 .  GVH spleen ce ll suspensions 
were trea ted  as before w ith an ti-L y  1.1 or 2.1 serum and rab b it comple­
ment. Treated c e lls  (2.5x106) o f each group or a mixture (1.25x106 o f  
each) were added to 2x10? primed FI spleen c e lls . Table 25 shows th a t 
abrogation o f suppressor a c t iv ity  is  s t i l l  apparent in cultures which 
contained a mixture o f an ti-L y  1.1 and an ti-L y  2.1 trea ted  GVH c e lls ,  
in d ica tin g  th a t both determinants are present on the same suppressor
T c e l l .  The number o f v iab le  c e lls  present in  these cultures was also 
determined and no s ig n ific a n t d ifference found between cultures o f FI 
or FI + GVH c e lls . To estab lish  s p e c if ic ity ,  spleen c e lls  from 600r  
irra d ia te d  FI rec ip ien ts  in jec ted  6 days previously with e ith e r  8x10? 
CBA or C57BL parental c e lls  were treated  w ith an ti-L y  1.1 or a n ti-L y
1.2 serum and ra b b it complement. Treated c e lls  (2 .5x106) were added 
to 2x10? primed FI spleen c e lls  in  Marbrook cu ltu res . Despite the 
high antigen-independent background response in  th is  p a r t ic u la r  exp eri­
ment, i t  is c lea r th a t an ti-L y  1.1 serum abrogated CBA-induced GVH 
suppressor a c t iv ity  whereas C57BL-induced c e lls  were unaffected (Table  
26). The reverse s itu a tio n  is  apparent when GVH populations were 
pretreated w ith an ti-L y  1 .2 serum.
kE ffe c t o f an ti-L y  1 .1 , an ti-L y  2.1 and a n t i - la  sera 
on GVH suppressor c e lls  in vitro
Primed FI 
spleen c e lls
SRBC
(3x106)
GVH* c e lls  
(3x106)
Total PFC/culture^
2x10? + N il 5,813 ± 935
2 x lo / - N il 346 ± 102
2x10? + Treated Rct only 387 ± 27
2x10? + Treated a n ti-L y  1.1 
and RC
7,920 ± 2,643
2x10? + Treated an ti-L y  2.1 
and RC
9,653 ± 1,228
2x10? +
k
Treated a n t i - la  
and RC
2,163 ± 555
^Arithm etic mean ± s .e . (n = 3)
*GVH reactions induced in  600r FI rec ip ien ts  8 days 
previously w ith 8x10? CBA parental spleen c e lls .  
Î rC -  rab b it complement.
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E ffe c t o f a n ti-L y  1.1 or an ti-L y  1 .2 serum 
on GVH suppressor c e lls  induced by e ith e r  
CBA or C57BL parental spleen c e lls
Primed FI 
spleen ce lls
SRBC
(3x106)
GVH* c e lls  
(2.5x106)
Total PFC/culture^
2x10? + Nil 10,320 ± 654
2x10? - Nil 3,233 ± 125
2x10? + CBA-induced 
trea ted  RC*^only
3,673 ± 279
2x107 + C57BL-induced 
trea ted  RC only
3,053 ± 532
2x10? + CBA-induced 
treated  a n ti-L y  1.1 
and RC
11,933 ± 558
2x10? + CBA-induced 
treated  a n ti-L y  1 .2  
and RC
4,066 ± 1,212
2x107 + C57BL-induced 
treated  a n ti-L y  1.1 
and RC
4,113 ± 357
2x107 + C57BL-induced 7,346 ± 881
treated  a n ti-L y  1 .2  
and RC
A rithm etic mean ± s .e . (n = 3)
*GVH reactions induced in 600r FI rec ip ien ts  7 days previously  
w ith 8x10? spleen c e lls  from e ith e r  parental s tra in .
^RC -  ra b b it complement
2. In a b i l i ty  o f FI ta rg e t c e ll monolayers to adsorb GVH-induced 
suppressor c e lls
Further inform ation on the ch arac te ris tics  o f the suppressor ce ll 
was sought by attempting s e le c tiv e ly  to deplete GVH spleen suspensions 
o f suppressor c e lls  by adsorption onto FI ta rg e t ce ll monolayers. 
Confluent monolayers o f adherent FI peritoneal c e lls  were prepared by 
incubating peritoneal lavage suspensions in 50 mm p e tr i dishes a t 37°C 
fo r  16 hr. Non-adherent ce lls  were removed by thorough washing and 
1x10:^ C57BL induced GVH spleen c e lls  added to each residual monolayer. 
These m ixtures, together w ith p e tr i dishes containing GVH suspensions 
only, were incubated a t 37°C fo r  3 hr. Incubated suspensions were 
harvested and 2x10? c e lls  were in jec ted  in to  le th a lly - ir ra d ia te d  FI 
mice repopulated w ith 5x10? syngeneic spleen c e lls . Recipients were 
challenged the fo llow ing day with LE and CRBC.
The resu lts  from PFC assays performed 5 days la te r  showed th a t  
suppressor a c t iv ity  was not diminished by incubation on FI ta rg e t ce ll 
monolayers (Table 27 ). This im plies th a t suppressor c e lls  are d is t in c t  
from cytotoxic T c e lls  as the la t t e r  are known to be re a d ily  adsorbed 
by such procedures.
Several unsuccessful attempts to monitor the depletion o f cyto­
to x ic  T ce lls  were caused by technical d i f f ic u lt ie s  in  try in g  to  
demonstrate a s ig n ific a n t degree o f ta rg e t c e ll ly s is  by GVH c e lls  in  
a 6iCr release assay. In view o f the lack o f p o s itive  evidence fo r  
cytotoxic T ce ll dep le tion , these resu lts  must be accepted w ith some 
degree o f reservation .
3. E ffe c t o f GVH-induced suppressor c e lls  on GVH re a c tiv ity  
Attempts were made in a systemic GVH model to abrogate the
immunosuppression induced by in je c tin g  CBA parental c e lls  in to  FI 
rec ip ien ts  with C57BL-induced GVH spleen c e lls .  I t  has already been 
established th a t the immune response o f normal FI mice is  unaffected  
by a p r io r  in je c tio n  o f GVH ce lls  alone (Table 8 ) .  The resu lts  (Table
Attempted adsorption o f GVH-induced suppressor 
c e lls  on FI ta rg e t ce ll monolayers
900 rad FI rec ip ien ts  repopulated Number o f PFC/spleen^
w ith 5x10? syngeneic spleen c e lls LE CRBC
Nil 5,725 7,761
(3.76 ± 0 .06) (3 .89  ± 0.19
2x10? GVH* ce lls 127 <100
incubated 3 hours a t 37°C (2 .10  ± 0 .27) (<2 .00)
2x10? GVH ce lls <100 <100
incubated on FI macrophage (<2.00) (<2 .00)
monolayers 3 hours a t 37°C
^Geometric mean ± s .e . (n = 4)
*GVH reaction induced 12 days previously w ith 8x10? C57BL 
parental spleen c e lls .
The in a b i l i ty  o f GVH c e lls  to in h ib it  a systemic GVH reaction
FI rec ip ien ts Number o f PFC/spleen^
in jec ted  with LE CRBC
Nil 4.03 ± 0.08  
(10,752)
5.20 ± 0.02  
(159,422)
8x10? CBA spleen
una11engea
3.07 ± 0.06 3.28 ± 0.13
15 days
(1 ,179) (1 ,905)
8x10? CBA spleen 
+
5x10? GVH* spleen
a f te r  repopulation
3.19 ± 0.11 
(1 ,531)
3.18 ± 0.10  
(1 ,504)
Geometric mean ± s .e . (n = 4)
*GVH reaction idnuced with 8x10? C57BL spleen ce lls  
8 days previously.
28) show th a t the in je c tio n  o f 5x10? day 8 C57BL-induced GVH c e lls  
in to  FI rec ip ien ts  o f 8x10? CBA parental c e l ls ,  did not a l te r  the 
level o f suppression due to the la t t e r  c e lls  when rec ip ien ts  were 
challenged 7 days la te r .  However, since GVH spleen c e lls  f a i l  to  
modulate immune responsiveness when in jec ted  in to  normal un irrad ia ted  
FI re c ip ie n ts , y e t e f f ic ie n t ly  suppress normal FI c e lls  in vitro  ^ i t  
is  possible to argue th a t the m igratory ch arac te ris tics  o f transferred  
GVH c e lls  precludes th e ir  in te ra c tio n  w ith CBA parental c e lls .  This 
objection was circumvented by u t i l iz in g  the p o p litea l lymph node (PLN) 
local GVH assay.
In the f i r s t  experiment, FI mice were in jec ted  in one hind fo o t­
pad with CBA parental spleen c e lls ,  C57BL-induced GVH spleen c e lls  or 
mixtures o f both. The resu lts  (Table 29a) demonstrate th a t C57BL- 
induced GVH ce lls  were unable to im pair the enlargement caused by 
CBA parental c e lls  when admixed in  a ra t io  o f 1 :2 , but they profoundly 
suppressed the immune response o f transferred  normal FI c e lls  (Table  
29b). The resu lts  from a second s im ila r  experiment, using a 1:1 
ra tio  and in je c tio n  o f syngeneic FI spleen c e lls  in to  the contra­
la te ra l footpads, also ind icate  th a t C57BL-induced GVH c e lls  w il l  not 
in h ib it  node enlargement caused by CBA parental c e lls  (Table 30 ).
These experiments im ply, th ere fo re , th a t GVH-reactive c e lls  are a ffec ted  
to a much lesser extent than B c e lls  by GVH-induced suppressor c e lls .
4. E ffe c t o f  GVH-induced suppressor c e lls  on the response o f
normal FT spleen ce lls  to mitogens
The mitogenic response o f normal c e lls  to PHA and EPS in the 
presence o f GVH spleen c e lls  was investigated  to obtain add itiona l 
inform ation on the d if fe re n t ia l  s u s c e p tib ilit ie s  o f B and T c e lls  to  
suppressor c e lls .  PHA is  known to stim ulate T c e lls  p re fe re n t ia lly ,  
whereas EPS is  a B c e ll mitogen. Prelim inary studies revealed th a t  
the optimal concentration fo r  PHA was 1 y g /c u ltu re , w h ils t th a t fo r  
EPS was 10 yg /cu ltu re . The re s u lt o f the f i r s t  experiment is  shown
The inability of GVH cells to inhibit a local GVH reaction
a)
FI rec ip ien ts  in jec ted  
in to  l e f t  footpad w ith
Weight o f p o p litea l 
node (mg)
L e ft Right
PLN-index
2x107 CBA 3.69 Ï  1.46 0.56 Ï  1.14 6.65 Ï  1.49
2x107 GVH* 1.48 Ï  1.22 0.80 Ï  1.14 1.85 ? 1.26
2x107 CBA + 1x107 GVH 4.66 Ï  1.18 0.87 Ï  1.23 5.36 Ï  1.30
2x107 CBA + 5x10® GVH 3.47 Ï  1.10 0.67 Ï  1.37 5.18 Ï  1.38
^Geometric means ï s . e . ( n = 6 )
*GVH reaction induced w ith 8x10? C57BL spleen c e lls  8 days previously.
b)
900 rad FI GVH* c e lls Number o f PFC/spleen^
re c ip ie n t (2.5x10?) LE CRBC
5x10? FI - 27,039 21,988
(4 .43  ± 0 .08) (4 .34  ± 0 .10 )
5x10? FI + 257 1,518
(2.41 ± 0 .27) (3 .1 8  ± 0 .17 )
Geometric mean ± s .e . (n = 3) 
GVH c e lls  as fo r  a
Inability of GVH cells to inhibit local GVH reactions
FI rec ip ien ts  in jected Weight o f p o p lite a l
in to  footpad w ith
•t*
node (mg) PLN-index
L e ft Right L e ft Right
2x107 CBA 2x107 FI 6.25 Ï  1.15 1.22 Ï  1.18 5.12 Ï 1.23
2x107 CBA
+ 2x107 PI 5.01 Ï  1.15 1.00 Ï  1.04 5.01 Ï 1.15
2x107 GVH*
2x10? CBA
+ 2x10? FI 5.24 Ï  1.07 1.45 t  1.17 4.44 Ï 1.19
1x107 GVH
2x107 CBA
+ 2x10? FI 3.95 Ï  1.14 0.98 Ï  1.14 4.03 Ï 1.21
5x106 GVH
^Geometric mean ï s .e . (n = 6)
*GVH reactions were induced 9 days previously with 8x10? 
C57BL parental spleen c e lls .
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E ffe c t o f mitomycin C pretreatm ent on the 
mitogenic response o f normal FT and 
GVH Cells to PHA and EPS
4.
Counts per minute 
FI spleen c e lls  GVH* c e lls  (3H-Thymidine incorporation)
Nil PHA EPS
1.5x106 Nil 91 ± 7 2,244 ± 134 2,180 ± 140
1x106 5x106 257 ± 17 3,289 ± 180 1,671 ± 97
1x106 + 5x105 Mcl Nil 79 ± 3 458 ± 20 710 ± 128
l x l 06 5x106 MC 61 ± 8 591 ± 65 895 ± 67
1x106 MG 5x105 33 ± 3 83 ± 61 38 ± 2
1x106 MC Nil 30 ± 3 40 ± 6 24 ± 2
^Arithm etic mean ± s .e . (n = 4)
*GVH reactions induced 10 days previously w ith 8x10? C57BL 
parental spleen c e lls ,  
fmytomycin C treated
in  Table 31a. The add ition  o f 5x10^ day 12 C57BL-induced GVH spleen 
ce lls  to 1x1Q6 FI spleen c e lls  resulted in  a moderate in h ib it io n  o f  
the response to both PHA and IPS. In con trast, th is  same GVH popula­
tio n  produced a much greater in h ib it io n  o f antibody responses (Table 
31b). However, i t  is  possible to reconcile these d iffe r in g  leve ls  o f  
in h ib it io n  by assuming th a t the suppressor to ta rg e t ra t io  would be 
a t le a s t lOOx greater in  'c lo n a l' antibody responses than in  poly­
clonal a c tiva tio n  induced by mitogen.
The background incorporation o f ^H-thymidine by FI and GVH c e ll
mixtures in  the absence o f mitogen was s ig n if ic a n tly  elevated when 
compared to equal numbers o f FI c e lls  alone. Therefore, the next 
experiment was designed to determine the re la t iv e  contribution  o f 
each type o f c e ll suspension in  the mixtures by p re trea tin g  w ith the 
metabolic in h ib ito r  mitomycin C. The resu lts  show a s im ila r  e leva­
tio n  o f CPM in  FT + GVH c e ll cultures in the absence o f mitogen 
(Table 32). The e ffic a c y  o f the mitomycin C treatm ent is  re fle c te d  
in the negative response o f pretreated FI c e lls  to both PHA and LPS. 
However, the elevated response o f FI + GVH c e lls  in the absence o f  
mitogen is  not evident in  cultures in  which e ith e r  FI or GVH c e lls  
were pretreated w ith mitomycin C.
DISCUSSION
1. Characterization  o f the GVH-induced suppressor T ce ll
Since various sub-populations o f murine T c e lls  have been 
characterized recently  by means o f  T c e ll d iffe re n t ia t io n  an tigen ic  
markers (summarized in Table 33 ), fu rth e r  e f fo r t  was d irected towards 
typing the GVH-induced suppressor T c e ll fo r  i ts  Ly phenotype. Helper 
T c e lls  have been typed previously as Ly 1^2~3 (Cantor and Boyse 1975a; 
Feldmann et al. 1975), cytotoxic T c e lls  as Ly 1^2*3* in  CBA (Ly 1 .1 )  
mice or Ly 1 2^3^ in  C57BL ( ly  1 .2 ) mice (Cantor and Boyse 1975b) and
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suppressor T cells induced by antigen as Ly 1 2 3 (Feldmann et al.
1975; Cantor, Shen and Boyse 1976). Although both cytotoxic k i l l e r  
T c e lls  and antigen-induced suppressor T c e lls  in  Ly 1.2 mice were 
typed as Ly 1 2^3*, they have been separated according to th e ir  la  
antigen. Suppressor c e lls  are la"*" (Hammerling, Black, Segal and 
Eichmann 1976; Beverley, Woody, Dunkley, Feldmann and McKenzie 1976), 
whereas cytotoxic T c e lls  are la" (Beverley e t al. 1976).
The resu lts  from the f i r s t  re levant experiment ind icate  th a t  
GVH suppressor a c t iv ity  is  abrogated by pretreatm ent with an ti-L y  
1 .1 , a n ti-L y  2.1 or a n t i - la  sera and complement. Since the Ly 2 and 
Ly 3 a lle le s  are not s e ro lo g ica lly  separable, i t  is  concluded th a t 
CBA-induced GVH suppressor I  c e lls  are Ly 1^2^3^Ia*. By combining 
GVH populations pretreated w ith e ith e r  a n ti-L y  1.1 or 2.1 serum 
before add ition to normal FI c e ll cu ltu res , i t  was fu rth e r  shown th a t  
both the Ly 1 and Ly 2 lo c i are present on the same suppressor c e l l ,  
thereby excluding the p o s s ib ility  th a t suppression is  mediated v ia  a 
cooperative e ffe c t  between two d iffe re n t  I  c e ll subsets. The s p e c if ic ity  
of the a n ti-L y  sera was con tro lled  by reciprocal treatm ent o f CBA and 
C57BL-induced c e lls  w ith an ti-L y  1.1 or 1.2 sera (Table 26).
One important fa c t emerges from these experiments. Since the T 
c e ll which mediates the 'a llo g en e ic  e f fe c t ' was typed recen tly  as 
Ly 1^2 3 (P ic k e l, Hammerling and Hoffman 1976) and the suppressor 
c e ll in  the present studies was shown to be Ly 1^2*3*, they c le a r ly  
belong to d iffe re n t T c e ll subsets. Therefore, i t  is  h ighly u n lik e ly  
th a t the immunostimulatory and immunosuppressive influences exerted  
during GVH reactions are mediated by a common T c e l l .
Suppressor c e lls  induced by concanavalin A (Con A) (Dutton 1972),
were also typed recently  w ith an ti-L y  an tisera  (Jandinski, Cantor,
Tadakuma, Peavy and Pierce 1976). I t  was established th a t 1) Con A-
-  +  +induced ( l ik e  antigen-induced) suppressor T c e lls  were Ly 1 2 3 ,
2) Con A-induced suppressor ce lls  produce a soluble fa c to r; 3) Con A
activates both helper and suppressor T cell sub-sets.
In order to determine whether the suppressor T ce ll resides 
w ith in  the same T ce ll subset as cytotoxic  T c e lls  a se lec tive  
depletion o f GVH suspensions o f suppressor c e lls  on FI ta rg e t ce ll 
monolayers was attempted. Suppressor a c t iv ity  was not diminished by 
th is  procedure. Since cytotoxic  T c e lls  are depleted re a d ily  by th is  
same method (W igzell 1970; Mage and McHugh 1973; Bonavida and Kedar 
1974) these two c e ll populations appear to be d is t in c t . Adm ittedly, 
some reservation must be expressed about th is  in te rp re ta tio n , due to  
the lack o f pos itive  evidence fo r cytotoxic  T c e ll depletion in  th is  
p a rtic u la r  experiment.
2. Target c e ll towards which suppressor a c t iv ity  is  d irected
What is  the ta rg e t c e ll towards which suppressor c e ll a c t iv ity  
is  directed? The fa c t th a t responses to thymus-independent antigens 
are f u l ly  suppressed implies th a t a t le a s t the B c e ll is  susceptib le . 
Whether helper T c e lls  are also a ffected  to the same extent is  unknown. 
The observation th a t a llogeneic skin g ra ft  survival is  prolonged on 
GVH mice (Howard and Woodruff 1961; Lapp and M bller 1969) im plies  
th a t those T c e lls  which are involved in a l lo g ra ft  immunity are 
in h ib ite d .
The p o s s ib ility  th a t T c e lls  may be the ta rg e t o f GVH-induced 
suppressor a c t iv ity  was explored by attempting to in h ib it  GVH-reactive 
c e lls  which are known to be exc lus ive ly  T c e lls  in  both systemic and 
local GVH reactions. C57BL-induced (anti-CBA) GVH ce lls  were added 
to CBA parental spleen c e lls  p r io r  to in je c tio n  in to  (CBAxC57BL)Fl 
re c ip ie n ts . The onset and leve l o f immunosuppression caused by CBA 
c e lls  alone was not modified by the add ition  o f C57BL-induced GVH 
c e lls .  However, th is  experiment is  open to c r itic is m  because GVH 
c e lls  f a i l  to in h ib it  the immune response when in jec ted  in to  
un irrad ia ted  FI rec ip ien ts . I t  is  l ik e ly  th a t GVH c e lls  might f a i l  
to migrate to areas where in te ra c tio n  with FI host lymphocytes can
occur, particularly since GVH cells will suppress normal FI cells in
vitvo.
This objection was circumvented by u t i l iz in g  the PIN local GVH 
assay so as to contain ce ll mixtures w ith in  the in je c tio n  s ite .
Despite th is  precaution, no evidence o f suppression o f GVH re a c tiv ity  
was found even when 1:1 c e ll ra tio s  were used. In contrast to the 
negative e f fe c t  on T c e ll functio n , the same GVH-induced suppressor 
population was shown to suppress f u l ly  the antibody response o f trans­
ferred  normal FI c e lls  (Table 29 a and b ).
This d if fe re n t ia l  e f fe c t  o f GVH-induced suppressor T c e lls  on 
normal B and T c e lls  was investigated  fu rth e r  by ascerta in ing th e ir  
suppressive a c t iv ity  on normal FI c e lls  stim ulated with the mitogens 
PHA or LPS which p re fe re n tia lly  stim ulate T and B ce lls  resp e c tive ly . 
Results from the f i r s t  experiment revealed a s l ig h t ,  though s ig n if ic a n t ,  
in h ib it io n  o f PHA and LPS responses. The degree o f in h ib it io n  o f 
m itogenic ity  by GVH c e lls  was small when compared with the severe 
suppression o f antibody responses by the same GVH population. Conse­
quently , i t  is  conceivable th a t disparate or d is t in c t  d if fe re n t ia t io n  
and p ro life ra t io n  pathways are induced by antigen and mitogen 
resp ective ly . A lte rn a t iv e ly , i t  is possible th a t the suppressor to 
ta rg e t ra t io  is  considerably lower in  m itogenic ity  models in  which 
a high proportion o f the c e lls  are a c tiva ted , than in  'c lo n a l' a n t i­
body responses.
A p a rt ic u la r  po int o f in te re s t concerns the elevated background 
leve ls  o f 3H thymidine incorporation by normal FI and GVH c e ll mixtures 
in  the absence o f mitogen when compared w ith equ ivalent numbers o f  
normal FI c e ll alone (Tables 31 ,3 2 ). Even though cpm values are 
s im ila r  in normal FI or normal FI + GVH ce ll mixtures stim ulated w ith  
mitogen, the calculated stim ulation  index is  considerably lower in  
normal FI + GVH mixtures due e n t ire ly  to the elevated background. This 
was studied by p re -tre a tin g  the ind iv idual ce ll populations w ith
mitomycin C p r io r  to mixing and subsequent c u ltu re . The resu lts  
obtained demonstrate th a t the elevated background response disappears 
when e ith e r  normal FI or GVH c e lls  are p re -trea ted  with the drug.
Since normal FI or GVH c e lls  when cultured alone show low back­
ground a c t iv i ty ,  the im p lication  is  th a t a determinant on FI c e lls  is  
rendered non-stim ulatory to GVH c e lls  (or v ice  versa) by mitomycin C 
pretreatm ent.
T re iber and Lapp (1976) also showed in a recent report th a t  
antibody responses were suppressed by GVH c e lls  more profoundly than 
were delayed h yp ersen s itiv ity  responses. They argued th a t th is  was 
due to a greater s e n s it iv ity  o f helper T c e lls  than T c e lls  which 
p a rtic ip a te  in  delayed h yp ersen s itiv ity  to the GVH-induced suppressor 
c e lls . Since B c e lls  are suppressed f u l ly ,  i t  seems possible th a t  
GVH-induced suppressor a c t iv ity  could be d irected  against the la  
region o f the MHC, p a r t ic u la r ly  as la  antigens are known to be present 
on B c e lls  (but not on T c e lls )  in  high density (Sachs and Cone 1973; 
F re lin g er et al. 1974). Macrophages are also known to possess high 
leve ls  o f la  antigen (Sachs and Cone 1973) but i t  was not possible  
to ascerta in  from the present experiments whether th e ir  ro le  in  
macrophage-dependent responses is  in h ib ite d  by GVH c e lls .
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CHAPTER 3
Attenuation of GVH reactivity by azathioprine
Since azath ioprine is  used w idely to control homograft 
re je c tio n  in man i t  is  possible th a t th is  drug may act by p re fe r­
e n t ia l ly  in h ib it in g  T c e ll function . Therefore, i t  was decided to 
explore the e ffe c ts  o f azath ioprine , on a prelim inary basis, in  the 
present GVH model.
RESULTS
1. The e ffe c t  o f azath ioprine on an ongoing GVH reaction
I n i t i a l l y ,  a s ingle maximally to le ra te d  dose o f azathioprine  
was in jec ted  in to  FI rec ip ien ts  a t various times a f te r  GVH induction  
and the immune status o f these animals was ascertained 8 days post­
induction -  a time when the responses o f GVH mice are profoundly 
suppressed. The resu lts  (F ig . 8) show th a t 5 mg o f azath ioprine  
(approximately 200 mg/kg) in jec ted  i .p .  w il l  abrogate GVH-induced 
suppression most e f fe c t iv e ly  when administered 2 days a f te r  parental 
c e lls . I t  is  s l ig h t ly  less e ffe c tiv e  on days 1 or 3 and considerably  
less e ffe c tiv e  on day 7. When in jec ted  immediately a f te r  parental 
c e lls  i t  is  completely in e ffe c tiv e .
As there was some v a ria tio n  between responses in  ind iv idu al mice 
in  the group in jec ted  w ith azath ioprine 2 days a f te r  parental c e l ls ,  
in the next experiment one group o f mice was in jec ted  w ith azath ioprine  
on days 2 and 3. Table 34 shows th a t the v a ria tio n  in response o f  
ind iv idual mice given a sing le dose o f azath ioprine on day 2 and which 
is  re fle c te d  in  the large standard e rro rs , could be s u b s ta n tia lly  
reduced i f  azathioprine was administered on two consecutive days.
This e ffe c t  was explored fu rth e r by attempting to in h ib it  lymph
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Comparison o f single or consecutive in jec tio n s  
o f azathioprine (Imuran) on the abrogation 
o f GVH-induced suppression
C57BL-induced GVH mouse Number o f PFC/spleen^
in jec ted  w ith 5 mg Imuran on day LE CRBC
None 209 1,002
(2 .32  ± 0 .21) (3 .00  ± 0 .05)
0 322 2,571
(2.51 ± 0 .22) (3.41 ± 0 .21)
2 1,613 24,153
(3.21 ± 0 .40) (4 .38  ± 0 .29)
2 + 3 39,234 40,050
(4.59 ± 0 .20) (4 .60  ± 0 .07 )
^Geometric mean ± s .e . (n = 4)
node enlargement in  a local GVH assay. FI rec ip ien ts  were in jec ted  
in to  the footpad w ith 1x10? CBA parental c e lls ,  in jec ted  i .p .  w ith  
5 mg azathioprine on days 0, 1 , 2, 3 or 2+3 and the weight o f the 
p o p litea l lymph node was ascertained 7 days a f te r  parental c e ll in je c ­
tio n . Azathioprine e f fe c tiv e ly  prevented p o p litea l node enlargement, 
p a rt ic u la r ly  when given 2 and 3 days a f te r  parental c e lls  (Tables 35 
and 36).
2. Late onset o f immunosuppression in  GVH mice treated  w ith
azath ioprine
FI mice undergoing systemic GVH reaction induced by C57BL parental 
c e lls  and trea ted  w ith azath ioprine on days 2 and 3 in v a ria b ly  survived, 
whereas mice not given azath ioprine usually succumbed w ith in  3 to 4 
weeks. A group o f surviving mice was challenged 73 days a f te r  the 
in je c tio n  o f C57BL c e lls  and i t  was found th a t th e ir  response to 
SRBC was severely depressed when compared to normal FI controls (Table  
37). Since the immune response o f s im ila r ly  treated  mice was 
unimpaired when challenged 8 days a f te r  GVH induction, immunosuppression 
had not been prevented but s tr ik in g ly  delayed in  onset. An in ves tig a ­
tio n  o f the k ine tics  revealed a gradual decrease in  anti-CRBC RFC 
numbers as the time o f challenge in  re la tio n  to GVH induction is  
delayed (F ig . 9 );  however, complete suppression had not developed in  
many animals even by day 43, as is  re fle c te d  by the large standard 
erro rs .
Two p o s s ib ilit ie s  can be considered to explain  the va riab le  la te  
onset o f suppression in  GVH mice treated  w ith azath ioprine: 1) the
drug may have a se lec tive  deletory e f fe c t  on suppressor c e lls  which 
develop w ith in  a few days o f GVH induction or on th e ir  precursors. 
However, suppressor c e lls  may be recru ited  a t a la te r  stage by matura­
tio n  from donor-derived stem c e lls ;  2) azath ioprine may a f fe c t  most, 
but not a l l ,  parental donor c e lls  thus leading to a s itu a tio n  where 
the number o f GVH reac tive  c e lls  is  reduced but not e lim inated
The e f fe c t  o f in je c tin g  azathioprine (Imuran) 
a t various times a f te r  GVH induction on PLN enlargement
FI re c ip ie n t in jec ted  w ith  
1x10? CBA spleen c e lls  in to  
l e f t  footpad and in jec ted  i .p .  
with 5 mg Imuran on day
PLN-index^
None 3.47 Ï  1.19
0 2.51 Ï  1.29
X
1 2.31 ■ 1.28
2 1.57 Ï  1.19
3 2.01 ? 1.11
2 + 3 1.65 Ï  1.23
Calculated from geometric means (n = 6)
Abrogation of PLN enlargement by azathioprine (Imuran)
FI re c ip ie n t in jected  with
2x10? CBA spleen c e lls  in to  l e f t  footpad 
and 2x10? syngeneic FI c e lls  in to  r ig h t footpad
PLN-inde^
and in jec ted  w ith 5 mg Imuran on day
None 5.49 + 1.20
2 + 3 1.96 Ï  1.14
^Calculated from geometric means (n = 6)
Late onset o f immunosuppression in GVH 
mice treated  w ith azath ioprine (Imuran)
Recipient
Number o f anti-SRBC^ 
PFC/spleen
Normal FI 50,949 
(4.71 ± 0 .03)
C57BL-induced GVH* 
in jec ted  i .p .  w ith 5 mg Imuran 
on days 2 and 3
886
(2.95 ± 0 .38)
Geometric mean ± s .e . (FI -  n = 4; GVH -  n = 6) 
*Challenged 73 days a f te r  GVH induction
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e n t ire ly .  These two p o s s ib ilit ie s  were tested experim entally as 
described in  the next sections.
3. S e n s itiv ity  o f GVH-induced suppressor T c e lls  to azathioprine
in vitro
The p o s s ib ility  th a t suppressor c e lls  were s e le c tiv e ly  sen s itive  
to the drug was tested by p re trea tin g  day 12 C57BL-induced GVH spleen 
suspensions with 0 . 1, 1 or 10 yg/ml azath ioprine in vitro fo r  e ith e r  
2 or 6 hr before they were transferred  in to  le th a lly - ir ra d ia te d  FI 
rec ip ien ts  repopulated w ith syngeneic spleen c e lls .  Controls con­
sisted  o f GVH c e lls  incubated w ithout azath ioprine . Table 38 shows 
th a t suppressor c e lls  are not sen s itive  to the drug when incubated 
fo r  2 h r. There is  a marginal e f fe c t  when the incubation time was 
extended to 6 hr but, as 0.1 yg/ml o f azath ioprine is  as e ffe c tiv e  as 
10 yg/m l, i t  is  d i f f i c u l t  to a ttr ib u te  th is  to drug s e n s it iv ity  o f  
suppressor c e lls . I t  appears more l ik e ly  to re s u lt from a non -specific  
e f fe c t ,  p a r t ic u la r ly  since GVH c e lls  incubated in  medium only were 
less suppressive a f te r  6 hr than a f te r  2 h r.
4. GVH reactions induced w ith low numbers o f parental c e lls
GVH reactions were induced in FI rec ip ien ts  w ith low numbers
(2x10? or 5x106) o f C57BL parental spleen ce lls  and these animals were 
challenged a t various in te rv a ls  th e re a fte r . I f  azath ioprine treatm ent 
e ffe c t iv e ly  reduced the number o f GVH-reactive c e l ls ,  then a s im ila r  
la te  onset o f suppression should be evident in  FI rec ip ien ts  o f  low 
numbers o f parental c e lls .
The resu lts  (Table 39) ind icate  th a t the onset o f suppression 
in  FI mice in jec ted  with 2x10? C57BL parental c e lls  was not apparent 
u n til day 84 and even then i t  was only p a r t ia l .  Suppression was not 
observed in  FI rec ip ien ts  o f 5x106 C57/B1 spleen ce lls  a t any stage 
a f te r  GVH induction. Longer time in te rv a ls  could not be investigated  
as experiments were terminated due to an in fe c tio n  in  the mouse colony. 
However, these data are compatible w ith the p o s s ib ility  th a t aza th io -
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Immunosuppression in FI mice in jected  w ith low  
numbers o f C57BL parental spleen c e lls
FI mice 
in jec ted  
w ith C57BL challenge
Day o f Number o f
PFC/spleent
spleen c e lls LE CRBC
8x10?* 28 102 (2 .00  ± 0 .17) 275 (2 .44  ± 0 .13 )
2x1 O’ 17,494 (4 .24  ± 0 .12) 89,056 (4 .95  ± 0 .06 )
5x106 9,458 (3 .9 8  ± 0 .13) 83,885 (4 .92  ± 0 .05 )
None 12,342 (4 .09  ± 0 .30) 57,020 (4 .76  ± 0 .0 9 )
2x10? 42 15,369 (4.19 ± 0 .28) 67,806 (4 .83  ± 0 .04 )
5x106 12,933 (4.11 ± 0 .08) 36,491 (4 .56  ± 0 .04 )
None 22,720 (4.36 ± 0 .16) 11,503 (4 .06  ± 0 .15 )
2x10? 55 6,940 (3 .84  ± 0 .22)
5x106 16,386 (4.21 ± 0 .16) N.D.
None 6,660 (3.82 ± 0 .10)
2x10? 84 16,271 (4.21 ± 0 .17 )
5x106 N.D. 48,487 (4 .69  ± 0 .05 )
None 50,546 (4 .70  ± 0 .09 )
f Geometric mean ± s .e . (n = 4)
*F1 rec ip ien ts  o f 8x10^ C57BL spleen c e lls  did not survive past 
day 28.
N.D. not done
prine treatm ent causes a reduction in the number o f GVH-reactive 
c e lls .
5. GVH reactions induced w ith e ith e r  parental lymph node or bone
marrow c e lls
GVH reactions were induced in  FI mice w ith C57BL lymph node or 
bone marrow c e lls . These two populations were chosen as representing  
respective ly  high numbers o f  mature GVH-reactive T ce lls  and low 
numbers o f stem c e lls  or vice versa. I f  azathioprine treatm ent 
p re fe re n t ia lly  a ffected  mature GVH-reactive T c e l ls ,  then FI mice 
in jec ted  with parental lymph node c e lls  should develop suppression a t 
a la te  stage. Conversely, mice undergoing GVH reaction induced by 
bone marrow c e lls  would become immunosuppressed only as a re s u lt o f  
stem ce ll m aturation. FI mice in which GVH reaction was induced by 
5x10? o f e ith e r  o f these ce ll populations, were in jec ted  w ith  
azathioprine on days 2 and 3 and challenged w ith SRBC 126 days la te r .
The anti-SRBC RFC response in  FI mice in jec ted  w ith C57BL bone 
marrow was not s ig n if ic a n tly  d iffe re n t  from th a t o f normal FI con tro ls . 
However, the response o f FI mice in jected  w ith C57BL lymph node c e lls  
was in h ib ite d  su b s ta n tia lly  (Table 4 0 ). these resu lts  support the 
notion th a t mature GVH-reactive T c e lls  are only p a r t ia l ly  depleted  
by azath ioprine treatm ent. Whether or not stem c e lls  are also  
affected  is  so fa r  unknown, since parental bone marrow-repopulated 
animals treated  with azathioprine were not tested fo r  chimaerism.
6 . Dose o f azathioprine necessary fo r  the abrogation o f GVH reaction
The e ffe c tiv e  dose o f azath ioprine was ascertained by simple
t i t r a t io n .  Groups o f FI rec ip ien ts  in jec ted  2 days previously w ith  
8x10? C57BL parental spleen c e lls  were in jec ted  with various con­
centrations o f azathioprine and the end-point determined by cumulative  
death. Table 41 shows th a t only the highest dose (5 mg) o f azath ioprine  
successfully abrogated GVH disease.
The e f fe c t  o f azath ioprine (Imùràn) on FI mice undergoing GVH 
reaction induced by C57BL lymph node or bone marrow cel 1s
FI mice in jec ted 5 mg Imuran i .p . Number anti-SRBC PFC/spleen^
wi th on days
5x10? C57BL bone 2 and 3 53,886 " 4)
marrow c e lls (4 .73  ± 0 .04)
5x10? C57BL 2 and 3 7,019 " 3)
lymph node c e lls (3 .85  ± 0 .03)
None None
(n = 4)
54,400 
(4 .74  ± 0 .03)
^Geometric mean ± s .e .
The dose o f azath ioprine (Imùràn) required  
fo r  thé abrogation o f GVH réactions
GVH^  mice in jec ted  
i .p .  w ith Imuran on 
day 2 (mg)
M o rta lity Mean survival time ± s .e .
None 6/6 26.5 ± 2 .5
5 0/6 ' -
2 6/6 31.2 ± 2 . 8
1 6/6 29.2 ± 2 .4
0 ,5 6/6 25.8 ± 1 .4
^GVH reactions induced in  FI mice with 8x10? 
C57BL parental spleen c e lls .
7. Lack o f e f fe c t  o f azathioprine on GVH reactions induced in
s u b -le th a lly  irra d ia te d  FI rec ip ien ts
GVH reactions were induced in s u b -le th a lly  irra d ia te d  (600r) FI 
rec ip ien ts  w ith CBA parental c e lls  and these animals were in jec ted  
with various doses o f azathioprine on days 2 and 3. Since GVH 
reactions induced in  s u b le th a lly -ir ra d ia te d  FI mice with CBA parental 
c e lls  are le th a l,  cumulative death was again used as a c r ite r io n  fo r  
abrogation. In contrast to the b en efic ia l e f fe c t  o f azath ioprine in  
u n irrad ia ted  re c ip ie n ts , i t  was found th a t adm inistration o f the drug 
to irra d ia te d  FI mice resulted in  a s lig h t  shortening o f survival 
time (Table 4 2 ). The cause o f th is  e f fe c t  was not determined.
8 . Chimaerism in GVH mice treated  w ith azathioprine
Azathioprine as a treatm ent fo r  GVH disease would be o f l i t t l e
value i f  donor-derived ce lls  fa ile d  to estab lish  a chimaeric s ta te . 
Although the la te  onset o f immunosuppression in  a za th io p rine-trea ted  
rec ip ien ts  is  i t s e l f  strongly in d ic a tiv e  o f successful chimaerism, 
other tests  were also app lied . Prelim inary d iscrim inative  local or 
systemic GVH assays in  which spleen c e lls  from C57BL-induced GVH mice 
treated  with azathioprine were transferred  to fu rth e r  FI re c ip ie n ts , 
consis ten tly  fa ile d  to detect donor-derived c e lls .
Therefore, attempts were made to determine the o rig in  o f  
antibody forming c e l ls ,  a f te r  challenge w ith CRBC, o f C57BL-induced 
GVH mice treated  with azath ioprine , by p re trea tin g  spleen suspensions 
with anti-CBA alloantiserum  and complement before plaguing. The resu lts  
(Table 43) show th a t in 4 /5  GVH mice, RFC were in h ib ite d  to an exten t 
comparable with those o f normal FI controls (approximately 95%). In 
the remaining mouse PFC were in h ib ite d  only 38%, a fig u re  which is  
in d ic a tiv e  o f chimaerism.
In a second s im ila r  experiment (Table 44) in  which rec ip ien ts  
were challenged with SRBC 60 days a f te r  GVH induction, anti-SRBC PFC 
were o f FI host o rig in  in  3/6 aza th io p rin e -trea ted  GVH mice. The
Lack o f attenuation by azathioprine (Imùràh) on 
GVH reactions induced in 600r i r r a d iàtèd FI rec ip ien ts
GVH^  mice in jec ted  i .p .  with  
Imuran on days 2 and 3
Mean survival time ± s .e .
None 13.7 ± 0 .5
1 mg 9.5 ± 0 .8
2 mg 6.8 ± 0 .4
5 mg 8.0  ± 0.5
^GVH reactions induced in 600r irra d ia te d  FI 
mice with 8x10? CBA parental spleen c e lls .
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The immune response o f 900r i rràd ià tëd  FI r ë c iplehts in jec ted  
wi th spleen cel 1s from GVH mi ce treated  wi th azathi oprihe ( Imuran)
600 rad FI recip ients^ Number o f PFC/spleen^
in jec ted  with LE CRBC
1x108 syngeneic spleen c e lls  13,878 38,037
(4 .14  ± 0 .09) (4 .5 8  ± 0 .14)
2x10? C57BL spleen c e lls  N.D. N.D.
1x108 spleen c e n s  from 5,475 16,669
GVH* mice trea ted  w ith (3 .74  ± 0 .11 ) (4 .22  ± 0 .12 )
Imuran on days 2 and 3
p<0.05 p<0.025
^Mice were challenged 35 days a f te r  c e ll tra n s fe r .
+Geometric mean ± s .e . (n = 4)
*GVH rections induced 74 days previously w ith 8x10? C57BL 
parental spleen c e lls .
N.D. -  not done -  a l l  died before challenge.
remaining 3 mice fa ile d  to respond, suggesting th a t they were under­
going GVH reaction .
An attempt was made to induce GVH reactions in 600r irra d ia te d  
FI mice with 1x10® spleen c e lls  obtained from C57BL-induced GVH mice 
trea ted  w ith azath ioprine 74 days a f te r  GVH induction. This sub- 
le th a l dose o f ir ra d ia t io n  was administered to increase the s e n s it iv ity  
o f the assay. Controls consisted o f 600r FI mice in jec ted  w ith e ith e r  
1x10® syngeneic or 2x10? C57BL spleen c e lls . Mice in th is  la t t e r  group 
a l l  died by day 15 thus confirming th a t 600r had increased the a b i l i t y  
to detect C57BL parental c e lls . The two remaining groups were 
challenged w ith LE and CRBC on day 35. Table 45 shows th a t a small 
though s ig n ific a n t suppression o f RFC responses is  evident in  irra d ia te d  
FI mice repopulated with spleen c e lls  from GVH mice treated  w ith  
azath ioprine , suggesting th a t residual C57BL parental c e lls  may be 
present.
Although inconclusive, these observations imply th a t chimaerism 
is  present in  a proportion o f a za th io p rine-trea ted  GVH mice, but 
fu rth e r analysis w il l  necessitate using a more sen sitive  assay.
DISCUSSION
The effectiveness o f one or two in jec tio n s  o f azath ioprine in  
attenuating murine GVH re a c tiv ity  was demonstrated c le a r ly  in  several 
experiments. The e ffic a c y  o f azath ioprine is  c r i t ic a l ly  dependent on 
the time o f adm inistration and in je c tio n  1 to 3 days a f te r  parental 
ce ll in je c tio n  was found to be most e f fe c t iv e . The v a r ia b i l i t y  
associated with a s ingle in je c tio n  o f the drug was circumvented by 
adm inistering i t  on two consecutive days. Azathioprine also appears 
to be equally e ffe c tiv e  in  in h ib it in g  both PLN enlargement and systemic 
GVH reactions. A previous report (Owens and Santos 1971) ind icated  
th a t 6-MP was in e ffe c tiv e  in attenuating GVH disease produced in
cyclophosphamide trea ted  mice. However, drug in je c tio n  was not 
started  u n til 5 days a f te r  GVH induction, a t  a time when only sub- 
optimal e ffe c ts  were observed (F ig . 8) .  I t  is  also possible th a t  
cyclophosphamide pretreatm ent acts in  a s im ila r  manner to ir ra d ia t io n  
which has been shown to in te r fe re  w ith the therapeutic e ffe c ts  o f  
azath ioprine (Table 4 2 ).
When GVH mice which had been trea ted  w ith azath ioprine on days 
2 and 3 were challenged several weeks la te r ,  they were found to be 
immunosuppressed. In a subsequent experiment designed to in vestig a te  
the k in e tics  o f suppression, a considerable degree o f v a r ia b i l i t y  was 
noted between the responses o f ind iv idual animals. Since immuno­
suppression is  a dependable sequel o f GVH reac tio n , i ts  la te  onset is  
presumably due to an ongoing weak or moderate GVH reaction and 
attempts were made to gain some in s ig h t in to  the mechanism. The 
p o s s ib ilit ie s  considered were th a t 1) azath ioprine has a se le c tiv e  
e ffe c t  on suppressor c e lls  or 2) azath ioprine may act by de le tin g  most 
but not a l l  GVH-reactive T c e lls ,  thus leading to a s itu a tio n  s im ila r  
to in je c tin g  them in low numbers. The f i r s t  a lte rn a tiv e  was excluded 
by the find ing  th a t the GVH-induced suppressor c e ll is  not sen s itive  
to azath ioprine in vitvoy although an antecedent d if fe re n t ia t io n  stage 
may s t i l l  be susceptib le. The second a lte rn a tiv e  is  supported by 
experiments in  which GVH reactions were induced w ith low numbers o f 
parental c e lls .  M o rta lity  was not evident in  FI mice in je c te d  w ith  
2x10? C57BL spleen c e lls ,  but a marginal suppression was noted in  some 
mice when challenged several months la te r .  N either m o rta lity  nor 
suppression was observed in  FI rec ip ien ts  o f 5x10^ C57BL spleen c e l ls .  
This implies th a t a 75% reduction in  parental spleen c e ll numbers is  
s u ff ic ie n t  to avoid death. However, i t  is  also possible th a t two T 
ce ll subsets co llaborate during suppressor c e ll induction and the 
simple d ilu tio n  o f parental donor c e lls  may lead to a s itu a tio n  where 
one o f these subsets becomes l im it in g . Although data from experiments
in  which FI rec ip ien ts  were in jec ted  w ith C57BL lymph node or bone 
marrow c e lls  and azath ioprine ind ica te  th a t a proportion o f mature 
GVH-reactive c e lls  are elim inated, the contribution  o f T c e lls  which 
may have matured from parental stem c e lls  has not been resolved.
I t  was also established th a t the dose o f azath ioprine is  
c r i t ic a l ly  im portant. Reducing the amount in jec ted  from 5 to 2 mg 
prevented the therapeutic  e f fe c t .  Attempts were made using other 
assays to ascerta in  whether chimaerism was present in GVH mice 
treated  w ith azath ioprine. The d iscrim inative  GVH assay which 
detects T ce ll function , produced negative resu lts  w ith e ith e r  sys­
temic or local GVH assays. However, th is  system is  r e la t iv e ly  
in sen s itive  and a low percentage o f donor-derived ce lls  are not 
detectab le . In con tras t, the immune response o f 600r FI rec ip ien ts  
in jected  w ith spleen c e lls  from GVH mice treated  with azath ioprine  
was m arginally depressed, an observation which suggests th a t donor- 
derived suppressor c e lls  were present. I t  is  assumed th a t th is  
resulted from the raised s e n s it iv ity  o f irra d ia te d  rec ip ien ts  to 
allogeneic c e ll in je c tio n .
Results were inconclusive from two experiments in  which tests  
were made fo r  B ce ll chimaerism by p re trea tin g  RFC with anti-CBA 
alloantiserum  and complement p r io r  to p la tin g . In the f i r s t  exp eri­
ment mice were challenged 14 days a f te r  GVH induction and 
azath ioprine treatm ent. In only one mouse do the resu lts  suggest 
th a t RFC were derived from the C57BL parental population. Mice were 
challenged 60 days a f te r  GVH induction in  the second experiment and 
in  th is  case RFC from h a lf  o f the animals were in h ib ite d  by anti-CBA 
a llo a n tis e ra  to an extent comparable to those in  normal FI con tro ls . 
The remaining mice fa ile d  to respond and although th is  unresponsive­
ness is  typ ica l o f GVH reac tio n , RFC in h ib itio n s  were valueless.
Considerable e f fo r t  has been d irected  towards the use o f  
immunosuppressive drugs to control GVH disease which occurs in v a ria b ly
a f te r  a llogeneic bone marrow g ra ftin g  in  humans, even when donors and 
rec ip ien ts  are matched by HLA typing. In man, rec ip ien ts  also require  
some form o f immunosuppressive therapy, p rio r to g ra ftin g , to control 
re je c tio n ; a regime which is  not necessary in  parentaT»Fl animal 
models. Drugs which have been used to t re a t  GVH disease in  exp eri­
mental animal models include: cyclophosphamide or 6MP (Owens and Santos 
1971), azath ioprine (Nouza 1968; Skopinska, Sankowski and Nouza 1969; 
Swingle, Grant and V a lle  1973), Con A (Tyan 1975) and methotrexate 
(S torb, Epstein, Graham, Kolb, Kolb and Thomas 1974). The ra tio n a le  
fo r  such treatm ent is  to suppress or e lim inate  the GVH-reactive T 
ce ll w h ils t allowing other c e lls  (e .g . stem c e lls ,  B c e lls )  to p r o l i f ­
erate and eventually  form stab le  chimaerism
Out o f 21 patients su ffering  from a p las tic  anaemia who were 
pretreated with cyclophosphamide followed by continuous methotrexate 
therapy a f te r  g ra ftin g  with bone marrow from HLA-matched s ib lin g s , 11 
survived w ithout developing symptoms o f GVH disease (Storb et al, 1974). 
Consequently, since azathioprine is  e ffe c tiv e  across a major H-2 
b a rr ie r , i t  is  conceivable th a t extended therapy combined w ith a 
lesser degree o f antigenic d is p a rity  may produce highly s a tis fa c to ry  
protection from GVH disease. The find ing  th a t azath ioprine was not 
e ffe c tiv e  when administered to 600r irra d ia te d  FT rec ip ien ts  o f parental 
c e lls  suggests a po ten tia l disadvantage in  c lin ic a l s itu a tio n s  where 
immunosuppression o f the host is  o ften necessary to avoid g ra ft  
re je c tio n , although lower doses o f ir ra d ia t io n  or pretreatm ent w ith  
a lte rn a tiv e  immunosuppressive regimes (e .g . cyclophosphamide) may 
prove b e n e fic ia l. ALS treatm ent has also produced a s im ila r  lack o f  
protection against GVH disease in irra d ia te d  mice in jec ted  w ith  
allogeneic c e lls  (Haskovcova and Nouza 1970).
GENERAL CONCLUSIONS
These experiments have demonstrated d ec is ive ly  th a t immuno­
suppression is  a consistent development in  FI mice which are 
undergoing GVH reaction induced by adequate numbers o f parental 
lymphocytes. I t  is  concluded th a t active  suppression is  mediated by 
T c e lls  o f parental donor o rig in  and a ro le  fo r  macrophages could not 
be established. I f  i t  is  assumed th a t events in  in ta c t  GVH mice 
p a ra lle l those in  active  suppression, then suppression can be 
a ttr ib u te d  to a sub-population o f suppressor T c e lls  which arise  v ia  
a d iffe re n t ia t io n  process in it ia te d  by allogeneic a c tiv a tio n . These 
conclusions d i f f e r  from those reached both by SjOberg (1972), who 
a ttr ib u te d  suppression to macrophages, and by Lapp et al, (1974; E lie  
and Lapp 1976), who postulated th a t suppression was due to a defic iency  
of T c e ll products.
I t  seems c lear th a t B ce ll function is  affected  to a greater  
extent than is  T c e ll function . However, whereas Lapp (T re ib e r and 
Lapp 1976) ascribed th is  to d if fe r e n t ia l  s e n s it iv ity  between helper 
T c e lls  and T c e lls  which p a rtic ip a te  in  cell-m ediated immunity, the 
present experiments demonstrate th a t suppressor a c t iv ity  may be 
directed p re fe re n tia lly  against B c e lls  which are known to possess a 
high density o f la  antigen (S c h re ffle r  and David 1975), p a r t ic u la r ly  
since la  antigens are thought to be the p rin c ip le  ta rg e t in  some 
other immune phenomena, such as enhancement (S ta ines , Guy and Davies 
1974,1975).
The delayed tra n s fe r o f GVH c e lls  to ir ra d ia te d , repopulated  
rec ip ien ts  which had been challenged w ith antigen, together w ith  the 
low number o f nucleated c e lls  recovered from the spleen o f repopulated  
FI mice in jec ted  w ith GVH c e lls ,  suggests th a t some form o f a n t i­
p ro life ra t iv e  a c t iv ity  is  involved. The observation th a t GVH-induced 
suppressor c e lls  are la"*" and the find ing  th a t the number o f v iab le
c e lls  recovered from cultures o f FI or FI + GVH c e lls  are s im ila r ,  
exclude cytotoxic T c e ll k i l l in g  as a cause. Moreover, GVH-induced 
suppressor c e lls  could not be adsorbed onto FI ta rg e t c e ll monolayers, 
a procedure which re a d ily  depletes cytotoxic  T c e lls  (Mage and McHugh 
1973).
Since the same GVH suspension which v ir tu a lly  abrogates the 
antibody response o f FI c e lls  to levan has a much lesser suppressive 
e ffe c t  on th e ir  response to the B c e ll mitogen LPS, i t  is  possible  
th a t ea rly  events a f te r  trig g e rin g  are r e la t iv e ly  unaffected. Support 
fo r  th is  view comes from the recent find ing  th a t whereas the signal 
fo r d if fe re n t ia t io n  is  provided by e ith e r  mitogen or antigen, the 
signal fo r  p ro life ra t io n  is  provided exc lus ive ly  by antigen.(Nakashima 
et al, 1976). In a recent series o f experiments, the mitogenic  
response o f normal human lymphocytes was found to be in h ib ite d  by Con 
A-pretreated c e lls  (Shou, Schwartz and Good 1976). However, the 
maximum level o f in h ib it io n  observed (approximately 0 .2  log^^ or 50%) 
is  much less than th a t observed in the in h ib it io n  o f antibody responses 
(2 .0  log-jQ or 99%) when s im ila r  suppressor to ta rg e t ra tio s  were 
u t il iz e d  (Jandinski et al, 1976; Tadakuma, Kuhner, Rich, David and 
Pierce 1976). A s im ila r  dichotomy is  shown also in  the present exp eri­
ments on GVH-induced suppressor c e lls .
GVH-induced immunosuppression has been considered to represent a 
classica l case o f antigenic competition (Lawrence and Simonsen 1967; 
M üller 1971, Sjüberg 1972) but the present resu lts  are not compatible 
with th is  view, since antigenic competition occurs only between thymus- 
dependent antigens and the leve l o f suppression is  usually only 50-75% 
(Feldmann and Schrader 1974).
GVH-induced suppressor T c e lls  were typed as Ly 1 ^ 2 *3 *Ia * . These 
d i f fe r  from antigen-induced suppressor T c e lls  in  H-2  ^ mice which were 
typed previously as Ly 1 2^3^Ia* and from cytotoxic  T c e lls  which were 
typed as 1^2*3^Ia" (Beverley et al, 1976). More im portant, the recent
report (P ickel et al, 1976) th a t T c e lls  which mediate the allogeneic  
e f fe c t  are Ly 1 2 3 ind icates th a t the po ten tia tion  and suppressive 
stages o f GVH reaction are mediated by d iffe re n t  T c e ll subsets.
Thus, a merely q u a n tita tiv e  basis fo r  these two opposite e ffe c ts  o f 
GVH reaction can be discounted. Experiments in which GVH c e lls  were 
recombined a f te r  treatm ent w ith a n ti-L y  1.1 or an ti-L y  2.1 sera, show 
th a t suppression is  not mediated v ia  a cooperative e f fe c t  between two 
T ce ll populations.
Jandinksi et al, (1976) demonstrated th a t Con A-induced suppressor 
T c e lls  were able to in h ib it  the generation o f cytotoxic  T c e lls  in 
vitro. I f  th is  find ing  was to apply also to GVH-induced suppressor 
T c e lls ,  i t  may account fo r  the prolongation o f survival o f th ird  party  
skin g ra fts  on GVH mice. GVH-induced suppressor T c e l ls ,  l ik e  those 
induced by Con A, w il l  in h ib it  immune responses n o n -s p e c ific a lly .
However, Con A-induced suppressor c e lls  w il l  in h ib it  the immune 
response o f syngeneic spleen c e lls .  In  con trast, GVH c e lls  are only  
able to exert th e ir  in h ib ito ry  function a f te r  stim ulation  w ith FI 
ta rg e t c e lls  to which they are immune, but once stim ulated, they 
suppress the immune response o f c e lls  which bear d iffe re n t  major h is to ­
co m p atib ility  antigens. This type o f s p e c ific  induction o f non -specific  
suppression has been reported in  other models (Asherson and Zembala 1975; 
Yonkosky, B uffet and Bennet 1976).
One or two i .p .  in jec tio n s  o f 5 mg azathioprine (approxim ately  
200 mg/Kg), in jec ted  in to  FI rec ip ien ts  2 to 3 days a f te r  a llogeneic  
C57BL spleen c e lls ,  prevented the ea rly  onset o f immunosuppression 
and subsequent m o rta lity . At a la te r  stage a f te r  treatm ent, a variab le  
degree of suppression was noted in some animals. This degree o f  
protection obtained w ith one or two in je c tio n s  o f azathioprine has 
not, to the author's knowledge, been documented previously. However, 
lim ite d  treatm ent w ith e ith e r  cyclophosphamide (Owen and Santos 1971) 
or Con A (Tyan 1975) has produced good pro tec tive  e ffe c ts .
The most l ik e ly  mechanism o f protection by azathioprine seems 
to be a p a r t ia l e lim ination  o f mature GVH-reactive T c e lls .  This 
conclusion is  based on data from experiments in  which GVH reactions  
were induced w ith low numbers o f parental c e lls  or parental c e lls  o f 
lymph node or bone marrow o r ig in . GVH-induced suppressor c e lls  are 
in sen s itiv e  to pretreatm ent w ith azath ioprine in vitro y but the 
p o s s ib ility  th a t antecedent d if fe re n t ia t io n  stages are susceptible  
cannot be excluded.
The la te  onset o f immunosuppression in  GVH mice treated  w ith  
azath ioprine is  a sen sitive  in d ic a to r o f mild GVH reac tion . How­
ever, tests fo r  both T and B c e ll chimaerism were not e n t ire ly  
conclusive and i t  is  an tic ip a ted  th a t more sen sitive  assay systems 
(e .g . induction o f GVH reactions w ith B ce lls  which carry a llo typ e  
markers or T ce lls  with the Thy 1.1 antigen) w il l  resolve the 
problem. In view o f the c lin ic a l a c c e p ta b ility  o f aza th ioprine , 
the encouraging prelim inary resu lts  obtained from th is  model deserve 
fu rth e r  exp loration .
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